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-Abstract -
Mixed Lineage Leukaemia (MLL) refers to the protein implicated in translocating with 
over 30 partner genes to form fusion proteins that lead to the development of acute leukaemia. 
MLL mediated leukaemia predominantly afflicts children under 5 years of age or younger, and 
is associated with very poor survival rates. Although MLL shares limited homology with the 
Drosophila Trithorax (TRX) protein, both MLL and TRX are speculated to alter gene 
expression profiles by modulating higher order chromatin structures.
The work presented here introduces Drosophila melanogaster as a supplementary 
model system for understanding how MLL leukaemic fusion proteins can contribute to 
leukemogenesis. The expression in the Drosophila system of the two most widely generated 
fusion proteins in leukaemic patients, MLL-AF9 and MLL-AF4, has defined pathway(s) 
through which the proteins may interfere with to induce fly lethality. Both fusion proteins 
were found to affect higher order chromatin structure by modifying the méthylation pattern of 
histone H3 at lysine 9. Modified higher order chromatin modulates pathways targeted by 
specific MLL fusion protein, suggesting that the C-terminal portion of the fusion proteins 
triggers this step in cell cycle deregulation. Finally, the finding that late trx lethals are also 
associated with similar modified higher order chromatin structures displayed by MLL fusion 
proteins uncovered an additional role for TRX in the late development of Drosophila.
The results provide guidance in understanding why so many PcG and trxG members 
cause cancer when mutated, and suggest the existence of additional and distinct functions by 
PcG and trxG proteins at late development. The expression of MLL fusion proteins in 
Drosophila unveils relevant and concrete pathways through which particular MLL fusion 
proteins may act to prevent proper cell cycle progression. Put simply, this study links the 
targeting by MLL fusion proteins to TRX functions required for completion of late 
Drosophila development.
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- 1
Introduction
1.1 The emergence of epigenetics
Throughout evolution, the essential mechanisms involved in generating complex 
structures from a small number of undifferentiated cells have been conserved (see Section 1.2). 
The failure to properly execute these conserved pathways prevents the completion of 
embryonic development. Although epigenetic phenomena, the regulation of gene expression 
independent of DNA sequence, have been described for many decades, the accumulation of data 
demonstrating the importance of epigenetics on proper development was only very recently 
revealed.
A convincing piece of evidence supporting the role of epigenetics in development comes 
from studies involved in nuclear transfer technology. It was observed that cloning of animals by 
the transfer of isolated nuclei from somatic cells into enucleated oocytes were associated with 
high level of embryonic lethality, whereas those that survived, often acquired respiratory and 
circulatory problems and showed increase in birth weights (Wilmut et al., 1997; Kato et al.,
1998; Baguisi et al., 1999; Onishi et al., 2000; Polejaeva et al., 2000). These defects have been 
shown in part to be due to unstable gene expression of genes that have not acquired proper 
imprinting (Humphreys et al., 2001). The widespread dysregulation of genes in survived cloned 
animals, demonstrates that mammalian development appears to allow a certain margin of 
epigenetic abnormalities. The accumulation of epigenetic aberrations affecting a number of genes 
higher than the tolerated threshold, results in lethality, as observed with the majority of the 
cloned animal cases (reviewed in Rideout et al., 2001).
In this respect, it is not surprising that mutations in several epigenetic pathways are also 
correlated with cancer, namely defects in cell homeostasis. During the past decades, experiments 
directed at unravelling the mechanisms associated with abnormal cell proliferation have resulted 
in the generally accepted notion that aberration of at least two major pathways are required for a 
cell to behave cancerous. The first involves desensitizing the cell, whereas the second introduces 
modified mitogenic factors that allow cell proliferation (reviewed in Hannah and Weinberg,
2001). The recent finding of tumor inducing cell lines generated by expressing SV40 large-T 
antigen, the telomerase catalytic subunit, and H-Ras oncoprotein in human mammaiy epithelial 
cells (HMECs), support the above model, as it illustrates that compromising the defence system
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of a cell, in conjunction with the introduction of a mitogenic factor, do lead cells to uncontrolled 
proliferation (Elenbaas et a l, 2001). The observation that the microenvironment surrounding 
transformed cells influences the ability of these cells to survive and to invade normal tissue, 
reinforces previous ideas that external factors greatly impact the stability of cells (Elenbaas et al., 
2001). Furthermore, the recent demonstration that inactivation of a “nodal” or central point of a 
pathway is required to deregulate the cell cycle speaks for the redundancy of common pathways 
in mammalian cells (Chan et al., 2000). Finally, cell type has been shown to be a strong factor in 
determining which cells can be transformed. The report that epithelial cells as opposed to 
fibroblasts can accumulate mutations more easily, partly unravels why breast cancer is highly 
prevalent (Romanov et al., 2001).
Considering the points mentioned above, it becomes clear that cancer cells usually have 
compromised self-defense systems and proliferate in an unchecked manner. Given the abundance 
of different mutated signalling pathways in different cancerous cell types (reviewed in Hannah 
and Weinberg, 2001), it is likely that mutation of the basic gene expression regulation system, 
responsible for controlling the response to signalling pathways, as well as for maintaining the 
most crucial part of any cell, is likely to underlie the cancerous phenotype. This basic regulation 
system comprises the factors that control chromatin accessibility and gene expression. Several 
mechanisms that regulate gene expression have been described. Among them, epigenetics has 
emerged exponentially within the past few years. Although the molecular mechanisms by which 
epigenetics functions remain elusive, it is increasingly clear that epigenetics plays an important 
role in the biology of cancer, extending the influence of epigenetics beyond embryonic 
development, and into development after birth.
1.2 Conservation of developmental building blocks
The coordination of differentiation and proliferation for a small population of cells is 
central for the development of an organism. In insects and in mammals, mechanisms governing 
this process have been evolutionarily conserved.
The repeated, identical segments present in the Drosophila embryo, orginate ftrom a small 
set of founder cells. Each segment is defined by a unit of cell lineage. The array of embryonic
3 -
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segments subsequently diversifies to give rise to different structures, and is maintained in the 
same organisation as the adult body parts. Within each embryonic segment, or parasegment, two 
groups of founder cells are destined to either make the anterior or the posterior compartment of 
an adult segment. Consequently, the two founder cells within one embryonic parasegment give 
rise to the posterior compartment of an adult segment and to the anterior compartment of the 
next segment.
The definition of compartment has been postulated to be specified by selector genes 
acting on two sets of founder cells. The unique combination of selector gene expression in each 
founder cell population is associated with a particular type of compartment. According to the 
hypothesis, mutation in a selector gene results in an entire transformation of a given body 
compartment to another (Morata and Lawrence, 1975; Garcia-Bellido, 1975; Lawrence and 
Morata, 1994; Mann and Morata, 2000). Importantly, the faithful expression of selector genes 
throughout development is required for the determined state, indicating that selector gene 
expression must be maintained over many cell cycle generations.
The homeotic clusters were determined to be selector genes since mutations in any of the 
gene clusters resulted in entire compartment transformation. The Drosophila homeotic cluster 
comprises of two complexes, the antennapedia complex (ANT-C) and the bithorax (BX-C) 
complex. The five genes belonging to ANT-C and the three genes corresponding to the BX-C 
together pattern the identity of the embryonic segments giving rise to adult structures by 
activating specific developmental pathways. These genes act alone or in combination to generate 
specific gene expression profiles associated with particular body segments. Moreover, the 
activation of a gene at a specified parasegment is maintained posteriorly. Interestingly, the ANT- 
C and BX-C are spatially organized along the anterior-posterior (A-P) axis of the embryo 
according to their time of expression, where ANT-C genes are first expressed followed by genes 
in the BX-C. This phenomenon is referred to as “colinearity.”
Similar to Drosophila embryonic patterning, the restriction localisation of homeotic gene 
expression in mammals is necessary for the proper patterning along the A-P and other 
embryonic axes. The expression of 39 homeobox genes {Hox), grouped in four distinct homeotic 
clusters (HoxA-HoxD), determines the identity of cells giving rise to final embryonic structures 
(Krummlauf, 1994). The mammalian Hox genes, like their ANT-C and BX-C counterparts in the
4 -
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fly, are arranged in 3’ to 5’ in the clusters corresponding to their sequential time in expression, 
and more posterior HOX proteins are functionally dominant over anterior ones (Duboule and 
Morata, 1994; Mann and Morata, 2000). The identification of a specific DNA regulatory 
element upstream of the HoxD cluster, required for the proper colinear expression of HoxD 
genes, suggests that a repressive mechanism is installed to prevent more posterior genes from 
acting prematurely (Kondo and Duboule, 1999). Although the transcription initiation o f Hox 
genes occurs at the most posterior region (“Hox induction field”) of the embryo, gastrulation 
movements ensure that different cells are continually exposed to specific Hox expression profile 
at the correct time in development (Tam and Beddington, 1987; Lawson et al, 1991). Studies 
have implicated retinoic acid (RA) and fibroblast growth factors (FGFs) as potential early Hox 
inducers since alteration of either of these signals can modulate Hox gene expression (Partanen et 
al., 1998; Simeone et al., 1990). Moreover, the identification that the cdx family, the mammalian 
homologue of the Drosophila maternal caudal, controls Hox gene expression, reinforces the 
conservation of Hox genes as direct targets by early patterning factors (Subramanian et al., 1995; 
Charité et al., 1998).
In addition to the selector gene hypothesis, control of cell proliferation rate has been 
proposed to be an additional mechanism through which Hox genes may generate diversity (Dolle 
et al., 1993; Kostic et al., 1994; Hérault et al., 1999). The fact that mammals have budding-out 
segments during development underscores the impact of cell proliferation. Accordingly, 
homeotic transformations in Hox mutants have not been observed in the limb, which is generated 
by a mechanism of branching and segmentation and which is not derived from pre-existing 
modules (Duboule, 1995). The existence of altered blood cell proliferation in Hox mutants 
further substantiates the idea (Bjomsson et al., 2001; Buske et al., 2001). In addition to 
proliferation defects, anterior/ posterior transformations have been documented among different 
Hox gene mutants along the vertebral column (Rijli et al., 1993).
Although the mechanism(s) by which the Hox genes act to generate body segment 
identity in mammals encompasses additional layers of complexity as compared to flies, the 
association of two families of proteins. Polycomb group (Pc-G) and trithorax group (trx-G), has 
been shown to be essential in mammals and in flies for continued Hox gene expression beyond 
the time Hox inducers have decayed (“cellular memory”). PcG and trxG use epigenetic features
- 5 -
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for their function and elicit additional activities from nucleosome remodelling complexes and 
DNA/protein modifying enzymes to insure cellular memory.
1.3 Polycomb and Trithorax Protein Families
The PcG protein family was initially discovered by studies of mutants exhibiting 
posterior transformation of body segments in Drosophila melanogaster. Since trxG mutants 
exhibit anterior transformation of body segments, it was hypothesized that these two sets of 
protein families possess counteracting functions. Importantly, mammals mutant for PcG or trxG 
members exhibit corresponding posterior and anterior transformations. On the basis of mutant 
phenotypes, PcG members are thought to maintain repressed gene expression while trxG 
maintains activated states (Fig 1.1). With the exception of pleiohomeotic (PHO), the Drosphila 
homolog to YYl, no other PcG/trxG member was found to bind directly to DNA (Brown et al., 
1998). To date PHO has not been reported to bind to any of the other PcG/trxG members. 
Therefore, it appears that the faithful maintenance of particular gene expressions through mitosis 
by PcG/trxG involves an unknown mechanism, which tethers appropriate complexes onto 
specific response elements (Polycomb Response Elements (PREs) or trithorax Response 
Elements (TREs)) (Cavalli and Paro, 1998). A consensus DNA sequence for PREs/TREs has yet 
to be identified.
- 6
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Figure 1.1. A spaghetti model to explain PcG/trxG function. Like spaghetti, particular 
chromatin domains consist of intermingled strands coiled within one another, thereby creating 
a mostly inaccessible environment to transcription factors. However, at certain parts, there are 
strands that are able to escape the repressive force of high-order structure, and consequently, 
form an activated domain. PcG and trxG members are classically thought to maintain 
specified gene expression by acting through these high-order chromatin structures. PcG 
facilitates the formation of heterochromatin-like structures, allowing repression of gene 
targets, while trxG counteracts this obstruction through its nucleosome remodelling activities.
1.3.1 Insights into PcG mechanism(s)
The PcG family appears to require inactive templates determined by early patterning 
transcription factors for repression. Two hypotheses have been formulated to account for PcG 
repression, which can only occur in cells, which lack enhancer activity (Poux et al., 1996; Poux et 
al., 2001). The first explanation postulates that PcG complexes are stabilised by similar 
molecular chromatin structures exhibited by the repressed locus, whereas the second considers 
PcG repression as a default state for PREs. In the latter case, actively transcribed genes would 
have to prevent the assembly or destabilisation of PcG complexes.
PcG repressed chromatin structure has been explained by the ability of PcG complexes 
to spread to adjacent genes, generating a repeated array of heterochromatin-like structures (Paro,
1990), or alternatively, by the formation of PcG repressed higherorder chromatin structures over
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long distances (Pirotta, 1998). Studies of PcG regulated genes in vivo appear to support the 
second explanation as to how PcG may repress its target genes. Chromatin formaldehyde cross 
linking immunoprécipitation (X-Chip) experiments revealed that PcG members bind to PREs 
and to promoter regions, and appear to not spread significantly to adjacent DNA sequences 
flanking the PREs (Orlando and Paro, 1993; Strutt et al., 1997; Orlando et al., 1998). The dual 
binding by PcG members at the promoter and at PREs is reminiscent of enhancer-promoter 
scenarios where protein-protein interactions are required to bring enhancers close to promoters 
for transcription activation. Analogously, PcG members may ensure inactivity of target genes by 
joining PREs and promoters via PcG interaction. In support of this idea is the long time 
observation that PcG repression is dependent on protein dosage and is pairing sensitive, and can 
compete with transcription factors for DNA binding (Francis and Kingston, 2001; Hodgson et 
al., 2001; Zink and Paro, 1995). The recent report that general transcription factors (GTFs) are 
present at PcG repressed loci proposes that PcG may also somehow inihibit GTFs from 
activating transcription (Breiling et ah, 2001). A similar mechanism has been suggested for SIR 
(Silent Information Regulatory) proteins, which are involved in heterochromatin silencing. Here, 
evidence has demonstrated that SIR blocks a step downstream of the recruitment of the RNA 
polymerase II pre-initiation complex, rather than limiting factor accessibility (Sekinger et ah, 
2001). Furthermore, DNA accessibility is not altered in PcG-repressed loci as would be expected 
if spreading by PcG complexes indeed coat the DNA fiber (McCall and Bender, 1996; Boivin 
and Dura, 1998), although a recent study has demonstrated that transcription and site-specific 
recombination are restricted in Po/ycow6-repressed segments (Fitzgerald and Bender, 2001). In 
this respect, an interesting consideration is that distinct bindings by PcG at particular sites, as 
indicated by X-Chip experiments, could in fact represent spreading of PcG complexes along 
higher order chromatin fibers, which would not be dependent on the DNA sequence (Francis and 
Kingston, 2001).
The findings that PcG members aggregate at discrete nuclear domains in both the mouse 
and the fly implicate nuclear domains as an additional mechanism for PcG silencing. The well- 
established observations of telomere silencing in yeast, of centromeric silencing in mammals, and 
of limited gene activity by boundary insulators in Drosophila suggest that nuclear 
compartmentalization may be important for gene silencing. The association of different
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developmental genes with scaffold associated regions (SARs) for proper development in 
Xenopus underscores the relevancy of nuclear domains in development (Vassetzky et ah, 2000). 
Although not much is known about PcG bodies, the fact that these bodies have been observed in 
human cell lines and in nuclei of Drosophila embryos suggest that nuclear domains are required 
for proper PcG action. In support of this speculation is the association of the disruption of 
promyelocytic leukaemia (PML) bodies with acute leukaemia by the PML-RARa fiision 
(Hodges et ah, 1998).
1.3.2 Identification of two classes of PcG complexes
Co-immunoprecipitation data and chromatin immunoprécipitation results of PcG and 
trxG members have confirmed the significance of protein complex mediated function, since 
colocalisation of PcG and trxG members at particular chromosomal response elements was 
observed (Zink and Paro, 1989; Franke et ah, 1992; DeCamillis et ah, 1992; Rastelli et ah, 1993; 
Chinwalla et ah, 1995; Tripoulas et ah, 1996). For PcG members, two classes of complexes have 
been reported. The first appears to play a role in the initial establishment of PcG silencing, while 
the second may take over the maintenance function once PcG silencing has materialised.
The first class consists of PcG complexes comprised of Enhancer of Zeste (E(z)) and 
Extra Sex Combs (Esc). The association between E(z) and Esc appears to form the core of this 
complex (Tie et ah, 1998; Jones et ah, 1998). In addition, Rpd3 histone deacetylase and p55, a 
histone-binding protein found in the NURF nucleosome remodelling complex, have been 
reported to bind to this complex core (Tie et ah, 2001). The early Esc expression in development 
and the transient requirement of Esc during PcG silencing suggested that Esc containing 
complexes may only function during the early stages of PcG repression (Simon et ah, 1995; 
Struhl and Brower, 1982). Unlike Esc, E(z) is important for additional PcG binding onto 
chromosomes in later embryonic stages, indicating that E(z) is required for continuous 
repression of at least some PcG target sites (Rastelli et ah, 1993).
Recently, the second class of PcG complex, PRCl (Polycomb Repressive Complex 1), 
was purified and was found to consist of PC (Polycomb), PH (Polyhomeotic), PSC (Posterior 
Sex Combs), and SCM (Sex comb midleg) (Saurin et ah, 2001). In addition to PcG proteins.
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cytoskeleton components, histone deacetylases, and pol II associated proteins have been 
reported to stably associate (Saurin et ah, 2001). Although not much is known on how PcG 
complexes repress their target loci, the ability of PRCl to bind to PREs and to prevent 
nucleosome remodelling by the SWI/SNF complex implies that PRCl acts at the nucleosome 
level for its silencing function (Shao et ah, 1999). In support of this, Pc has been reported to 
bind to core histones (Breiling et ah, 1997).
1 3 3  TrxG function depends on chromatin remodelling activities
The trxG family consists of a diversified repertoire of proteins. Members of this family 
have been reported to remodel nucleosome via ATP dependent activity and to modulate 
chromatin structure by yet undefined mechanisms. Since trxG members are associated with 
chromatin, trxG mediated activation of genes appears to occur at the chromatin template.
The best studied nucleosome remodelling complex in Drosophila is the brahma (Brm) 
complex which is analogous to the SWI/SNF family of chromatin-remodelling complexes 
(Tamkun et ah, 1992; Papoulas et ah, 1998; Kal et ah, 2000). The Brm complex is composed of 
around ten proteins, including Mor (Moira), Snrl (Snf5-Related 1), and Osa (Crosby et ah,
1999; Dingwall et ah, 1995; Collins et ah, 1999). Brm, Mor and Snrl appear to form the core of 
this complex, while Osa has been speculated to specify target genes for Brm activity (Collins et 
ah, 1999). The Brm complex, like the SWI/SNF remodelling complex in yeast, uses ATP energy 
to change nucleosome structure, either to permit or to prevent gene activity. In particular, 
SWI/SNF remodelling includes the ability to slide nucleosomes, to transfer histone octamers to 
naked DNA, to alter nuclease susceptibility and the topology of closed circular nucleosomal 
templates (Flaus and Owen-Hughes, 2000; Vignali and Hassan, 2000). In addition to the above 
complex, Brm has been reported to associate with ASHl and ASH2 to form to distinct 
complexes (Papoulas et ah, 1998).
The direct association of TRX (Trithorax) protein with Snrl suggested that recruitment 
of nuclesome remodelling may be essential for opening of chromatin mediated by TRX 
(Rosenblatt-Rosen et ah, 1998). In addition, the interactions between ASHl (Absent, Small, 
Homeotic discs; Tripoulas et ah, 1994) and TRX and between ASHl and histone 
acetyltransferase, CBP (CREB Binding Protein; Kamei et ah, 1996), implies that modification of
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the N-terminal sequences of histones also acts to keep chromatin open (Bantiginies et ah, 2000; 
Rozovskaia et ah, 1999; Petruk et ah, 2001). On the other hand, recruitment of SWI/SNF or Brm 
activity by Osa to repressive Wingless target genes expands an emerging theme that depending 
on the chromatin context, trxG members may also suppress gene activity (Collins et ah, 1999).
In support of this, GAGA, which is encoded by trithorax-like, synergises with another 
remodelling complex, NURF for its activity and has been found to interact in vitro with PcG 
complexes (Tsukiyama et ah, 1995). Likewise, Zeste, another trxG member, has been reported to 
function in both trxG-mediated activation and PcG-mediated repression (Rastelli et ah, 1993; Kal 
et ah, 2000). GAGA and Zeste both bind to unique DNA sequences, and have been postulated 
to recruit both PcG and trxG complexes (Kal et ah, 2000; Gildea et ah, 2000).
The isolation of TAG 1 (Trithorax Acétylation Complex 1) demonstrated that trithorax 
(TRX) in association with CBP is required for the proper regulation of gene expression of the 
homeotic gene, ubx (ultrabithorax) (Petruk et ah, 2001). Like the TRX mammalian counterpart 
MLL (Mixed Lineage Leukemia), TRX was found to stably interact with Sbfl (see Section 
1.3.6). Sbfl and CBP appear to be closely linked in the maintenance of Hox gene expression, 
presumably through their interaction with TRX (Petruk et ah, 2001).
1.3.4 Dual functions for limited members of the PcG/trxG families
PcG and trxG members are not just responsible for the maintenance of gene repression 
and activation, respectively, as briefly discussed in Section 1.3.3. Mutants of different members 
of both families have been found to exhibit both maintenance of activated and repressed gene 
activity. The best example to date is E(z), which although classified as a Polycomb group 
member, can actually maintain activated gene expression (LaJeunesse and Sheam, 1996). Recent 
work by the Sheam laboratory has clearly affirmed the dual function for PcG and trxG proteins. 
The authors identified several PcG members in a screen for enhancers of a trxG mutant, ashl 
(Gildea et ah, 2000). Three conclusions can be extrapolated from the study. The first is that 
trxG and PcG members interact with one another in the establishment of a functional complex 
regulating gene expression. Second, although it was previously thought that PcG and trxG have 
separate binding sites, termed PRE and TRE, respectively, it is clear that certain members from
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both groups can bind to the same response element. The documentations that the PRE and TRE 
within the regulatory element {hxd) of ultrabithorax, in the BX-C, partially overlap, as well as 
the modulation of Fab-7 (a PRE regulator of Abdominal B gene in the BX-C) mediated 
repression by both trxG and PcG genes, already hinted to this idea (Tilib et ah, 1999; Cavalli and 
Paro, 1999). Finally, in addition to a PcG and trxG group family, a third family of proteins 
involved in the maintenance of gene expression appears to exist. This third group, ETP 
(Enhancer of trithorax and Poly comb), includes members of PcG and trxG which exhibit the dual 
property of maintaining both activated and inactivated states (Gildea et ah, 2000). In the light of 
these new results, it has been suggested that elements bound by both PcG and trxG members 
should be renamed to MEs for Maintenance Elements (Brock and van Lohuizen, 2001).
1.3.5 PcG /trxG conservation in mammals
Like in Drosophila, mammalian PcG/trxG members are also responsible for maintaing the 
correct expression of homeotic and other unidentified target genes. Conservation of PcG/trxG 
function hotxiQon Drosophila and mammals has been well documented (Table 1.1; Gould, 1997; 
van Lohuizen, 1999; Brock and van Lohuizen, 2001). In addition to the similar homeotic 
transformation of trxG/PcG mutants in mammals and in flies, the best examples supporting 
PcG/trxG conservation include: (i) the demonstration that M33, a mammalian PC homologue, 
functionally rescues, at least in part, pc null mutants, and (ii) that Bmi-1, a mammalian Psc 
homologue, co-localised with Pc on polytenes, indicating that Bmi-1 can integrate into functional 
PcG complexes (Müller et al., 1995; Sharp et al., 1997).
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Drosophila proteins Mammalian Homologues
PcG
Polycomb M33,MPC2
Polyhomeotic Mphl/rae28, Mph2
Extra sex combs EED
dRing Ringla, Ringlb
Pleiohomeotic YYl
Polycomb-like PHFl
d-Mi2 Mi2
Multi sex combs --
Super sex combs --
trxG
trithorax MLL
ashl hASHl
brahma mBrm, BRGl
Snf5 Related 1 (Snrl) hSnf5/inil
ETP
Additional sex combs Asxll, Asxl2
Enhancer of Polycomb Epcl,Epc2
Sex combs on midleg Scmll, Scml2, Scmhl
Posterior sex combs Bmi-1, Mel 18
Enhancer of Zeste Enxl,Enx2
Suppressor of zeste 2 Bmi-l,M ell8
Table 1.1. PcG/trxG members are conserved between mammals and flies. PcG: 
Polycomb Group, trxG: trithorax Group, ETP: Enhancer of trithorax and Polycomb.
Based on the heterogeneous phenotypic patterns in PcG null mutants, two classes within 
the PcG family can be considered to exist. The first class is termed PcG initiating (PcGi), the 
members of which first take over the function of early repressors during development. Mutants 
of these proteins cause very early lethality in mouse development (Bed and Enxl/EZH2). The 
second class comprises the more classical PcG proteins such as M33, Bmi-1, Mel-18, RinglB, 
and so forth, and is called PcG maintenance (PcGm). This set of proteins is proposed to 
function by stabilising gene expression of early embryogenesis. Mutants of PcGm in general 
cause subtle morphological transformations, due to slight derepression of Hox gene clusters.
Unlike in Drosophila, the partial redundancy present in the mammalian system, 
especially seen for the PcGm proteins, provides an additional layer of complexity in gene 
regulation. As an example, Bmi-1 and Mel-18 were found to be homologues of the Drosophila 
melanogaster Posterior Sex Combs (Psc). Psc is a member of the PcGm family. Bmi-1 null
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mutant mice show only subtle anterior shifts of certain Hox gene expression boundaries during 
development. Mel-18 -/- mice likewise, display similar subtle defects (van der Lugt et ah, 1996; 
Akasaka et ah, 1996). The clear indication that Mel-18 and Bmi-1 overlap in function, was 
provided by double null mutant mice (Mel-18 -/-, Bmi-1 -/-) whose phenotypes are more severe 
than the single mutants (Akasaka et ah, 2001). These mice die at an earlier stage at B9.5 in 
development and are characterised by severe, aberrant Hox gene expression boundaries. In 
addition to Mel-18 and Bmi-1 null mice, M33, a Drosophila Pc homologue, and Bed, a 
Drosophila homologue of Esc, have also been generated. Like the single null mutant mice, M33 
null mice exhibit weak posterior skeletal transformation, indicative of a polycomb-like function 
and of additional mammalian proteins with similar functions (Core et ah, 1997). However, in 
contrast to most PcGm members. Bed, a PcGi protein, exhibited early embryonic lethality 
(Schumacher et ah, 1996).
Co-immunoprecipitation experiments have shown that like in Drosophila, mammalian 
PcG members are stably associated in protein complexes. Two such different complexes have 
thus far been identified. One consists of PcGi members including the mouse homologues of 
Drosophila E(z), Enxl and Enx2, and o f Drosophila Esc, Bed (van Lohuizen et ah, 1998; Seewalt 
et ah, 1998; Ng et ah, 2000). As discussed above for the Drosophila E(z)/Esc complex, the 
mammalian counterpart has also been postulated to provide the first recognition of PcG onto its 
regulatory sites, as exemplified by the report that in eed -/- mutants, arrest in development 
occurs prior to Hox gene expression (Simon et ah, 1995). The second complex constitutes 
interactions among members of PcGm, M33, MPc2, Mphl/rae28 and Bmil or Mel-18, and is 
analogous to the Drosophila PC, PH and PSC complex (Alkema et ah, 1997; Strutt et ah, 1997).
Likewise, the activities of trxG members in the regulation of Hox genes in mouse have 
been well conserved both in structure and in function. MU (Mixed Lineage Leukemia) knock-out 
mice, the mammalian homologue of Drosophila trithorax, die at El 0.5 showing multiple 
patterning defects in neural-crest derived structures (Yu et ah, 1995; Yu et ah, 1998). 
Heterozygous mice display anterior and posterior homeotic transformations. Similar to mutants 
of trithorax, correct initiation of Hox genes expression is observed in MU -/- embryos, but 
subsequent maintenance of this expression is lost. The reports of trxG misregulation with 
alterations in cell proliferation have also implicated control of cell cycle as a regulatory target by
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certain trxG members. For example, the hBRM and BRG-1, murine homologues of Drosophila 
Brm, were found to bind to “active” retinoblastoma (Rb) protein to induce cell cycle arrest 
(Dunaief et ah, 1994; Zhang et ah, 2000). hBRM may recruit the activities of the SWI/SNF 
remodelling complex to regulate gene activity (Reyes et ah, 1997). The reduction of hBRM levels 
appears to facilitate cell transformation (Muchardt et ah, 1998), whereas the human homologue 
of SNF5 (encoded by the Inil and homologous to Drosophila Snrl) has been identified as a bona 
fide tumour suppressor (Versteege et ah, 1998; Klochendler-Yeivin et ah, 2001). The regulation 
of cell cycle control is not only limited to trxG members, but also involves the actions of PcG 
(see Sections 1.3.6 and 1.4.3).
1.3.6 New roles for PcG and trxG members
PcG and trxG members are classically thought to act only at the chromatin fiber of 
developmental genes, like homeotic clusters, in maintaining proper gene expression. However, 
several observations linked chromatin proteins with cell cycle regulation. The identification of 
functional activities by several motifs shared among PcG/ trxG members is potentially insightful 
in elucidating the mechanisms behind PcG/ trxG actions. The pioneering works are described in 
detail below.
Studies with Bmi-1, the mouse homologue of Psc, first provided evidence that PcG- 
mediated regulation directly targets cell cycle control genes. In Bmi-1 overexpressing mice, two 
tumour suppressor genes within the ink4a locus were found to be downregulated, thereby 
demonstrating that immortalisation of lymphoid cells overexpressing Bmi-1 is possible (Jacobs 
et ah, 1999a; Jacobs et ah, 1999b). Additional data with Bmi-1 knock-out mice showed for the 
first time a mammalian target gene directly regulated by a PcG group member (see Section 1.4.3; 
Jacobs et ah, 1999). Since then, HPC2 (the human homologue to Drosophila Pc) in conjunction 
with Ringl (the human homologue to Drosophila dRing), has been demonstrated to be important 
for cell cycle arrest by Rb (Dahiya et ah, 2001). In addition, Eed has been shown to antagonise 
Bmi-1 effects on blood cell proliferation, demonstrating that like in Drosophila, some PcG/trxG 
proteins exhibit a dual function in both repressing and activating target genes (Lessard et ah,
1999).
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A second link with cell cycle regulation has been identified by studies on the SET 
domain. The SET domain was initially identified as a homology region among three proteins, 
Su(var)3-9, Enhancer of Zeste (which belong to the PcG family of proteins; Jones et ah, 1990), 
and Trithorax (Tschiersch et al., 1994). For years, the possible role of SET remained elusive, 
although it was becoming apparent that proteins belonging to both PcG and trxG contained the 
SET domain. Interestingly, it was shown that SET domains are able to interact with other SET 
domains as well as with chromatin remodelling proteins (INI1/SNF5) (Rozenblatt-Rosen et ah, 
1998; Rozvoskaia et ah, 2000). A clue to the role of SET in cell cycle regulation was revealed by 
the finding that the SET domains of mammalian MLL, of Drosophila E(z), and of yeast SETl 
interact with Sbfl, a member of the dual-specificity phosphatase family (dsPTPases) (Cui et ah,
1998). The dual-specificity phosphatase family includes myolotuburin, which is involved in X- 
linked myotubular myopathy, and Sbfl. The interaction between Sbfl and the SET domain is 
interesting, since Sbfl contains an inactive phosphatase domain. Importantly, it is known that 
proteins containing a phosphatase domain, whether active or inactive, can bind to a 
phosphorylated target protein. It was suggested that possibly MLL, when phosphorylated, is 
bound by Sbfl. This binding may shield MLL Jfrom associating with its endogeneous, active 
dsPTPases, and thus, allows continued proliferation by possibly maintaining the MLL 
phosphorylated form. Indeed, overproduction of Sbfl in NIH 3T3 cells causes cell 
transformation (Cui et ah, 1998). These experiments point to the involvement of proper MLL 
activity in cell cycle regulation.
Furthermore, the SET domain of human Su(var)3-9 (hSUV39Hl) was shown to 
remarkably possess methylating activity of histone H3 (Rea et ah, 2000). This activity, 
however, was not present in all SET domain-containing proteins. Most importantly, MLL was 
found to lack this particular methylating activity. In the prototypic protein Su(var)3-9 it turned 
out that in addition to the SET domain, adjacent regions with high cysteine content, were 
required for the activity. If these cystein-containing regions were mutated or absent (as is the 
case in other proteins containing the SET domain), the H3-methylating activity was lost. 
Moreover, the group was able to modulate the activity by introducing marks on histones. In 
particular, they focused on the phosphorylation of H3 normally found in condensed, 
heterochromatic chromatin. When phosphorylated histones were offered as a substrate to
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Su(var)3-9, méthylation of H3 was not detectable. Likewise, in the reciprocal experiment, 
méthylation of H3 histone prevented subsequent phosphorylation. It appears that modification 
of histones by specific SET domains is tightly regulated to cell cycle dependent modulation, 
since aberrant mitotic divisions were observed in hSUV39Hl mutant cells. Moreover, the 
finding that HPl and H3 méthylation are recruited to cell cycle genes by the Rb protein further 
indicates that this type of mechanism plays an important role in the regulation of cell 
proliferation (Nielsen et al., 2001).
Since Su(var)3-9 is involved in heterochromatic silencing and thus affects position effect 
variegation, it was suggested that méthylation by Su(var)3-9 provides a code for additional 
silencing proteins to dock onto heterochromatic sites (Rea et al., 2000). This mechanism has 
been found to be conserved across species. The C. elegans homologue Clr4, like the human and 
Drosophila Su(var)3-9, is able to methylate histone H3. Also, a recent report shows that Swi6, 
the fission yeast homolog of HPl, can only bind at heterochromatic regions when H3 is 
methylated, and that the phosphorylation of serine 10 inhibits méthylation and consequent 
binding of Swi6, demonstrating an analogous system as found in human cells (Nakayama et ah, 
2001). Moreover, deacetylation of H3 Lysl4 by Clr3 and the presence of a WD-40 containing 
protein, rikl, were required prior to méthylation of histone H3. In light of these recent 
demonstrations, there appears to be a layer of regulation, which ensures that correct targets are 
methylated, and that this layer is regulated by the interaction, either directly or indirectly, of 
several epigenetic factors.
In addition to the role of the SET domain in cell cycle control, several other domains 
shared among the proteins in the PcG and trxG families, have emerged to associate with specific 
functions. These include WD repeats, RING fingers, bromodomain and chromodomain. The 
RING domain of the RNF2/RinglB protein has been shown to exhibit E3 ubiquitin ligase 
activity, implicating proteolytic degradation of histones or unknown targeted proteins as a 
possible regulatory mechanism (Lee et ah, 2001). The bromodomain recognises acetylated 
modified histones (Dhalluin et ah, 1999; Winston et ah, 1999; Owen et ah, 2000), whereas direct 
evidence for the function of WD repeats, other than units mediating protein-protein interaction, 
is lacking.
- 17-
Introduction
On the other hand, the chromodomain appears to have diversified in its function in vivo. 
Initially, the chromodomain was found to be shared between two proteins. Polycomb and 
Heterochromatin Protein 1 (HPl) (Paro and Hogness, 1991). Both proteins are responsible for 
repression of gene expression. The artificial exchange of the chromodomains between Pc and 
HPl revealed that the chromo domain was responsible for targeting Pc or HPl to its correct 
target site of action (Platero et al., 1995). Because the chromodomain did not bind a DNA 
sequence specifically, it was postulated that targeting by the chromodomain occurs through 
protein-protein interaction. Interestingly, HPl was found to bind to the H3 tail methylated at 
Lys 9 via its chromodomain (Lachner et ah, 2001, Bannister et ah, 2001). Additionally, the 
interaction between the chromodomain and untranslated rox RNA was required for proper 
dosage compensation of the X chromosome in Drosophila (Akhtar et ah, 2000). What prevents 
the chromodomain from randomly interacting with various elements is not known. Probably, the 
flanking protein sequences endow at least in part chromodomain’s specificity.
1.3.7 The histone code
Although modified histones have been known to exist for over three decades, their 
importance has re-emerged with the recent identification of several trxG/PcG members’ ability to 
modify histones and/or their association with histone-modifying enzymes. The histone code 
hypothesis has been formulated to incorporate histone modifications as a set of information 
affecting regulation of gene activity (Strahl and Allis, 2000; Turner, 2000).
The histone code centralises on the assumption that signalling pathways converge on 
histones (Cheung et ah, 2000). The various covalent modifications on the N-terminal tails of 
histones, such as acétylation, phosphorylation, méthylation, ubiquitination, and ADP- 
ribosylation, provide a signal for different epigenetic regulators to bind and to regulate gene 
activity. The hypothesis also predicts that many modifications of histone tails can occur within 
the same nucleosome. An extension to this idea is the “nucleosome code”, which postulates that 
euchromatin and heterochromatin domains are dependent on their convalent nucleosome 
modifications (Turner, 2000; Jenuwein and Allis, 2001). Depending on the composition of the 
modified nucleosomes, various epigenetic states can be created that would impinge on the ability
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of a cell to proliferate or to differentiate. It should be stressed that modification on histones at 
various residues, other than the ones described below, have been reported, although functional 
significance for those modifications is lacking.
Several covalent modifications have been reported and have been correlated with either 
gene activity or repression, as well as other cellular processes, as depicted in Table 1.2. The fact 
that single acétylation of histones can be associated with both repressed and active loci enforces 
the idea that probably the combination of various types of covalent modifications within one 
nucleosome, reflect a specific signal. In addition, multi-modified nucleosomes are apparently 
created by a dynamic interplay between various enzymatic complexes responsible for particular 
histone modifications. To date, the best understood example illustrating these concepts is the 
coordinated actions of various enzymes, which modulate the tail of histone H3. As described in 
detail and in connection with the cell cycle above (see Section 1.3.6), phosphorylation at serine 
10 of H3 by the Ipll/aurora kinase inhibits méthylation of H3 at lysine 9 by hSUVAR39Hl 
(Rea et ah, 2000). If H3 at serine 10 is phosphorylated, a tendency for acétylation at lysine 14 
of H3 by the GCN5 family (Brownell et al., 1996) is increased. The combination of H3 
phosphorylation at serine 10 and acétylation of lysine 14 of H3 creates an epigenetic tag for 
transcription (Kuo et ah, 1996; Lo et al., 2000; Clayton et al., 2000). This tag is also influenced 
by acétylation of H3 at lysine 9, since a peptide containing acetylated lysine 9, can still be 
phosphorylated at serine 10 (Krebs et ah, 1999). In Drosophila, a similar scenario has been 
reported where phosphorylation of H3 at serine 10 in conjunction with acétylation of H4 at 
lysine 16 allows enhanced transcription activity firom the male X-chromosome (Jin et ah, 1999; 
Turner et ah, 1992).
Interestingly, the same phosphorylation tag at H3 serine 10 has been a marker for 
condensed chromosomes during mitosis (Bradbury, 1992; Koshland and Strunnikov, 1996), and 
has been linked with the gene expression of c-jun, c-fos, and c-myc (Mahadevan et ah, 1991; 
Chadee et ah, 1999). The recent characterisation of an additional phosphorylation site of H3 at 
serine 28 preferentially associated with mitotic chromosomes suggests that co-phosphorylation 
of H3 at serine 10 and 28 marks condensed chromosomes (Goto et ah, 1999). Analogously, HI 
has been reported to be phosphorylated in mitotic chromosomes and its phosphorylation has 
been linked to transcription (Bradbury, 1992; Koshland and Strunnikov, 1996; Dou and
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Gorovsky, 2000). Other cellular processes, such as apoptosis and DNA damage, have been 
associated with H2B and H2A phosphorylation, respectively (Rogakou et ah, 1999; Ajiro, 
2000).
In addition to phosphorylation and H3 acétylation, H4 acétylation has been widely 
documented at lysines 5, 8, 12, and 16. Already mentioned above, acétylation of lysine 16 is 
correlated with hypertranscribed Drosophila male X-chromosome. Acétylation of H4 lysine 5 
and lysine 12 appears to allow gene transcription, since mutants which affect silencing exhibit 
higher levels of acétylation at both loci (Rundlett et al., 1998). However, acétylation of only 
lysine 12 of H4 is associated with heterochromatin formation in the mating type locus in yeast 
(Braunstein et al., 1996; Turner, 2000). Although both H3 and H4 are pre-acetylated when 
incorporated into newly synthesised DNA, only H4 acétylation at lysine 5 and lysine 12 seems 
to be conserved (Sobel et ah, 1995; Kuo et ah, 1996). However, some organisms display H3 
acétylation at lysine 9 (Sobel et ah, 1995). At least for the di-acetylated H4, erasure by 
deacetylases occurs several minutes after the completion of DNA replication (Taddei et ah,
1999).
Finally, the recent identification of methylated histones has spurred several studies 
directed at understanding the significance of the modification. Méthylation of lysine 9 of H3 is 
correlated with silencing as described in Section 1.3.6 (Nielsen et ah, 2001). However, 
méthylation of lysine 4 of H3 and of arginine 3 of H4 have both been reported to allow 
transcriptional activity, although méthylation of lysine 4 of H3 has also been required for 
repression (Strahl et ah, 1999; Litt et ah, 2001; Noma et ah, 2001; Wang et ah, 2001; Boggs et 
ah, 2002; Briggs et ah, 2001). As in the case for phosphorylation at serine 10 of H3, méthylation 
of arginine 3 of H4 facilitates subsequent acétylation of H4 at lysines 8 and 12 (Wang et ah, 
2001).
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Modification Functional Association
H4 (non-Ac)
H4: K12Ac 
H4: K5Ac, K12Ac 
H4: K8Ac 
H4: K16AC 
H4: K20Me 
H4: R3Me
heterochromatin
silencing, heterochromatin
transcription, chromatin assembly
transcription
transcription
transcription
transcription
H3 .(non-Ac)
H3: K14Ac
H3: K9Ac, K14Ac
H3: K14AC, K23Ac
H3: K9Me
H3: K4Me
H3: K4Me, K14Ac
H3: SlOP, S28P
heterochromatin
transcription
transcription, chromatin assembly 
chromatin assembly 
silencing, heterochromatin 
transcription/repression (?) 
transcription
mitotic chromosome condensation
H3:S10P,K14Ac 
H3:S10P,H4: K16Ac 
H3:S10P,H1:P 
H l:U bi 
H2A.X: 139P 
H2B: 32P
transcription
transcription
transcription/silencing (?)
transcription
DNA repair, apoptosis
apoptosis
Table 1 2 .  The Histone Code. Combinations of various histone modifications 
are speculated to represent different signals affecting gene activity and other 
cellular processes, as indicated. Ac: acétylation, P: phophorylation. Me: méth­
ylation, Ubi: ubiquitination.
1.4 The influence epigenetics has in cancer
1.4.1 Interfering with enzymatic complexes
Characterisation of many complexes possessing acetyltransferase or deacetylase activity 
has indicated that these activities are essential for proper regulation of genes. It is clear that such
- 21 -
Introduction
enzymatic activity is necessary for the integrity of the cell (Ikura et al, 2000; Tsai et ah, 2000). 
Although in the majority of the cases, histones were reported to be the target substrates, several 
other substrates have been identified. Most notably, one report showed that deacetylation of 
p53 is an important means of regulating p53 activity (Luo et ah, 2000). Furthermore, the 
acétylation of HMGI/Y (high mobility group I/Y) an architectural protein, by PCAF (p300/CBP 
associated factor; Yang et al., 1996) /GCN5 (Brownwell et al., 1996) acetyltransferase prevented 
its degradation and allowed enhancement of interferon-13 gene expression (Munshi et ah, 2001). 
The CARMl (coactivator associated arginine methyltransferase 1; Chen et ah, 1999) dependent 
methlylation of the acetyltransferase p300/CBP allows full activation of nuclear receptor target 
genes while attenuating p300/CBP mediated cAMP-induced transcription, thereby modulating 
several regulatory pathways (Xu et ah, 2001).
Several studies collectively support an emerging theme of interference with proper 
recruitment or with association of deacetylases by oncoproteins. Recruitment of deacetylases 
was found to be influenced by oncogenic proteins. It was shown that activation of oncogenic Ras 
results in an increased expression of HDAC4. Interestingly, this increased expression of 
HDAC4 was found to be associated with an elevated level of kinase activity. Possibly, the 
kinase activity associated with the HDAC4 complex transduces signals from the RAS-MAPK 
pathway. If indeed this hypothesis turns out to be true, Ras mediated cell deregulation might 
directly act through chromatin remodelling (Zhou et ah, 2000). Recruitment of deacetylases by 
ETO (Eight Twenty One) in acute myeloid leukaemia is crucial for its ability to promote 
leukemogenesis (Gelmetti et ah, 1998; Stunnenberg et ah, 1999). The retinoblastoma (Rb) 
protein, a nodal point in regulating gene repression during the S phase of the cell cycle, also 
recruits the HDACl deacetylase. The presence of an oncoprotein, E7, prevents this association 
and thus allows activation of target genes (Brehm et ah, 1998). Most importantly, oncoproteins 
such as Set/TAFIB and MTAl have been identified as members of the INHAT, inhibitor of 
acetyltransferases (p300/CBP and PCAF), and of the NURD deacetylase and remodelling 
complexes, respectively (Seo et ah, 2001; Xue et ah, 1998). The recent report showing that 
BRCAl transcription is repressed by histone hypoacetylation and chromatin condensation, and 
consequently, the predisposition of breast epithelial cells for cancer by BRCAl misregulation, 
perfectly illustrates how an epigenetic misregulation can be a first step in tumourigenesis (Rice et
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al., 2000). In addition, the interaction between the RING finger of tumour-suppressor BRCAl 
and its associated partner BARDl, which harbours an E3 ligase activity that is inactivated in 
breast cancer-derived mutations, again shows that enzymatic activity is a target in 
tumourigenesis (Hashizume et ah, 2001; Brzovic et ah, 2001).
1.4.2 Nucleosome remodelling connecting with cancer
A flurry of reports has demonstrated interactions between nucleosome remodelling 
complexes and cell cycle regulators (Harbour and Dean, 2000). Chromatin remodelling and 
transcription factor accessibility are both required for gene activation. The improper recruitment 
of such complexes to loci that should be kept repressed can easily result in deregulation of cell 
function. Therefore, reports of INH/SNF5 deletion at chromosome 22, which correlates with 
malignant rhabdoid tumours and lymphoid malignancy, are not surprising (DeCristofaro et ah, 
1999: Yuge et ah, 2000). Moreover, mutations in BRGl, also a member of the human SWI/SNF 
remodelling complex, have been associated with multiple human tumour lines, including breast 
cancer. The direct association of BRCAl with BRGl has recently been shown (Bochar et ah,
2000). The presence of a dominant-negative mutant of BRGl, or of a cancer-causing deletion 
mutant of BRCAl, abrogates transcription activation of BRCA-1 upon p53 signalling. B R G l’s 
interaction with Rb, which is required to repress cyclin E and A and cdc2, provides an 
alternative mode of action which when abrogated can lead to tumourigenesis (Zhang et ah, 2000).
1.4.3 Bmi-1 in cancer
The activities of PcG and trxG in cell integrity and cell proliferation were underscored by 
the finding that members of both groups are often mutated in several types of cancer (also 
described above). The best studied PcG/trxG proteins which are implicated in cancer and cell 
cycle control are Bmi-1 and MLL. Bmi-1 was found to be a potent collaborator of the c-myc 
oncogene in lymphomogenesis (van Lohuizen et ah, 1991a; van Lohuizen et ah, 1991b), while 
MU is consistently translocated and fused with several partner genes in lymphoid and myeloid 
derived leukaemia (see Section 1.5; Ayton and Cleary, 2001).
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The synergistic actions between Bmi-1 and c-Myc were explained by the recent 
connection of Bmi-1 as a regulator of an important cell cycle control gene, the ink4a-Arf locus 
(Jacobs et ah, 1999). The mechanism(s) through which Bmi-1 acts remains unknown.
Apparently, cell transformation was achieved by the repression of tumour suppressor genes 
present in the ink4a-Arf locus, through the over-expression of Bmi-1, and by subsequent 
deregulation of cell cycle progression by c-Myc. The Bmi-1 and ink4a-Arf connection was 
confirmed to be relevant since cells lacking Bmi-1 expression undergo premature senescence.
This is due to the derepression of the ink4a-Arf locus, resulting in the expression of p i and 
p i9'^ ’’^ tumour suppressor proteins. The inactivation of the ink4a-Arf locus rescued this 
premature-senescent effect and demonstrated that the gene activity status of ink4a-Arf locus is 
critical for cell immortalisation and senescence. The relevance of this discovery was illustrated 
by the finding that the same mechanism of repression of ink4a-Arf by over-expressed Bmi-1 was 
documented in primary human osteosarcoma, in non-small cell lung cancer, and in several forms 
of non-Hodgkin lymphomas such as Mantle cell B lymphomas (Vonlanthen et ah, 2001; Bea et 
al., 2001; van Kemenade et ah, 2001). These observations indicate that overexpression of Bmi-1 
or particular PcG proteins may contribute to tumourigenesis of lesions where the activity of the 
ink4a-Arf locus is retained. Additionally, the principle that both cell defence and proliferation 
control must be mutated for tumourigenesis is reinforced (see Section 1.1).
Mechanistically, the ink4a-Arf products p i6 and pl9A rf act as upstream regulators of 
the Rb and p53 tumour-supressor pathways, which act at specific check-points of cell cycle 
progression (Sherr, 2001). Recent studies strongly argue that the proper regulation of ink4a-Arf 
is crucial for normal cell integrity, and propose that negative regulators of cell cycle control 
genes, such as ink4a-Arf, may in fact be unidentified oncogenes contributing to tumourigenesis 
(Sherr, 2001; Kimperforst et ah, 2001; Sharpless et ah, 2001). In addition to Bmi-1 itself, the 
ability to immortalise senescence-predisposed cells lacking Bmi-1 by the over-expression of the 
T-box transcription factor TBX2 provides strong support for this hypothesis (Jacobs et ah,
2000). In this study, the alleviation of cell senescence was mediated by the repression of the 
p i 9^^ expression.
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1.5 Mixed Lineage Leukemia
1.5.1 The disease
Acute leukaemia is generally characterised by genetic translocations and inversions, 
leading to the activation of proto-oncogene proteins (Rabbits, 1994; Sawyers, 1997). Acute 
leukaemia can be derived from either the myeloid (Acute Myeloid Leukemia, AML) or 
lymphoblastic (Acute Lymphoblastic Leukaemia, ALL) lineages. Some activated proto­
oncogenes can lead to the development of both cell lineage leukaemias, such as MLL (Mixed 
Lineage Leukaemia), the human homologue of the Drosophila Trithorax.
As described in detail below, the MU gene, residing at the 1 lq23 position, is translocated 
to a variety of partner genes to create an in-frame expressible fusion protein. Activation of this 
fusion protein has been correlated with the onset of acute leukaemia. It was observed that a high 
percentage of patients who took a therapeutic drug that inhibits the action of topoisomerase II, 
developed acute leukaemia and exhibited a break point at the 1 lq23 locus. This observation 
underscored the importance of the translocation event at the MU locus, which consisted of 
several Alu sequences, in generating acute leukaemia. Translocations involving the MLL gene 
account for up to 80% in leukaemia in infants, representing 23% of cancer diagnoses in children 
under the age of 15 (Heerema et ah, 1994; Pui et ah, 1995; Pui, 2000).
The MLL disease is associated with very poor prognosis, with 75-80% of diagnostic 
cases surviving up to 5 years (Pui et ah, 1995; Pui, 2000). In addition to elevated numbers of 
white blood cells, the disease is also associated with leukaemia of the central nervous system 
(CNS) (Pui et ah, 1995; Pui, 2000). Patients with mutated MLL lesions do not respond well to 
anti-cancer drugs and chemotherapy, although acute leukaemia derived from activation of proto­
oncogenes other than MLL are associated with long-term event-free survival rate of 80% in 
children (Pui et ah, 1994; Saha et ah, 1998; Pui, 2000). Gene expression analyses of MLL 
derived leukaemic samples revealed a highly distinct gene expression profile in comparison to 
conventional ALL and AML (Armstrong et ah, 2002). In fact, these differential gene expression 
profiles can be used to distinguish MLL-based leukaemic patients from conventional ALL/AML
- 2 5  -
Introduction
leukaemic patients with 95% accuracy. This study has proposed that MLL should be treated as 
a separate disease, and that the distinct pattern of gene activity by MLL associated leukaemia 
provides an explanation as to why patients with MLL respond poorly to conventional 
therapies.
1.5.2 Structure homology to TRX
TRX and MLL share two homologous domains at the C-terminus, and one domain at the 
N-terminus (see Chapter 2: Figure 2.1). At the N-terminus, TRX and MLL both contain two 
stretches of SNL (Speckled Nuclear Localization), which mediate speckled sub-nuclear 
localization (Yano et ah, 1997). It was conjectured that the disruption of the localisation of both 
MLL and TRX at nuclear domains may play a significant role for the appearance of leukemia 
(Yano et al., 1997; Ayton and Cleary, 2001). With the exception of the putative nuclear receptor 
type DNA binding domain at the N-terminus of TRX (Stassen et ah, 1995), the N-terminus of 
MLL consists of several additional functional sequences. The N-terminal sequence of MLL 
comprises three AT hooks (Tkachuk et ah, 1992), a cysteine-rich region similar to DNA 
methlytransferase (MTase) (Domer et ah, 1993; Cross et ah, 1997; Hendrich and Bird, 1998), a 
repression domain (Zeleznik-Le et ah, 1994; Prasad et ah, 1995), and an activation domain at its 
C-terminus (Zeleznik-Le et ah, 1994). AT hooks are speculated to bind at minor grooves of 
DNA via their RGR motif, and are thought to establish open chromatin configuration at AT-rich 
regions (Reeves and Nissen, 1990; Huth et ah, 1997). Interestingly, the third AT hook of MLL 
shares similarity with an ATP binding site found in HMGI/Y proteins (Zeleznik-Le et ah, 1994). 
HMG proteins are postulated to be involved in maintaining higher order open chromatin 
structure by possibly competing with histone HI (Reeves 1992; Huth et ah, 1997). Actions at 
higher order chromatin structure by AT hooks, have been reinforced by the finding that this 
region binds SARs (Scaffold Attachment Regions), which organise interphase and mitotic 
chromatin into loops (Gasser et ah, 1989; Zhao et ah, 1993; Khadake and Rao, 1997). The recent 
structural resolution of HMGI/Y bound to DNA suggests that MLL binds with weaker affinity 
to the minor groove, and thus, possibly the weak interaction by MLL may be used to indirectly 
stablise protein-DNA interactions (Huth et al, 1997). Interestingly, the possibility of AT hooks
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phosphorylation links MLL again with regulation by cell cycle dependent phosphorylation 
(Nissen et ah, 1991; Reeves et ah, 1991; Ayton and Cleary, 2000). The MTase-like region, as 
the name implies, consists of a cysteine rich motif (CxxC), which shows homology to DNA 
methyltransferases (DMT) and methyl binding domain protein 1 (MBDl) (Domer et ah, 1993; 
Cross et ah, 1997; Hendrich and Bird, 1998). DMTs are able to methylate DNA, whereas 
MBDs bind methylated sequences. Shown recently is the ability of the MT domain to bind 
unmethylated CpG sequences (Birke et ah, 2002).
Finally, two important domains in TRX and in MLL, the PHD fingers and SET domain, 
require special notice since they are not only present in several members of both trxG and PcG 
families, but have also been thought to play an important role in TRX/MLL mediated gene 
activity. Although the exact role of the PHD fingers is still not known, they are classically 
regarded as a moiety that is able to bind DNA. However, PHD fingers in MLL and TRX share 
greater homology to plant PHD fingers, which are thought to mediate protein-protein interaction 
(Aasland et ah, 1995). The importance of PHD fingers fox Hox gene regulation was shown by 
the interaction of the third PHD finger of MLL with Cyp33, a nuclear cyclophilin containing a 
RNA binding domain known to regulate gene expression by interacting with transcription factors 
and deacetylase complexes (Fair et ah, 2001). In this study, it was shown that Cyp33 
interaction with MLL represses HOX expression in tissue culture. Notably, the third PHD 
finger of MLL is absent in all leukaemic fusion proteins. Therefore, the lack of the interaction 
with Cyp33 by the fusion proteins could imply that the chimeric proteins are constitutively 
active. Indeed, overexpression of Cyp33 in leukemic cell lines lacking the third PHD finger, was 
not found to have any effect on gene expression (Fair et ah, 2001).
Several research groups have begun to elucidate in detail the role of the SET domain (see 
Section 1.3.6). The recent discovery that the SET domain of Su-(var)3-9 possesses a histone 
methylating activity has encouraged studies to understand why in contrast, the SET domain of 
TRX lacks the methylating activity. An understanding of this phenomenon was provided by the 
finding that the SET domain of TRX acts as a histone recognition module, that is essential for 
TRX regulation of gene expression (Katsani et ah, 2001). The zW trx  mutant allele which lacks 
an intact SET domain is pupal lethal and was shown to be incapable of binding to core histones 
and to nucleosomes (Katsani et ah, 2001).
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1.5.3 MLL fusion proteins
MLL was initially discovered in leukaemic patients, who consistently possessed 
translocations between the MLL locus and various fusion partners (Table 1.3; Gu et al., 1992, 
Tkachuk et al., 1992; Nakamura et al., 1993; Shilatifard et al., 1996). The MLL fusion proteins 
are translocated at a region called the "Break Point Cluster" which spans parts of the PHD finger 
of MLL. Notably, the SET domain and at least half of the PHD finger of the full-length MLL are 
lost and replaced by new C-terminal sequences upon trahslocation. Since at least 30 different 
fusion proteins, which contain the N-terminal part of MLL are known to date, this portion was 
speculated to be of great importance in the predisposition of lymphoid and myeloid derived cell 
lineages to cancer. Additional functions contributed by the C-terminal fusion partner of the 
chimeric proteins were postulated to enhance loss of cell proliferation control. Clear evidence 
supporting the model is lacking.
Among the characterised MLL fusion proteins, two classes can be formulated based on 
the latency period required for the onset of leukaemia (Ayton and Cleary, 2001). MLL-ELL, 
MLL-CBP, MLL-|3gal, and MLL-PTD display AML after a long gestation period, whereas 
MLL-AF4, MLL-AF9, MLL-ENL, and MLL-AFIO are associated with aggressive AML and 
ALL. Accordingly, MLL-CBP, MLL-ELL, and MLL-PTD are generally associated with elderly 
patients whilst the more aggressive translocations, particularly MLL-AF4 and MLL-AF9, are 
correlated with infants aged a few weeks old to a few years.
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Gene Localization Domains in Fusion Protein 
Retained Lost
Disease
MLL 11q23 SNL1&2, AT Hooks SET, PHD ALL & AML
A F lq lq 2 1 whole gen e  p ro d u c t ? AML
AF4 4q21 tran sac tiv a tio n , CHD ? ALL
AF9 9 p 2 2 tran sac tiv a tio n , NLS ? AML/ALL
AF6 6 q 2 7 kinesin, m yosin Ras activation AML/ALL
AFIO 10 p 1 2 LZ, Q-rich PHD AML
AF17 17q21 LZ, Q-rich PHD AML
AFX Xq13 ? DNA binding AML
ELL 19p13.1 R2, R3, R4 R1 AML
ENL 1 9 p 1 3 .3 tran sac tiv a tio n , NLS ? AML/ALL
CBP 1 6 p l3 BR, HAT PHD, CREB(?) AML
p 3 0 0 2 2 q l1 .2 BR, PHD, Q-rich CREB, ZF AML
Table 13. MLL Partners. The 12 most common MLL partners are depicted above. The name, 
localisation, and domains retained or associated with the fusion protein, are described. In addition, the 
leukaemic disease, whether derived from the myeloid (AML) or lymphoid (ALL) lineages, is given. 
SNL: speckled nuclear localisation, CHD: C-terminal homology domain, NLS: nuclear localisation 
signal, LZ: leucine zipper, Q-rich: glutamine rich, BR: bromodomain, HAT: acetyltransferase, ZF: 
zinc finger, R1-R4: domains in ELL.
The C-terminal partners of MLL leukaemic fusion proteins do not appear to share any 
common functions, although many of these MLL partner genes are generally ubiquitously 
expressed. ELL was isolated biochemically by its ability to act as a transcriptional elongation 
factor for RNA polymerase II (Shilatifard et ah, 1996). Its central R2 domain, which is present 
in the fusion protein, prevents pol II pausing along the DNA template, thereby increasing the 
rate of RNA synthesis (Shilatifard et ah, 1997). Interestingly, this R2 domain was found to be 
dispensible for myeloid immortalisation by MLL-ELL, although another conserved region of 
ELL, R4 was required (DiMartino et ah, 2000). The interaction of R4 with EAFl (ELL 
associated factor 1; Luo et ah, 2001), which intriguingly is homologous to AF4, another fusion 
partner of MLL, facilitated transactivation by ELL’s R4 (Lavau et ah, 2000).
ENL, like ELL, possesses transactivation domains which were found to be conserved 
with ANCl (actin non-complementing), a component of the SWI/SNF chromatin remodelling 
complex in yeast and which is thought to endow dominant gain of MLL function by keeping 
MLL target genes active (Cairns et ah, 1996; Saha et ah, 1998; Rowley, 1998; Ayton and Cleary,
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2001). Both the AT hooks and CxxC motif of MLL and the last 84 amino acids of ENL domains 
were required for myeloid transformation (Slany et ah, 1998). In addition, another partner gene, 
AF9 shares extensive homology with ENL (Nakamura et ah, 1993). Both acquire a NLS signal 
and transcription transactivation domain (characterized by serine and proline rich stretches), 
which has been shown to be important for their ability to transform cells (Slany et ah, 1998). 
Although the function(s) for AF9 in normal cell progression is not known, it has been speculated 
that many fusion partners (such as AF9, AF4, ELL, and ENL) appear to interact with the RNA 
polymerase II transcription machinery (Prasad et ah, 1995; Rubnitz et ah, 1994).
Like the above fusion partners, AFIO also uses transcriptional effector properties to 
derail the rate of cell proliferation. The LZ domain of MLL-AFIO in conjunction with a 
conserved octapeptide sequence (EQLLERQW) was sufficient for myeloid immortalization and 
was able to activate Hoxa7, a MLL target gene (Ayton and Cleary, 2001). Although 
transactivation potential by MLL-AFIO is weaker than for MLL-ENL or MLL-ELL, 
transplantation of MLL-AFIO into immuno-compromised mice resulted in aggressive AML, 
developing within 60 days (Ayton and Cleary, 2001).
The AF4 gene, when translocated to MLL, is associated predominantly with infant pro- 
B ALL (Domer et ah, 1993; Nakamura et ah, 1993; Johansson et ah, 1998). Supporting a 
unifying theme, AF4 acts as a transcriptional activator when fused with the GAL4 DNA binding 
domain (Prasad et ah, 1995). The central conserved domain was found to mediate this potent 
transcriptional activation (Ma and Staudt, 1996; Morrissey et ah, 1997). In addition to AF4, 
other family members, such as AF5q32 and LAF4 have been reported to fuse with MLL (Taki 
et ah, 1999; von Bergh et ah, 2001). The generation of null AF4 mice revealed that AF4 is 
required for proper hematopoietic development, particularly in the transition between pre-B cell 
to mature B cells (Isnard et ah, 2000). The identification of the Drosophila AF4 homolog, 
lilliputian, connected MAP kinase (MAPK) and PI3-kinase/ Protein Kinase B (PI3K/PKB) 
pathways as possible additional venues through which the AF4 protein may act (Tang et ah, 
2001; Wittwer et ah, 2001).
Since the identification of CBP as one of MLL’s fusion partners, aberrant enzymatic 
activity has been proposed to be a contributing factor in leukemogenesis. CBP regulates several 
signalling pathways and was shown to exhibit histone acetyltransferase activity, therefore
- 30 -
Introduction
implicating CBP as a regulator of transcription at the level of epigenetics. Both the bromodomain 
and the HAT activity were sufficient to immortalise myeloid cells and allow development of 
AML in vivo (Lavau et ah, 2000). The ability of bromodomains to recognise and to bind to 
acetylated H3 and H4 may tether MLL-CBP to critical target genes and in conjunction with 
CBP’s HAT activity, allow accessibility to the transcription machinery (Dhalluin et al., 1999).
Finally, the surprising report that MLL-|3gal can induce AML, albeit with long latency, 
underscores the importance of the disruption of MLL normal function (Dobson et al., 2000).
The fact that duplication of part of the amino-terminal of MLL (PTD) and the absence of MLL 
exon 8, which contains part of the first PHD finger, are associated with long latency leukaemia, 
indicate that abrogation of normal MLL function predispose cells for tumorigenesis (Schichmann 
et al., 1994; Caligiuri et al., 1996; Lochner et al., 1996). How these MLL lesions contribute to 
the inhibition of normal MLL function is not known.
1.5.4 MLL fusion proteins and apoptosis
In addition to their effect on transcription, MLL fusion proteins have also been 
implicated in inducing apoptosis (Ayton and Cleary, 2001).
The presence of MLL-AF9 in cells resulted in cell death within 72 hours, caused G1 
arrest and cell differentiation, and induced upregulation of p53 target genes (Caslini et al., 2000). 
However, if the protein concentration of MLL-AF9 is reduced to levels only detectable by RT- 
PCR, for example, by expressing with a weak endogenous promoter, cells are able to survive, as 
exemplified by the MLL-AF9 knock-in mice (Corral et ah, 1996; Dobson et ah, 1999). Both 
results imply that high amounts of MLL fusion proteins are toxic to the cell, or alternatively, 
that mis-expression of the protein in cells that do not inherently express appropriate target 
genes, are susceptible to an apoptotic response (Ayton and Cleary, 2001).
However, the relation between MLL fusion proteins and apoptosis is not absolutely 
clear since several studies have reported both induction and inhibition of apoptosis directly by 
MLL fusion protein. The finding that the leukaemic MLL fusion proteins (such as MLL-ENL, 
MLL-AF9, and MLL-ELL) inhibit GADD34-induced apoptosis whereas wild-type MLL does 
not, indicates that possibly MLL fusion proteins directly prevent normal cellular apoptotic
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response (Adler et a l, 1999). Furthermore, the treatment of cells with antisense oligo­
nucleotides against MLL-LTG19 or against MLL-AF9 arrests cell growth and induces apoptosis 
(Akao et a l, 1998; Kawagoe et a l, 2001). However, it was noted that MLL-ENL and MLL-ELL 
also arrest cell proliferation by causing cell maturation or by activating apoptosis, respectively 
(Schreiner et a l, 2001; Johnstone et a l, 2001). Clearly, the effect by MLL fusion proteins on 
apoptosis is ambiguous. Nevertheless, in order to generate leukaemia, aversion of cell death by 
MLL fusion proteins must occur. Whether MLL fusion proteins deactivate the apoptotic 
response, directly or indirectly remains to be conclusively shown.
1.5.5 Mechanism(s) by which MLL fusion proteins generate leukaemia
A central question in understanding how MLL fusion proteins promote leukaemia is to 
explain why particular MLL fusion proteins are associated with myeloid (AML) or lymphoid 
(ALL) derived leukaemia. Two hypotheses have formulated to account for this discrepancy. The 
first postulates that translocation events between MLL and fusion partners are restricted to cell 
lineage, and thus dependent on factors that allow illegitimate recombination to occur. The 
second takes into account that lineage specific leukaemia is largely determined by the MLL 
fusion partner. The facts that many MLL fusion partners are ubiquitously expressed and that 
MLL fusion proteins are associated with both types of leukaemia, would indicate that lineage 
specific transformation by the MLL fusion partner is not absolute.
In vitro cell culture assays and in vivo mouse models collectively support the role for 
MLL fusion proteins as gain-of-function mutations. Whether the disruption of normal MLL 
function or the additional, potential activities by the C-terminal partners is most crucial for cell 
transformation is unclear. However, it appears that both events are critical for leukemogenesis.
The importance of the C-terminal partner in the control of cell proliferation was shown 
in knock-in mice expressing the MLL-AF9 chimeric fusion protein (Corral et a l, 1996). It was 
shown that MLL-AF9 mice exhibited elevated levels of lymphoid cells after several hionths, 
while mice expressing the truncated N-terminus of MLL tagged with myc (MLL-myc) remained 
normal. In addition, MLL-AF9 in vivo was found to rapidly increase myeloid cell proliferation.
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suggesting that this increase in cell growth rate may facilitate additional mutations for 
development of leukaemia (Dobson et al., 1999).
The effect on leukemogenesis by the lack of a functional C-terminal portion of MLL 
(such as in MLL-myc mice) was addressed by introducing the fusion protein, MLL-(3gal 
(Dobson et al., 2000). (3-gal has been extensively used as a marker in model systems, is capable 
of oligomerisation, and has no known tumourigenic effect. Intriguingly, mice expressing the 
MLL-|3-gal fusion developed leukaemia, albeit a milder form than the MLL-AF9 control mice. 
This study suggested that the partial loss-of-flinction of MLL and the ability to oligomerise via 
the (3-gal domains, perhaps to stabilise the fusion protein, are sufficient to render MLL-p-gal 
oncogenic. Self-oligomerisation of the fusion proteins may also represent a gain-of-fimction 
necessary for oncogenesis. In support of this proposal, the C-terminal domains of known fusion 
partners of MLL (for example, AFIO and AF17) contain leucine zippers. However, MLL is 
also known to translocate to non-oligomerising proteins (such as p300/CBP and ELL), where the 
fusion proteins cause cancer. In these cases, it could very well be that an additional enzymatic 
or transcriptional activity contributes to their oncogenicity. Thus, it appears that the C-terminal 
portion of the fusion protein enhances the cancer phenotype. Furthermore, the ability of MLL 
fusion proteins to transform myeloid progenitors in a wild-type background (i.e. in the presence 
of two MLL copies) underscores the importance of MLL C-terminal partners.
An additional consideration to keep in mind is the effect the disruption of the wild-type 
function of the C-terminal fusion partner has on cell homeostasis. Analogous to MLL, inhibition 
of the physiological function of the C-terminal partner by the MLL fusion protein may also 
contribute to leukemogenesis. As an example, the MLL partner, AF6 gene, has been shown to 
directly transactivate the Fas ligand gene and the tumour suppressor p27 '^^  ^ to promote 
apoptosis and cell cycle arrest (Brunet et al., 1999; Medema et al., 2000). Conceivably, the 
MLL-AF6 fusion protein may interfere with the normal ability of AF6 to induce apoptosis, and 
thus enhance cell survival to promote leukemogenesis (Ayton and Cleary, 2001). Ultimately, the 
identification of MLL regulated target genes and the molecular characterisation of the C-terminal 
partners will be required to unravel how the chimeric fusion proteins modulate the activities of 
MLL and its C-terminal partners to misregulate cell proliferation.
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1.6 Aims of the Thesis
The aim of the work described in this thesis was to develop Drosophila melanogaster as 
a supplementary model system that would provide a deeper understanding of how MLL fusion 
proteins contribute to the development of leukaemia. Two MLL fusion proteins were selected 
for these studies. They include MLL-AF4 and MLL-AF9, which account for 40% and 27% of 
infant acute leukaemia cases, respectively (Ayton and Cleary, 2001).
The thesis addresses several points. First, the establishment o f Drosophila as a system 
to study MLL fusion proteins should provide a more feasible means of identifying pathways 
through which MLL-AF9 and MLL-AF4 misregulate. This system would define the initial 
contours of the possible physiological functions for AF9 and AF4, which to date, remain 
unknown. Analyses of the expression of MLL and/or MLL fusion proteins in flies would assert 
(i) whether the MLL fusion proteins are the sole cause of leukaemia, and (ii) whether chromatin 
architecture has been compromised. Second, the expression of wild-type MLL as well as of 
MLL fusion proteins would comment on the relevancy of the C-terminal fusion partner in 
leukemogenesis. If MLL-AF4 and MLL-AF9 manifest similar molecular phenotypes, a 
conclusion that disruption of wild-type MU, or its equivalent homologue in the fly, trithorax, is 
sufficient in part to facilitate cell transformation, would be heavily substantiated. Alternatively, 
different effects by MLL-AF4 and MLL-AF9 would suggest that the AF4 or AF9 portion of 
the fusion proteins targets specific pathways for deregulation of cell integrity. Third, MLL 
fusion protein effect on apoptosis could be clarified. The modulation of MLL fusion protein 
expression levels is simplified with the UAS-Gal4 system in Drosophila, and the generation of 
cells, which either express or do not express the MLL fusion proteins within the same 
developmental setting, can be assessed for direct apoptotic activity. Finally, the possibility that 
trithorax possesses additional functions required for the completion of Drosophila development, 
as implied by the multitude of trithtorax mutants exhibiting diverse phenotypes, can be 
investigated. Importantly, MLL fusion proteins may target this pathway(s) to account in part 
for its oncogenicity.
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CHAPTER 2
MLL fiision proteins specifically induce lethality at late Drosophila
development.
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2.1 Introduction
The disease Mixed Lineage Leukaemia refers to the over-proliferation of specific blood 
cells derived from either the lymphoblastic or the myeloid lineages. The 1 lq23 locus was 
observed to be consistently translocated and fused to several partner genes throughout the 
genome in patients suffering from the disease. It was hypothesized that the gene disrupted in 
1 lq23 may have a crucial role in the progression of leukaemia. Subsequent cloning of the locus 
identified a gene (named Mixed lineage leukemia, MU) that only retained its N-terminus in 
patients with a translocation involving the 1 lq23 locus. The discovery that MLL showed 
homology to the Drosophila Trithorax (TRX) protein was a major stepping stone, since the 
similarity between the two proteins provided a first clue of what the function of MLL may 
be. TRX is the prototype member of the trithorax group (trxG) family. Together with the 
Polycomb group (PcG), trxG members are thought to regulate gene expression by maintaining 
correct higher order chromatin structure associated with either active or inactive genes, 
including the homeotic gene clusters (Hox), set by transcription factors during early 
embryogenesis.
Since its identification as a homologue of TRX, MLL has been knocked-out in mice. 
Results confirmed that MLL is not only homologous to TRX in structure but also in function 
(Fig 2.1). Mice lacking a functional MLL die at E10.5 days, and show anterior skeletal 
transformations (Yu et al., 1995; Yu et al., 1998; see Section 1.3.5). Likewise, 'm Drosophila, 
null mutants of TRX are embryonic lethal and display an anterior transformation of body 
.segments (Ingham, 1998; see Section 1.3.5).
Despite these early studies, the function of MLL still remains elusive. The only 
insight into how MLL may possibly function in mammals was deduced from MU -/- mice and 
has been extrapolated from studies of TRX by taking advantage of their conservation. MLL 
and TRX have been shown to be important for maintaining an open chromatin configuration 
since animals lacking TRX or MLL function result in repression of homeotic gene boundaries, 
and consequently, an anterior body transformation is observed (Ingham, 1998; Yu et al., 1995; 
Yu et al., 1998). TRX is bound at its regulatory elements dynamically throughout early
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Drosophila development (Orlando et al., 1997). It is postulated that many different TRX 
complexes exist that differentially regulate its target genes since several types of TRX mutants 
are able to survive past embryogenesis into larval to pupal stages (Breen, 1999). However, 
different combinations of trx alleles have rendered flies that are viable and that are often 
associated with anterior transformation of body segment (Breen, 1999). In addition, two 
conserved domains, the SET domain and PHD fingers, which are shared between TRX and 
MLL and several other PcG/trxG members are thought to play an important role in TRX 
function. Interestingly, it is worth to note that MLL fusion proteins found in leukaemic 
patients contain an altered PHD finger, often missing at least half of the domain, and 
completely lacking the SET domain.
Several attempts have been made to create a mammalian model system to study the 
function of MLL and its fusion proteins identified in leukaemic patients. To date, the only 
surviving mouse harbouring an MLL fusion construct is MLL-AF9 (t(9.T 1)) (Corral et al., 
1996) These mice are viable and develop leukaemia within 4-12 months. Attempts to create 
MLL-AF4 (t(4:l 1)) mice have been unsuccessful (E. Canaani, personal communication). Due 
to difficulties in generating transgenic mice and in manipulating mice genetically, the field has 
relied heavily on cell culture systems to study the behaviour of cells lacking MLL wild-type 
function. However, tissue culture usage is limited since cells already harbour inherent 
mutations allowing continued proliferation. To study specifically how MLL fusion proteins 
contribute to leukemogenesis in tissue culture becomes extremely complicated when 
considering the unaccountable influence inherent mutations may have on cell behaviour.
In this respect, a more suitable model system that can be implemented to study MLL 
fusion protein function per se is Drosophila melanogaster. The advantages of using 
Drosophila as a model system rely on its well-documented genetics and on the availability of 
the full genomic sequence. Genetic screens can be performed to identify interacting proteins 
that can modulate a specific phenotype. Most importantly, proteins selected through a screen 
function in a complex chromatin and in a multi-cell environment, a scenario more relevant for 
cancer research. The identification of proteins is then easily accomplished by using BLAST 
analysis against the attained sequences. Finally, the expression of MLL fusion proteins in 
Drosophila allows the study of the function associated with only MLL fusion proteins in the
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absence of any influence from additional mutations as found in cell cultures and in primary 
tumour cell lines isolated from patients.
The fact that conservation exists both in PcG/trxG families (Section 1.3.5) and in the 
immune systems (Section 3.1) hotwoon Drosophila and mammals provide an ideal situation to 
establish Drosophila as an additional model system to study MLL fusion proteins. Chapter 2 
focuses on presenting data validating Drosophila as an additional tool to study MLL fusion 
function. The results indicate that MLL fusion proteins specifically interfere with proper 
Drosophila development causing lethality, while MLL expressing flies are completely viable. 
Lethality is manifested when the fusion proteins are expressed in the blood cells and in neural 
cells. Moreover, this lethal phenotype is not a result of the mere presence of the fusion 
proteins since crosses with several Gal4 driver lines generate healthy, viable flies. The results 
are discussed in detail in relation to known phenotypes of MLL fusion proteins expressed in 
the mouse and to symptoms of patients harbouring the specific MLL translocation.
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2.2 Results
2.2.1 MLL and TRX share limited homology, whereas the human MLL C-terminal 
partners are conserved in Drosophila.
Over 30 partner genes have been identified to fuse with MLL to cause over 80% of 
infant leukaemia. Two of these fusion proteins were selected for their expression in 
Drosophila. The MLL-AF4 (t(tl 1:4)) translocation was chosen because over 40% of children 
with leukaemia harbour this translocation. The prognosis of MLL-AF4 derived lymphoblastic 
leukaemia is very poor, as survival rates are less than 25% by the age of 5 years. The second 
chimeric protein expressed in Drosophila is MLL-AF9 (t(l 1:9)). MLL-AF9 is also widely 
mutated in leukaemia and is generally associated with 27% of myeloid derived leukaemia in 
infants. Mice expressing MLL-AF9 have been generated and have been observed to develop 
leukaemia, recapitulating the human case (Corral et al., 1996). Figure 2.1 depicts a schematic 
representation of the constructs used to generate the transgenic fly lines.
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Figure 2.1. A schematic representation of TRX, M LL and M LL fusion 
proteins. (A) TRX and MLL share homologies mainly at the PHD fingers and 
the SET domain. BLAST analyses between the fijll cDNA sequences of TRX 
and MLL reveal that at the nucleotide level, the PHD fingers are homologous at 
63% while the SET domain shares 71% homology. Additional homologous 
regions were not identified by BLAST analysis. (B) The two MLL fusion 
proteins expressed in the fly are MLL-AF9 and MLL-AF4. Both translocations 
and expression of fusion proteins have been identified most fi-equently in acute 
lymphoblastic or myeloid leukaemia. The AF9 and AF4 C-terminal portions of 
the fusion proteins are characterised by rich proline and serine stretches, which 
have been postulated to mediate protein-protein interaction (Nakamura et al., 
1993). SNL: speckled nuclear localisation; DBD: DNA binding domain; MT: 
methyltransferase homology; RD: repression domain; PHD: plant homology 
domain; BD: bromodomain; AD: activation domain; SET: Su(var)3-9, E(z), 
TRX homology domain.
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The functions of AF9 andAF4 in mammals are not known to date. Since at least one 
putative homologue for AF9 has been identified in Drosophila by the Berkeley Drosophila 
Genome Project, the implication here is that a homologous AF9 activity exists in Drosophila 
(Adams et al., 2000). The generation of an AF9 mutant in Drosophila, which is more feasible 
than in a mammalian system, would provide the first clues as to what this gene does. 
Furthermore, the reports of a Drosophila homolog for AF4, lilliputian, has implicated 
lilliputian in the regulation of cell growth in Drosophila (Adams et al., 2000; Tang et al., 2001; 
Wittwer et al., 2001). The presence of analogous proteins in Drosophila supports the 
continued dogma that partner genes fused with MLL are also conserved (Fig. 2.2; Rowley, 
1998).
Protein Name Score P(N) Accession No. Cvtological Location
lilliputian 
(homolog to human AF4)
5.1 X 10" Q9VQI9 23C1-2
ENL/AF9 
(homolog to human AF9)
7 X 10'®“ Q9VF92 88E11-13
CG9207 
(homolog to human AF9)
7.3 X 10 " Q9VM63 27C4-7
Figure 2.2. BLAST searches for homologous proteins in Flybase for AF4 and for 
AF9 reveal that Drosophila and mammals share similar regulatory pathways. Protein 
sequences for the human AF4 and AF9 sequences were submitted for BLASTP analysis 
against the predicted protein sequence of the Drosophila melanogaster genome. Both AF4 
and AF9 have homologs in Drosophila as reported by the recent completed sequence of the 
fly genome (Adams et al., 2000). Interestingly, both AF4 and AF9 are conserved across 
species, where homologous proteins in C. elegans, S. cerevisiae, S. pombe, and M. 
musculus have been reported, indicating that the pathways through which these proteins 
function, are likely conserved. P(N): statistical probability that two given sequences are 
randomly similar; Accession No.: the associated number given to the identified gene in 
Flybase; Cytological location: the location of a given gene on polytenes.
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2.2.2 Steps involved in the generation of MLL, MLL-AF4, and MLL-AF9 transgenic 
fly lines.
A specific P-element Drosophila vector, pUAST, was utilised to clone the MLL, 
MLL-AF9, and MLL-AF4 sequences as described above. The clones were generated as a 
collaborative effort by Tanya Rozovskaia from the laboratory of Eli Canaani at Weizmann 
Institute, Rehovot, Israel. At least three clones were created and sequenced at the N-terminus 
of the protein sequence to confirm that the open reading frame was intact. Restriction enzyme 
analysis reaffirmed that the correct sequences were properly cloned (Fig. 2.3).
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Numbers Lanes Expected Band Sizes (bp)
Roche MW VI 
Roche MW III 
MLL
Stu 1/ BamHI 
MLL 
Stu I
MLL-AF4 
Stu 1/ BamHI 
MLL-AF4 
Stu I
MLL-AF9 
Stu 1/BamHI 
MLL-AF9 
StuI
21226, 5248, 4973, 4268, 3530, 2027, 1904, 1584, 1375, 947, 831, 564 
2176, 1766, 1230, 1033, 653, 517, 453, 394, 298, 234/220, 154 
7749, 3218, 2837, 2137, 2076, 1293, 859, 700, 30, 12
9042, 6557, 3260, 2076
7749, 2837, 2700, 1292, 1256, 12
9041, 4093, 2712
7749, 2837, 1460, 1325, 12
9042, 4337
c.
Figure 2.3. Positive clones of pUAST-MLL, pUAST-MLLAF4, and pUAST- 
MLLAF9 were verified by restriction digests. Diagnostic restriction enzyme digests with 
either Stu I or with Stu I and BamH I revealed that MLL, MLL-AF4, and MLL-AF9 were 
properly cloned into pUAST. (A) A schematic representation of the pUAST constructs used 
to make transgenics. Protein expression requires the binding of Gal4 onto the five UAS 
regulatory elements. The white gene is used as a selection marker to detect which flies have 
integrated the pUAST construct into the genome, whereas ampicillin resistance facilitates 
propagation of the pUAST plasmid. (B) Expected band sizes after the indicated digestion. 
(C) Electrophoresis gel showing that the pUAST constructs digested as expected.
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pUAST-MLL, pUAST-MLL-AF9, and pUAST-MLL-AF4 were microinjected into 
w^ *^  ^embryos harbouring a mutation at the white locus. Around 30-50% of the embryos 
survived and were then crossed to Bcgl/Cyo virgins or males (Fig 2.4). Bcgl/Cyo marks the 
second chromosome o f Drosophila and was used to map which chromosome the pUAST 
construct integrated. Progeny from this cross were screened for the presence of white 
expression, which was used as a transformation marker. At least 5 randomly integrated 
independent transgenic lines for each P-element pUAST construct were obtained and were 
maintained as separate stocks.
pUAST Construct No. of w embryos injected Percentage of hatched No. of Transgenic Fly
embryos____________Lines generated
MLL 339 50.4%
MLL-AF4 528 36.9%
MLL-AF9 488 55%
Figure 2.4. Injection of embryos with pUAST-MLL, pUAST-MLLAF4, 
and pUAST-MLLAF9, recovered 7-8 independent lines. Two lines of each 
construct were selected for further experiments.
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2.2.3 MLL fusion proteins induce larval to pupal lethality in Drosophila.
To identify phenotypes that are induced by the MLL fusion proteins (designated as 
MLL-AF4 or MLL-AF9) and/or by full-length MLL (referred to as MLL), the UAS-Gal4 
system was employed. The UAS-Gal4 system adapts the yeast Gal4 as an intermediary 
protein for the expression of protein sequences juxtaposed to the UAS (Upstream Activating 
Sequence), which allows transcription upon specific binding by GAL4 (Brand and Perrimon, 
1993; Fig. 2.5). Two separate fly lines are required for this system: one expressing the Gal4 
protein, or the "Gal4 driver" , and a second containing the appropriate pUAST fly line. The 
advantage of using the system is that protein expression can be limited to specific tissues and 
to desired time windows.
(VaW lu bei'
Veil'll (»ul4 Gene
tissue-specific or 
inducible enhancer I
p i  AS I (  niJ^Ïflicl
UAS hsp70 
promoter
target protein white
Figure 2.5. The UAS-GaI4 system. The controlled expression of a desired transgenic 
protein (“target protein”) is achieved by crossing a fly line harbouring the pUAST construct 
encoding the “target protein” with a Gal4 driver line. The Gal4 driver consists of a tissue 
specific promoter or inducible enhancer element, upstream to the yeast Gal4 gene. The 
promoter or enhancer element limits Gal4 expression to specific tissues at defined times in 
development depending on the element’s natural activity. The expression of the “target 
protein”, which is under the control of the Gal4 UAS regulatory elements and a minimal heat 
shock promoter, requires the binding of Gal4 to UAS. Therefore, the “target protein” 
expression is defined by the expression profile of Gal4.
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MLL, MLL-AF9, and MLL-AF4 transgenic lines were crossed to several Gal4 drivers, 
and progenies were then analyzed for phenotypes induced. All Gal4 drivers used to express 
MLL resulted in completely normal, viable flies. On the other hand, expression of MLL-AF4 
and MLL-AF9 caused larval stage 2 to pupal lethality when expressed ubiquitously in the fly 
(Fig. 2.6). Interestingly, it was noted that the time of development was significantly 
prolonged for MLL-AF4 and MLL-AF9 transgenic lines. At 29 °C, Drosophila requires 8 
days to develop from an embryo into an adult fly. Flies expressing MLL fusion proteins enter 
larval stages like wild-type and MLL expressing flies; however, at larval and pupal stages, 
development extends over time (Fig 2.6). This phenomenon has never been observed for flies 
expressing full-length MLL.
It is important to note that for all crosses, at least two independent lines were used.
The reason for this precaution is to confirm that indeed the phenotype induced is not a 
consequence of the insertion site of the pUAST vector during microinjection. Additionally, 
because gene expression varies according to the chromatin environment at the site of 
integration, the severity of the lethal phenotype can be correlated with transgenic protein 
expression levels. It has been established that the extent of red eye pigment reflects the 
accessibility Gal4 has to the UAS regulatory element (Brand and Perrimon, 1993).
Accordingly, for each transgenic construct, an earlier lethality is observed for fly lines with 
darker eye pigments (such as MLL-AF9-T2 and MLL-AF4-T1G in Fig 2.6). Western blot 
analysis, using specific antibodies, which recognise the N-terminus of MLL, confirmed that 
indeed differential levels of protein expression exist, and that these levels correlate with the 
severity of the lethal phenotype (Fig 2.7).
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Approximate
Developmental
embryonic
T 1 T 0
larval
^  1
pupal
Stage Lil iLiô ^1
Days
MLLAF9-T2
MLLAF4-4C
MLLT2 
M LLA F4-T1G
-«H-MLLT5
-A f-M LLA F9-T5
Figure 2.6. MLL fusion proteins, but not full-length MLL induce lethality in 
Drosophila melanogaster. To determine what kind of effect MLL, MLL-AF4, and 
MLL-AF9 may have on fly development, expression of the transgenic proteins by a 
strong Gal4 driver was used. The daughterless Gal4 (da Gal4) driver was selected since 
Gal4 expression is induced in high levels and begins at embryogenesis lasting 
throughout development. Transgenic flies, harbouring the pUAST-MLL, the pUAST- 
MLLAF4, or the pUAST-MLLAF9, were crossed to the daughterless Gal4 driver at 29 
”C, and progenies were analysed for developmental malformation(s). Strikingly, MLL- 
AF4 and MLL-AF9 were found to strongly inhibit completion of Drosophila 
development, by apparently interfering with later developmental pathways. It was 
observed that embryogenesis proceeded like wild-type, whereas a delay in larval and 
early pupal development was observed. MLL-AF4 and MLL-AF9 expressing flies 
eventually died at larval to pupal stages. Importantly, this remarkable phenotype was 
never observed significantly with MLL expressing transgenic lines. Although MLLT2 
displayed a lethality of 20% at late pupal stages, control crosses x da GaI4), were 
also noted to exhibit a similar percentage of lethal pupae.
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Figure 2.7. Transgenic proteins are expressed both at the RNA and at the protein 
levels. MLL, MLL-AF4, and MLL-AF9 were expressed with the daughterless Gal4 driver 
at 29 °C. (A) As shown, RT-PCR specific against the N-terminus of the MLL gene 
demonstrated that the complete ORF was being transcribed. (B) Western blot analysis 
revealed that the appropriate proteins, corresponding to the approximate expected transgenic 
protein sizes (MLL: 437 kDa; MLL-AF4: 250 kDa; MLL-AF9: 171 kDa), were detected 
from 20 dissected imaginai discs isolated from instar larvae in the presence of Gal4. The 
bands were found to be absent in fly lines harbouring the pUAST constructs alone (right). 
Arrows point to the specific transgenic protein band corresponding to the protein indicated 
above the lane, whereas the protein band defined by the arrow head has been consistently 
observed in MLL Western blots (R. Slany, unpublished results).
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2.2.4 Directed expression of MLL fusion proteins at late developmental stages, in 
blood or in neuronal cells is sufficient for lethality.
To uncover additional effects caused by MLL and/or by MLL fusion proteins in 
Drosophila, a series of Gal4 driver lines were selected. These Gal4 driver lines possess 
special qualities that limit protein expression to specific tissues or to defined time in 
development. All crosses were performed in three different temperatures, at 18 °C, 25 °C, and 
29 °C. The increase in temperature has been documented to cause higher protein expression 
levels due to a rise in Gal4 levels (Brand and Perrimon, 1993). Importantly, in all Gal4 drivers 
used to express MLL-AF9 and MLL-AF4, progenies were either normal or were lethal, 
indicating that MLL fusion proteins specifically and strongly alter an important pathway(s) 
necessary for completion of development. Figure 2.8 summarises the Gal4 driver lines used 
and indicates whether the lethal phenotype is observed.
Three different classes of Gal4 driver lines were tested for the lethal phenotype. The 
first category expresses the desired protein only at early embryogenesis (Fig. 2.8B). This is of 
particular interest since TRX and MLL are required to maintain appropriate gene expression 
during early development. In principle, MLL and/or MLL fusion proteins could prevent 
proper maintenance of gene expression patterns by TRX during embryogenesis. However, the 
lethal phenotype was never observed in any of the transgenic lines. This result indicates that 
MLL-AF9 and MLL-AF4 are not altering the classical pathway of TRX, involving the 
maintenance of early gene expression patterns.
The second class of Gal4 drivers used has been collectively termed late expressing lines 
(Figure 2.8B). These Gal4 drivers induce expression from late embryogenesis and throughout 
development. GawB is a constitutive promoter, which becomes active in all imaginai discs 
(Wilder and Perrimon, 1995). Act5C was isolated from the actin promoter and allows 
expression throughout development, peaking at late larval and pupal stages (Ito et al., 1997). 
Daughterless is a maternal protein ubiquitously expressed throughout development 
(Cronmiller and Cummings, 1993). Expression of MLL-AF9 and MLL-AF4, but not of MLL, 
under the control of these three drivers resulted in lethality. Manifestation of lethality 
correlated with the presence of proliferating tissues, which in Drosophila occur primarily in
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imaginai discs at larval stage. These results, in conjunction with those involving early 
expressing lines, suggest that MLL-AF9 and MLL-AF4 interferes with a TRX-dependent or - 
independent function operating during late stages of development.
The third class of Gal4 drivers examined, were tissue specific. The MZ1580 driver, 
which expresses Gal4 in blood cells, induced lethality in MLL-AF9 and MLL-AF4 transgenic 
lines (Figure 2.8B). The MZ1580 driver was initially isolated in an enhancer screen for Gal4 
expression in glial cells (Hidalgo et al., 1995). It was subsequently noted that this driver 
induces expression in macrophages (hemocytes). The latter comprises most of the Drosophila 
immune system. Gal4 expression commences at stage 11 when the first macrophages are 
released from the mesoderm of the procephalon. Following embryogenesis, Gal4 expression 
by MZ158Û becomes ubiquitous (Figure 2.9). When MLL-AF9 and MLL were driven by 
MZ1580, MLL-AF9 and MLL-AF4 alone, and not MLL, induced a severe lethal phenotype.
Using a Gal4 driver, gem (glial cell missing) Gal4 which limits the expression of MLL 
and MLL fusion proteins at macrophages only (Bemardoni et al., 1997), revealed that MLL- 
AF9 and MLL-AF4 could not induce the full lethal phenotype, although partial lethality was 
observed. No effect of MLL expression by this gem Gal4 driver on fly development was 
observable. The outcome of these experiments suggested that MLL fusion protein expression 
confined only to macrophages is not sufficient to completely inhibit fly development, again 
supporting the idea that expression of MLL fusion proteins in additional tissues at late 
development is an important event to recapitulate the late lethal phenotype. In this respect, it 
is interesting that the lethal phenotype was also observed when MLL-AF9 and MLL-AF4 
were expressed in neural cells using the elav Gal4 driver, which sustains strong protein 
expression throughout development (Yao and White, 1994).
Taken together, the strong biological effect conferred by MLL-AF9 and MLL-AF4, 
together with the failure to find any effect associated with expression of normal MLL, 
supports the notion that Drosophila is a physiologically relevant system to study the role of 
MLL fusion proteins in a whole organism setting.
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Figure 2.8. Directed expression of MLL fusion proteins at late developmental stages 
and at neuronal and blood cells is sufficient to induce the lethal phenotype. MLL, 
MLL-AF4, and MLL-AF9 transgenic flies were crossed to several Gal4 drivers expressing 
Gal4 at different times and at specific tissues during development. (A) Several GaI4 driver 
lines used to express the transgenic proteins resulted in no observable phenotype, 
indicating that the presence of the exogeneous proteins is not toxic to the flies. (B) While 
early expression of MLL-AF9 and MLL-AF4 induced no lethal phenotype, expression of 
the MLL fusion proteins throughout or during late development caused fly lethality. 
Expression of MLL-AF9 and MLL-AF4 in the hematopoietic system or in neurons was 
also found to be sufficient for the manifestation of MLL fusion associated lethality. 
Importantly, lethality was never observed for MLL transgenic lines using any of the Gal4 
drivers. ( v ; viable, t  : lethal, +/-: partial lethality (+/- 50%), ND: not determined)
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UAS-GFP
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Figure 2.9. The blood cell MZ1580 Gal4 driver expresses Gal4 ubiquitously 
after embryogenesis. Since the pattern of Gal4 expression by the MZ1580 
enhancer has only been characterised in embryogenesis (Hidalgo et ah, 1995), the 
pattern of Gal4 expression at later developmental stages was defined by crossing 
UAS-GFP with MZ1580. As shown, Gal4 expression by the undefined enhancer 
becomes ubiquitous throughout larval and pupal stages.
2.2.5 MLL cannot relieve late lethality induced by MLL-AF9 and MLL-AF4.
Since the expression of transgenic proteins by other strong Gal4 drivers did not affect 
larval or pupal development (Figure 2.8A), the lethal phenotype induced by MLL fusion 
proteins, when expressed at specific tissue and time in development (Figure 2.8B), is not due 
to a toxic effect by transgenic protein levels. To explore the relation between MLL and MLL 
fusion proteins on fly viability, stable lines containing several copies of one pUAST contruct 
or combinations of several pUAST constructs were generated. Since a higher amount of MLL 
fusion proteins correlates with a more severe lethal phenotype, as shown in Figure 2.6, 
increasing the copy number of MLL-AF4 or MLL-AF9 predicts an earlier stage lethality. As 
shown in Fig. 2.10, two copies of MLL-AF4 or MLL-AF9 induced lethality at pupal or larval 
stages, respectively. The similarity in phenotypes as shown in Figure 2.6 suggests that the 
lethal effect exhibited by the MLL fusion proteins can only be modulated to a certain extent, 
whereby additional amount of proteins has no effect.
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To investigate if the presence of wild-type MLL can alleviate the lethal effect exhibited 
by MLL fusion protein expressing flies, by possibly interacting with MLL fusion proteins 
and thus creating non-functional entities, MLL was expressed with either MLL-AF9 or MLL- 
AF4. Effect on the lethal phenotype was not observable (Fig 2.10). The expression of MLL- 
AF9 and MLL-AF4 together also did not affect the severity of the fly lethality observed in 
flies expressing either MLL-AF9 or MLL-AF4 alone. This result implies that the MLL fusion 
proteins appear to not synergise in functional activity (Fig 2.10). Collectively, the results 
indicate that MLL fusion proteins interfere with fly development by acting in a dominant 
negative fashion, irrespective of full-length, and that MLL fusion proteins appear to target 
distinct pathways.
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Figure 2.10. Additional expression of MLL or of MLL fusion protein does not alter 
the lethal phenotype. Stable stocks, containing several copies of MLL or of MLL fusion 
protein constructs, and of various combinations of MLL and MLL fusion constructs, were 
expressed with the blood MZ1580 and the late expressing ActinSc Gal4 drivers. Both 
Gal4 drivers were observed to induce the lethal phenotype with one copy of MLL-AF9 and 
of MLL-AF4 (Fig. 2.8), but not with one or two copies of MLL. Excessive copies of 
MLL-AF9 or MLL-AF4 did not alter the stage of the lethal phenotype, nor did flies 
expressing both MLL-AF4 and MLL-AF9 exhibit an earlier lethal phenotype. Presence of 
MLL with MLL-AF9 or MLL-AF4 could also not enhance fly viability. These results 
indicate that MLL fusion proteins act in a dominant negative fashion, irrespective of wild- 
type MLL, to inhibit vital pathways required for the completion of fly development, and 
appear to target separate pathways. Bars represent what stage progenies with the indicated 
genotype developed. Percentage numbers reflect the portion of progenies lethal at that stage 
in development (the remaining offspring was normal and viable).
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2.3 Discussion
The results presented in Chapter 2 display a clear dichotomy in functional interference 
between MLL and MLL fusion proteins in Drosophila development. Apparently, MLL 
fusion proteins have gained additional functions possibly through their novel C-terminal 
sequences, which specifically inhibit or deregulate an essential pathway(s) necessary for 
Drosophila viability. Full-length MLL, on the other hand, has no effect in all conditions 
tested. Initially, the similar and severe phenotype induced by both MLL fusion proteins, 
MLL-AF9 and MLL-AF4, suggests that possibly, MLL fusion proteins deregulate a common, 
essential pathway necessary for cell survival at late developmental stages in Drosophila. This 
speculation is supported by the facts that (1) the presence of the transgenic proteins is not 
toxic, and (2) that all Gal4 drivers used to express MLL fusion proteins generated either 
normal or lethal progenies. However, the lack of a more severe lethal phenotype by the 
expression of both MLL-AF4 and MLL-AF9 argues for MLL-AF9 and MLL-AF4 targeting 
separate and important pathways necessary for the completion of development. The 
identification and subsequently dissection of the pathways with which these proteins interfere 
may potentially elucidate the contribution to leukemogenesis by MLL fusion proteins at the 
molecular level. In this context. Drosophila melanogaster would provide an invaluable tool for 
studying the functional roles MLL fusion proteins have acquired and/or have lost within a 
complex chromatin setting.
The finding that MLL fusion proteins can recapitulate the lethal effect by their 
presence in the blood system of the fly support the only published results in mice 
demonstrating that expression of MLL-AF9 induces cancer in myeloid, and to a certain extent, 
lymphoid blood cells, as in the human disease, and correlate with symptoms from human 
patients where aberrant MLL proteins are associated with leukaemia (Corral et al., 1996; Fui, 
2000; Ayton and Cleary, 2001). The surprising result that expression of MLL fusion proteins 
at macrophages only cannot recapitulate the lethal phenotype suggests several points. First, 
MLL fusion proteins may not acquire the full capacity to deregulate the function of the 
immune system on their own, because of their inability to interact with conserved 
transcription factors regulating hematopoeitic differentiation (Chapter 3). Alternatively, low
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transgenic protein levels induced by the weak expressing gem Gal4 driver may be insufficient 
to induce complete lethality. In this respect, Figures 2.7 and 2.8 linked the severity of the 
lethal phenotype with transgenic protein levels. Second, and more likely, additional tissues 
expressing the fusion proteins are necessary for the manifestation of the lethal phenotype. In 
Drosophila immune system, the interplay between fat bodies and lymph glands/macrophages 
is necessary for appropriate immunological functions (Hoffinan et al., 1999). The fat body 
has been documented to produce anti-microbial peptides, which aid in the recognition of “non­
self ’ antigens (Meister et al., 1997; Ferrandon et al., 1998; see Section 3.1). The misregulation 
of peptide production causes a dysfunctional immune system (Meister et al., 1997).
Therefore, expression of MLL fusion proteins only at macrophages by the gem Gal4 driver 
may not be sufficient to disrupt regulation of the blood system. Indeed, GFP expression 
studies with the blood Gal4 driver MZ1580 shows that upon completion of embryogenesis, 
an ubiquitious expression pattern takes over throughout the remaining developmental stages. 
The fact, that lethality is observed in crosses with MZ1580, indicates that the expression of 
MLL fusion proteins in all imaginai tissues is an important event to acquire lethality. The 
finding that lethality is observed when Gal4 expression is sustained during later stages of 
Drosophila development underscores this point.
In addition to over-proliferation of blood cells, 3% of patients suffering from MLL- 
derived acute leukemia have been diagnosed to display extramedullary disease associated with 
the central nervous system (CNS) (Reaman et al., 1999; Dordelman et al., 1999). Failure to 
include specific therapy directed towards the CNS has resulted in the development of CNS 
leukemia in 50-70% of MLL patients (Pui et al., 1998). These reports indicate that MLL 
fusion proteins may have secondary tumourigenic effect beyond their effect on blood cell 
proliferation. In this respect, it is interesting that the Drosophila system has identified an 
additional pathway with which MLL-AF9 and MLL-AF4 interfere. The lethality observed in 
these studies, when MLL-AF9 and MLL-AF4 are expressed in neurons, may bear on the CNS 
disease.
Several models have been proposed to account for the existence of a heterogeneous 
MLL fusion protein population in leukaemia. At first, it was suggested that the N-terminal 
portion of MLL was crucial for leukemogenesis. However, the disruption of only the MU gene
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is not sufficient for the development of leukaemia as indicated by MLL-myc mice, which do 
not develop the disease (Corral et al., 1996). Most importantly, the study pointed to the C- 
terminal portion of the fusion protein as an entity conferring the chimera proteins 
tumourigenic. In support of this argument, the findings in the fly demonstrate that likely, the 
AF4 and AF9 C-terminal sequences enable the MLL fusion proteins to affect cell viability. 
Generation of Trx-AF4 and Trx-AF9 fusion proteins in Drosophila would validate if indeed 
only the C-terminal partner inhibits fly viability.
The study of MLL in Drosophila also comments on the relevancy of oligomerisation 
as a mechanism for oncogenesis. The recent publication of MLL-|3-gal causing leukaemia in 
mice, and the demonstration that MLL’s SET domain harbours the capacity to self- 
oligomerise and to oligomerise with ASHl resulted in the speculation that oligomerisation 
between MLL fusion proteins with other components confers tumourigenic potential to at 
least some of the fusion proteins (Dobson et al., 2000; Rosenblatt-Rosen et al., 1998). The 
fact that MLL does not interfere with TRX function, suggests that oligomerisation between 
the SET domains appears to not have any dire effects on fly viability. In this respect, the 
results with the expression of MLL-AF9 and of MLL-AF4 in flies would argue for the 
specific interference(s) with vital pathways as a venue to achieve cell deregulation. Future 
experiments designed to express various constructs consisting of the N-terminal MLL fusion 
sequence, of AF9 and of AF4 C-terminal sequences, and of lack of the SET domain in both 
MLL and TRX sequences should elucidate more precisely the role of oligomerisation as 
functions of MLL leukaemic fiision proteins.
Intriguingly, the presence of MLL fusion proteins during early development was found 
to cause no developmental aberrations. If it is assumed that MLL N-terminal function remains 
intact and targets the chimeric proteins to MLL target genes during early development, it 
should be expected that proper maintenance of genes regulated by TRX is perturbed, assuming 
that TRX and MLL are interchangeable due to their conservation. The change in gene 
expression profile would be a result of dominant gain-of-function activities presumably 
originating from the C-terminus of the fusion protein. It is known that a critical step in 
development occurs where the switch between maternal and segmentation transcription factor 
regulation to PcG/trxG regulation occurs during embryogenesis. The lack of interference
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observed with MLL fusion proteins at this level of regulation suggests that MLL fusion 
proteins appear to interfere with a TRX independent or a non-classical TRX pathway.
To date not much is known about how PcG and trxG members behave in later stages in 
development. It is forseeable that additional functions are mediated by PcG/trxG members 
during late development. A precedent in this respect is the well-established connection 
between Bmi-1, a PcG mouse homologue of Posterior sex combs (Psc), and ink4a-Arf, a cell 
cycle control gene (see Section 1.4.3). Over-expression of Bmi-1, as found in many cancers, 
causes the suppression of ink4a-Arf locus, which encodes two tumour suppressor genes. The 
potential that the Drosophila system can decipher a property similar to Bmi-1 for MLL in the 
regulation of cell cycle control is highly plausible and exciting. In this case, possibly, MLL 
fusion proteins alter a late TRX (and analogously, MLL in mammals) fonction required for the 
completion of Drosophila development (Chapter 4).
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CHAPTER 3
MLL fusion proteins do not generate leukaemia or interfere with the 
apoptosis pathways in Drosophila melanogaster.
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3.1 Introduction
The balance between cell proliferation and cell death has been postulated to be crucial 
during cell transformation (De Lorenzo et al., 1999). The remarkable discovery that insects 
are capable of developing neoplastic tissue demonstrated that the pathways controlling the 
regulation of cell proliferation are conserved across species. In addition, the ease with which 
insect models, especially the well-characterised Drosophila melanogaster, can be created to 
harbour mutations, allowed studies to elucidate the components required for neoplastic 
development. The pioneering studies, led particularly by the laboratory of Elisabeth Gateff, 
paved the way for the development of Drosophila as a model system to aid in the 
understanding of the mechanisms contributing to the onset of cancer (Gateff and 
Schneiderman, 1967).
The Drosophila model for cancer studies has identified several tumour suppressor 
genes, which were mutated in the human disease (De Lorenzo et al., 1999). The use of 
Drosophila genetics has also uncovered how different components relate to one another to 
abrogate cell integrity. The best example to date is the elucidation of Dig (discs large), Igl 
(lethal giant larvae), and scribble, whose actions act on a common pathway to maintain 
apical-basal cell polarity and proper cell proliferation (reviewed in Wodarz, 2000).
Specifically, all three proteins act on maintaining cell adhesion and are dependent on one 
another for correct localisation to septate junctions (Bilder et al., 2000). For epithelial-derived 
cancers, these results have large implications, suggesting that cytoskeletal organisation may 
aberrantly affect signalling components confined at cell junctions (Binder et al., 2000).
Mutations affecting blood proliferation and/or differentiation have also been studied 
extensively. The functional characterisations of these mutants are potentially insightful given 
the highly conserved hematopoetic systems between mammals and Drosophila . In mammals, 
the hematopoeitic system develops initially from the embryonic yolk sac and eventually 
diversifies into the myeloid and lymphoid cell lineages from stem cells in the bone marrow. 
Similarly, Drosophila's hematopoietic system commences at embryonic stage 11, and is 
released from the procephalon to give rise to hemocytes, or blood cells. Both the mammalian
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derived myeloid and lymphoid lineages as well as the Drosophila hemocytes are responsible 
for detection and disposal of invasive material, and use homologous transcription factors for 
their differentiation (Rizki and Rizki, 1981; Daga et al., 1996).
Simplistically, the immune response in mammals includes the recognition of non-self 
determinants by macrophages/monocytes, and the subsequent display of antigens to T-cells. 
T-cells in turn triggers specific immune response by activating B-cells for antibody 
production. The release of cytokines, triggered by activated macrophages, also help recruit 
and activate immune cells. In Drosophila, a similar response occurs. Identified non-self 
material is recognised by phagocytosing plasmatocytes or macrophages, and induce 
production of antimicrobial peptides, which facilitate recognition of invasive material. 
Encapsulation of the material occurs by the actions of lamellocytes, which aggregate around 
the pathogen. Somehow, activation of the crystal cells releases products of the phenoloxidase 
casacade which result in melanisation of the material (Ip and Levine, 1994). The ability of the 
Drosophila immune system to “remember” a foreign pathogen, as in the case in mammals, was 
remarkably demonstrated by Boman et al. (1972) who showed that flies injected with 
attenuated bacteria were protected against further infections.
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Proplasmatocyte Procrystal cell
Hemolymph
Proplasmatocyte Procrystal cell
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Plasmatocyte Crystal cell
1
Podocyte
1
Lamellocyte
signal(s)? FAT
BODY
Defense
Mechanism Phagocytosis
Melanotic
Masses
Antimicrobial
Peptides
Figure 3.1. A schematic representation of blood cell differentiation in Drosophila. The precursors of 
Drosophila blood cells, or hemocytes, are developed in the lymph gland of the larvae. Precursors are 
released to the blood stream (hemolymph), which circulates the larval and adult body cavities. During an 
infection, the precursors differentiate into mature cells associated with specific immune functions. 
Plasmatocytes and podocytes are phagocytosing cells that first detect pathogens wheras lamellocytes 
encapsulate foreign material by aggregating around it. The crystal cells are responsible for releasing 
products of the phenoloxidase cascade that allow melanisation to occur. Antimicrobial peptides, produced 
in the fat body, are thought to enhance immune activity, by recognising “non-self’ material, (adapted 
from Gateff, 1978; Mathey-Prevot and Perrimon, 1998; Hoffmann et al., 1999)
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Three types of mutations affecting blood cell development have been reported. The 
categories include (1) mutations preventing blood cell proliferation (Gateff, 1994; Braun et al., 
1998), (2) mutations allowing overgrowth of plasmatocytes and their differentiation into 
lamellocytes (Watson et al., 1991; Tôrôk et al., 1993), and (3) mutations inducing malignant 
neoplastic transformation of plasmatocytes (Gateff, 1978; Hou and Perrimon, 1997). The 
most striking mutations affecting the blood system include domino, which are devoid of 
hemocytes and which is similar to the “bloodless” phenotype of the mammalian null mutant 
for CBFA2/CBFB, and hopscotch, the only dominant Drosophila oncogene, which encodes 
the Jak kinase and which allows over 10 fold increase in plasmatocytes and premature blood 
cell differentiation at 29 °C (Braus et al., 1998; Binari and Perrimon, 1994; Hanratty and 
Dearold, 1993; Castilla et al., 1996; Okuda et al., 1996; Wang et al., 1996).
Interestingly, a member of the PcG family, multi sex combs (mxc), failed to 
complement the lethal(l)malignant blood neoplasm (l(l)mbn) mutation (Santamaria and 
Randhold, 1994). l(l)mbn is often considered as the prototype example of flies harbouring 
malignant blood cell tumours. l(l)mbn flies exhibit enlarged hematopoeitic organs, display 
constitutive expression of the antibacterial peptide diptericin, and are associated with 3-7 fold 
increase in blood cell counts and with a shift in blood cell differentiation fi*om the hemolymph 
to the lymph glands (Shresta and Gateff, 1982a; Shresta and Gateff, 1982b). It is speculated 
that the inability of the numerous free plasmatocytes to recognise “self’ from “non-self’ cause 
invasion of larval tissues for phagocytosis by abundant lamellocytes and podocytes (reviewed 
in Gateff 1994). The creation of these aggregates, or melanomes, is thought to result in pupal 
lethality. The fact that l(l)mbn is mxc, has implicated PcG members in regulation of specific 
cell-types. Interestingly, in humans, several PcG and trxG members induce several types of 
hematopoeitic cancers when mutated (see Sections 1.4 and 1.5).
In addition to alteration in blood cell proliferation, mutations giving rise to tumours in 
the fly have been shown to be important for the integrity of chromatin structure. Two papers 
have demonstrated that some Drosophila tumour inducing lines are associated with defect in 
somatic pairing, as determined by polytene analysis (Riede, 1996). The remarkable formation 
of polytenes in the brain, which never occurs in the wild-type situation, has also implicated
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these mutants to somehow induce DNA replication at S-phase of the cell cycle without 
mitosis. The net result is the detection of “polytene-like” structures in the brain (Reide, 
1996).
Chapter 2 presented evidence demonstrating that MLL fusion proteins act in a 
dominant negative manner to cause larval to pupal lethality, and importantly, their expression 
at the hematopoeitic system of the fly is sufficient to induce lethality. The finding that mxc is 
implicated in deregulating blood cell homeostasis encouraged experiments directed at 
elucidating the effect MLL fusion proteins have on blood cell development. For this, blood 
cells from the hemolymph were isolated from larvae and were found to be relatively normal in 
number and in morphology, indicating that expression of MLL fusion proteins does not cause 
leukaemia in a wild-type background. Although it appears that blood cell proliferation is not 
affected by MLL fusion proteins, analyses of polytenes revealed that only MLL-AF4 and 
MLL-AF9 are associated with defect in polytene pairing, although polytene-like structures in 
the brain were found in MLL and in MLL-AF4, and surprisingly, not in MLL-AF9.
Since MLL fiision proteins have been implicated to inhibit or to induce apoptosis in 
tissue culture experiments (see Section 1.5.4), it is conceivable that fly lethality by MLL 
fusion proteins may reflect the inability of cells to die or to survive at correct times in 
development, and therefore, halt developmental progression. To address if MLL fusion 
proteins affect the apoptosis pathway, cell clones expressing the appropriate proteins were 
generated. Isolated imaginai discs, containing the clones, were subjected to the apoptosis 
TUNEL assay. Results support that MLL fusion proteins appear to not affect cell death 
program during development, and demonstrate that MLL fusion proteins behave differently in 
a complex, multi-cellular environment.
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3.2 Results
3.2.1 Blood cells are normal in MLL and in MLL fusion chimera transgenic fly lines.
The hemolymph'm Drosophila consists of hemocytes, which collectively comprise the 
blood system of the fly (Mathey-Prevot and Perrimon, 1998). Within the hemolymph, 
several types of blood cells are detected. In wild-type flies, the hemolymph consists largely of 
plasmatocytes. However, blood tumour mutants possess various blood cell types in the 
hemolymph under non-infectious conditions (Gateff, 1994). Blood cell types include 
lamellocytes and podocytes, which are responsible for encapsulating and phagocytosing 
invasive, “non-self’ material. Normally, the differentiation of plasmatocytes into lamellocytes 
and podocytes occurs during larval infection. The finding of several classes of blood cells in 
the hemolymph of tumour mutants indicates that pre-mature differentiation has occurred.
To assess if MLL fusion proteins perturb the development of fly hematopoesis, 
hemolymph from 10 larvae from each transgenic lines was isolated. The hemolymph solution 
was placed on a drop of mineral oil on a hemocytometer, and hemocytes were counted. As 
shown in Fig 3.2, the numbers of hemocytes for each transgenic line were elevated as 
compared to wild-type. In addition, characterisation of the morphology of the hemolymph 
revealed that like wild-type only plasmatocytes were observed (Fig. 3.3). Differentiated cells, 
such as lamellocytes and podocytes, were not present. Taken together, these results 
demonstrate that the effect by MLL and by MLL fusion proteins alone on blood cell 
proliferation and blood cell differentiation, do not inhibit completion of Drosophila 
development.
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Figure 3.2. Hemocyte counts reveal that MLL and MLL fusion proteins 
equally affect blood cell proliferation. MLL, MLL-AF4, and MLL-AF9 were 
expressed using the MZ1580 blood cell Gal4 driver. (A) Hemolymph from 10 
larvae for each transgenic fly line and for wild-type was isolated and counted on 
a hemocytometer. Average of blood cell counts reveal an equal effect on blood 
cell proliferation by MLL and by MLL fusion proteins. (B) Relative ratios of 
hemocyte counts between MLL transgenic lines and wild-type. These results 
indicate that the elevation of blood cell numbers do not correlate with MLL 
fusion protein induced lethality.
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Figure 3.3. Blood cell differentiation is apparently unaffected in transgenic 
fly lines. MLL, MLL-AF9, and MLL-AF4 were expressed using the blood 
Gal4 line MZ1580. Under this condition, MLL fusion proteins induce larval and 
pupal lethality. Isolation of hemolymph from these larvae for all transgenic fly 
lines demonstrated that MLL, MLL-AF9, and MLL-AF4 expressing hemolymph 
comprised of plasmatocytes (B) as in the case of the viable Gal4 driver line, 
MZ1580 (A). Several blood types that have been documented in blood tumour 
fly lines are shown as follows: (C) plasmatocytes, (D) activated macrophages, 
(E) lamellocytes, (F) crystal cells (M. Meister, Strasbourg, France). None of 
these differentiated blood cells were observed in any of the hemolymph isolated 
from the transgenic lines.
3.2.2 Polytenes in the brain and somatic pairing defect in polytenes indicate that 
MLL fusion proteins affect chromatin integrity.
The reports that Drosophila brain tumour mutants displayed pairing defects of 
polytenes and possessed polytene-like structures in the brain suggested that for some tumour 
suppressor mutants, the compromise of chromatin architecture has influenced the cell cycle. 
Presumably, the presence of polytenes suggest that diploid cells in the brain must have 
replicated their genomes numerous times to allow detection of polytene-like strands at 
interphase of the cell cycle. Since MLL fusion proteins are associated with inhibiting the
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function of a chromatin regulator (MLL/TRX), analyses of salivary gland polytenes and of 
brain squashes were performed with the aim to ascertain if the defects were present.
As shown in Figure 3.4, pairing defects were clearly present for MLL-AF9 and MLL- 
AF4 transgenic constructs, although MLL expressing fly lines were never observed to display 
aberrant polytene morphology. In addition, polytene-like structures were found in MLL-AF4 
expressing brains, although not in MLL-AF9 (Fig. 3.5). Unexpectedly, detection of similar 
structures was also documented in MLL expressing fly lines. These results indicate that MLL 
fusion proteins may have a direct role in modulating chromatin architecture. However, effect 
on cell proliferation may not be a property conferred to all MLL fusion proteins.
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Figure 3.4. Pairing defect in polytenes is observed for MLL-AF4 and for MLL-AF9, but not for 
MLL. MLL, MLL-AF4, and MLL-AF9 were expressed using the daughterless Gal4 driver line, which 
allows the induction of the lethal phenotype associated with the MLL fusion proteins at 29 °C. 
Salivary glands were isolated from appropriate fly lines, were spread on slides, and stained with orcein. 
As shown, pairing defect was observed for MLL-AF9 (A; 40x, B: lOOx) and for MLL-AF4 (C: 40x, D; 
lOOx). These defects consist of splits along the arms of the chromosomes, as indicated by the arrows. 
However, splitting of chromosome arms, such as these polytene pairing defects shown, were not 
detected in full-length MLL and in wild-type.
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Figure 3.5. Polytene-like structures were observed in MLL and MLL-AF4, but 
not in MLL-AF9 expressing transgenic fly lines. MLL, MLL-AF4, and MLL- 
AF9 were expressed with daughterless Gal4 at 29 °C, Orcein-stained brain squashes 
with isolated brains from all transgenic fly lines revealed that polytene-like structures 
were present in MLL-AF4 (A) and in MLL (B) (1-2 spreads were observed per 
brain). Unexpectedly, such polytene-like structures were not observed in MLL-AF9.
3.2.3 TUNEL assay reveals that apoptotic pathways appear to be intact in MLL and in
MLL fusion chimera fly lines during Drosophila development.
Tissue culture studies have implicated MLL fusion proteins in the interference of 
apoptosis (see Section 1.5.4). To exclude that fly lethality induced by the MLL fusion 
proteins is a consequence of misregulated apoptotic pathways, clones were generated 
expressing the transgenic proteins, and then subjected to the TUNEL assay.
Figure 3.6 depicts the strategy employed to generate transgenic protein expressing 
clones. The idea is based on the use of the FLP-FRT system. The FLP protein is a site- 
specific recombinase which functions at specific sites called FRT (Dang and Perrimon, 1992). 
The expression of FLP allows recombination between two FRT sites with the outcome that 
sequences between the two FRT sites are excised. Fly lines were created harbouring the 
pUAST expressing transgenic protein construct and the FLP protein under a heat shock 
inducible promoter. These stable lines were then crossed to a Gal4 driver composed of the
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Act-5c promoter, the yellow marker flanked by FRT sequences, and the Gal4 open reading 
frame (AyGal4). A GFP marker under the control of the UAS enhancer has been recombined 
with AyGal4 to allow visualisation of the cells which expresses the Gal4 protein. This group 
of GFP positive cells (clones) also express the transgenic fusion proteins.
hs-FLP UAS- tran sg en ic  pro tein
1 hr, h e a t shock @ 37 ° c
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UAS-GFP
hs-FLP UAS- tran sg en ic  pro tein  A ctS c  p ro m o te r ^  Gal4 UAS-GFP
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hs-FLP UAS- tran sg en ic  p ro tein  ^  Gal4 UAS-GFP
A ctS c p ro m o te r
Generation of Clones: GFP positive & Expression of transgenic protein
Figure 3.6. The FLP-FRT system. Stable stocks were generated containing two DNA 
elements (left); one that allows expression of the FLP recombinase upon heat shock 
(green), and the second, that expresses a transgenic protein under the UAS-Gal4 system 
(yellow) (also see Fig. 2.5). These generated stable stocks were then crossed to an 
inactive Gal4 driver line under the ActinSc promoter (right). The expression of the FLP 
recombinase is induced by heat shocking first instar larvae for 1 hour at 37 °C. The 
presence of the FLP recombinase induces excision of the yellow marker flanked by the 
FRT sequences. This excision allows the expression of Gal4 regulated by the ActinSc 
promoter, thereby generating clones of cells, which express GFP and the desired 
transgenic protein (both are under the control of UAS).
First instar larvae were heat shocked for 1 hour at 37 °C water bath to allow expression 
of the FLP recombinase. Heat shocked vials were then kept at 25 °C until third instar larvae 
developed. From these larvae, all imaginai discs were isolated. The imaginai discs possessed 
GFP positive clones indicating that the FLP-FRT system was functional. If indeed MLL
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fusion proteins affect apoptosis, it is conceivable to expect changes in tissue morphology. If 
MLL fusion proteins inhibit programmed cell death, an outgrowth or an expansion of GFP 
positive tissues should be visible, causing abnormal imaginai disc morphology or large GFP 
positive clones relative to GFP negative areas. Alternatively, the induction of apoptosis by 
MLL fusion protein should cause underdeveloped imaginai discs containing little or no GFP 
positive cells. As shown in Figure 3.8, tissue morphology and clone size appeared normal.
To address the putative apoptotic role of MLL fusion proteins, TUNEL assays were 
performed in isolated imaginai tissues, and monitored for presence of GFP positive clones. 
The TUNEL assay is based on the detection of fragmented DNA, a hallmark for apoptotic 
cells (Robertson et al., 2000), by labelling DNA ends with fluorescein conjugated dUTP 
(Figure 3.7). Figure 3.8 demonstrates that for all transgenic lines, the number of apoptotic 
positive cells, as indicated by punctate red nuclear staining, were comparable in both GFP 
positive and negative cells. Therefore, results from the TUNEL assay demonstrated that the 
number of apoptotic cells were not enhanced or inhibited by MLL fusion proteins during 
Drosophila development.
Apoptotic Cell Healthy Cell
Fragmented DNA:ss-, ds-breale Intact DNA
Terminal deoxynucleotidyl transferase + 
Fluorescein conjugated dUTP (dUTP*)
lUTP* lUTP*
dUTP*
Incorporation & Labeling No Incorporation
Figure 3.7. Schematic represenation of the TUNEL assay. Apoptotic cells are characterised by 
their fragmented genome. The TUNEL assay uses deoxynucleotidyl transferase to label ends of 
DNA with fluorescine conjugated dUTP, Signals from fluorescein conjugated dUTP are enhanced 
by using a secondary antibody against fluorescein. Positively labelled nuclei reflect cells 
undergoing apoptosis.
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TUNEL Merged
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Figure 3.8. MLL, MLL-AF9, and MLL-AF4 do not affect apoptotic pathways 
during Drosophila development. (A) WT imaginai discs were subjected to the TUNEL 
assay. As shown for this leg disc, cells which are undergoing apoptosis during 
development exhibit positive nuclear staining (arrow). (B) MLL, MLL-AF9, and MLL- 
AF4 clones were generated using the FLP-FRT system. The clones, expressing the 
appropriate transgenic protein, are marked with GFP. Cells, which do not express the 
transgenic proteins, are GFP negative. Imaginai discs were isolated harbouring GFP 
positive clones and subjected to the TUNEL assay. The nuclear stainings (red) reflect 
cells that undergo developmental apoptosis. As shown, apoptosis (red nuclear staining) 
is not correlated with GFP positive clones.
70
Absense o f  leukaemia and lack o f  an apoptotic response by MLL fusion proteins
3.3 Discussion
Experiments in Chapter 3 were aimed to explore possible pathways through which the 
MLL fiision proteins may cause larval to pupal lethality in flies. The association of MLL 
fusion proteins in deregulating hematopoeitic homeostasis (see Section 1.5) and in interfering 
with apoptosis in cell cultures (see Section 1.5.4), validated experiments directed at asking if 
such pathways have been compromised.
Studies in mammalian model systems have reported that MLL-AF9 affect myeloid 
differentiation (Slany et al., 1998; Dobson et al, 1999). The finding that expression of MLL- 
AF9, and of MLL-AF4, can ellicit the lethal phenotype when expressed at the hematopoeitic 
system of the fly suggested that MLL-AF9 and MLL-AF4 may affect blood cell 
differentiation and/or proliferation (Chapter 2). The result that isolated blood cells are similar 
in viable MLL, in lethal MLL-AF9 and in lethal MLL-AF4 transgenic flies, indicates that 
MLL fusion proteins’ effect on blood cell differentiation or proliferation in Drosophila does 
not contribute to the induced lethality.
Although presumably MLL fusion proteins are expressed in all cells by the blood Gal4 
driver MZ1580 late in development, the effect by MLL fusion proteins on blood cell 
development, may be masked by a dominant wild-type background. In this respect. 
Drosophila mutants, which are lethal at pre-pupae stage and are deficient for particular 
immune functions, still exhibit intact immune response. The isolation of domino mutants, 
which are devoid of blood cells, illustrates this point (Braun et al., 1998). Remarkably, the 
domino mutants are able to fight septic injury indicating that hemocytes (blood cells) are not 
required for this process. Only in a sensitised background (for instance, additional mutations 
affecting anti-peptide synthesis or melanisation) is defective immune response detected 
(Braun et al., 1998). Therefore, MLL fusion proteins may indeed have a greater dire effect on 
blood cell homeostasis, possibly by inhibiting hemocyte function, but which may only be 
detectable in a sensitised background. Crossing in several Drosophila immune deficient 
mutants to MLL fusion proteins may reveal their effect on blood cell homeostasis. In support 
of this idea, the domino gene has been recently reported to encode novel members of the 
SWI2/SNF2, which are DNA-dependent ATPases working on chromatin to regulate homeotic 
genes (Ruhf et al., 20001). Although domino does not itself induce homeotic transformation,
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it was shown that the lack of domino exhibited classical cell proliferation defect, and 
interestingly, enhanced Polycomb group mutations and counteracted trithorax group effects 
(Ruhf et ah, 2001). Therefore, it appears that indeed chromatin regulation plays a significant 
role in cell viability and in blood cell homeostasis in Drosophila.
An alternative explanation to the lack of an apparent effect by only MLL fusion 
proteins on blood cell differentiation and/or proliferation resides with the ability of MLL 
fusion proteins to interact with conserved transcription factors required for blood cell 
development. In this case, MLL fusion proteins presumably cannot interact with 
transcription factors conserved between mammalian and Drosophila, such as Lozogen (AMLl 
homolog). Serpent (GATA homolog), glial cells missing, or hopscotch (JAK kinase), 
necessary for differentiation of hematopoietic lineages (Harrison et al., 1995; Lebstky et al.,
2000). Section 1.5.2 alluded to the limited conservation between TRX and MLL at their N- 
termini. Thus, the lack of over-proliferating blood cells in Drosophila may be a consequence 
of this unconserved MLL N-terminal sequence, with the implication that MLL fusion proteins 
cannot directly interact with putative transcription factors that may require TRX for their 
proper activities. The generation of an N-terminal TRX with AF9 or with AF4 sequence 
would clarify if this speculation is indeed true, and whether over-proliferation of blood cells 
can then be detected as reported for MLL-AF9 expressing mice (Dobson et al., 1999).
An important point to consider is that mice harbouring the MLL-AF9 translocation 
were demonstrated to not develop leukaemia until a gestation period of 4-12 months, as in the 
human case (Corral et al., 1996). This study indicated that additional secondary hits are 
required for the onset of leukaemia. The fact that leukaemia was not observed in MLL fusion 
protein expressing flies supports the mouse data. Possibly, the emergence of secondary 
mutations, which generate leukaemia in Drosophila, is precluded by the MLL-AF9 and ML- 
AF4 induced lethality.
In addition to characterising the effect of MLL fusion proteins on hematopoeitic 
development, interference with apoptotic pathways was considered as a venue through which 
MLL fusion proteins may cause fly lethality. If indeed MLL fusion proteins are able to 
suppress or enhance apoptosis, as reported by studies based on mammalian cell culture 
(Section 1.5.4), it would be expected that tissue morphology would be altered and that
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suppression or enhancement of apoptotic cells should be confined to cells expressing the MLL 
fusion proteins. As shown in Figure 3.8, neither of the two predictions existed. Therefore, at 
least in the Drosophila model system, apoptosis appears to not be one of the direct targets 
through which MLL fusion proteins interfere. The differing conclusion between the fly and 
mammalian cell culture data may reflect the behaviour of MLL fusion proteins in a relevant, 
developing, multi-cellular environment versus in transformed cell lines, which intrinsically 
possess altered cell cycle control points. Taken together, it appears that at least, MLL fusion 
proteins do not interfere with apoptosis as their primary target during leukemogenesis, 
although it cannot be excluded that MLL fusion proteins require components of a specific 
apoptotic pathway for their effect and for which is not present at the time the TUNEL assay 
was performed in Drosophila.
The finding that chromatin aberrations have been compromised in MLL-AF9 and in 
MLL-AF4 expressing transgenic flies offers an alternative route through which MLL fusion 
proteins target. In light that tumour inducing fly mutants and mutants deficient for 
hematopoetic components are linked with chromatin regulation, MLL-AF9 and MLL-AF4 
may disrupt chromatin integrity as their primary function. Thus, the late manifestation of 
lethality by MLL-AF9 and by MLL-AF4 may reflect the time required for MLL fusion 
proteins to completely disrupt chromatin integrity either directly, or more likely, by 
modulating the activity of chromatin regulators.
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Chromatin effects observed in late lethal trx mutants and in MLL-AF9 
transgenic fly lines are reminiscent o f replication mutant phenotypes.
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4.1 Introduction
Portions of the results presented in Chapter 3 alluded to an effect on the proper 
formation of higher order chromatin by MLL fusion proteins and suggested that polyploidy 
exists in both MLL and MLL-AF4, but not in MLL-AF9. Both these characteristics are 
shared by several tumour suppressor mutants in Drosophila (Riede, 1996b), and may reflect 
functions directly associated with specific MLL fusion proteins.
The polytene-like structures detected in the MLL-AF4 transgenic flies may reflect the 
deregulation of cell cycle control points, allowing continuous rounds of genomic replication.
In Drosophila, a screen for late third instar larval lethals identified numerous mutants 
compromising the fimction of essential components regulating the cell cycle (Gatti and Baker, 
1989). Interestingly, these so called "mitotic mutants" exhibit similar lethal phenotype as in 
MLL-AF9 and of MLL-AF4 transgenic flies. Although polyploid cells could be observed 
from squashed colchicine-treated brain preparations for some mitotic mutants, additional 
phenotypes, such as effects on chromatin condensation and on cell cycle progression, have 
been documented (Gatti and Baker, 1989). The brain squash preparation allows the detection 
for the presence of abnormal accumulation of mitotic figures from one nucleus (polyploidy), 
of aberrant chromatin condensation, and of improper cohesion between sister chromatids. 
Analysing colchicine-treated brain squashes would confirm if MLL and MLL-AF4 indeed 
have an influence on the cell cycle. If the polytene-like structures observed reflect cells that 
have undergone endoreduplication, metaphase spreads of affected cells should exhibit degrees 
of bundled sister chromosomes. In this respect, it is expected that polyploid cells should be 
observed for MLL and for MLL-AF4, but not in MLL-AF9.
A subtype of the mutants identified from the above screen mentioned (Gatti and 
Baker, 1989) has been reported to affect DNA replication and has been shown to play a role 
in cell cycle control checkpoint(s) (Krause et al., 2001). Mutants corresponding to different 
components of the replication machinery display aberrant sister chromatid cohesion, 
chromatin condensation and cell cycle progression defects, and compromised the timing of 
replication (Loupart et al., 2000; Pflumm and Botchan, 2001).
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Two of the three mutants belong to the ORC (Origin Replication Complex) family, 
which act in a complex comprised of six subunits, designated ORC 1-6. The ORC complex is 
thought to provide a "landing pad" for the pre-initiation complex prior to S phase, although 
yeast experiments indicate that the complex is not required for the activation of origins (Hua 
and Newport, 1998; Lee and Bell, 2000). The ORC subunits are in general bound to origins 
throughout the cell cycle, with the exception of ORCl and 0RC2 (Asano et al., 1999; 
Royzman et al., 1999). 0RC2 binding is relieved starting at prophase, and only resumes at 
anaphase (Loupart et al., 2000). The recent characterisation of mutants for 0RC2 and ORC5 
reveals that late larval lethality is a result of inhibited cell proliferation due to a first arrest at S 
phase, as expected (Loupart et al., 2000; Pflumm and Botchan, 2001). The observation that in 
0RC2 and 0RC5 mutants, a higher metaphase to anaphase ratio exists as compared to wild- 
type, indicated that defect in replication causes a second arrest point at metaphase. In 
addition, metaphase-like figures appeared highly condensed with interspersed decondensed 
chromatin fibers. Three different classes of chromosomal aberrations were documented for 
0RC2 and 0RC5 mutants (Pflumm and Botchan, 2001). The most severe class of aberrant 
mitotic figures consisted of less condensed, shorter chromosomes that possibly form as a 
result of loss of sister chromatid cohesion, or of precocious sister chromatid separation from 
metaphase to anaphase transition. This conclusion is supported by a mutant of “proliferation 
disrupter”, a centromeric binding protein, which displays similar mitotic figures in metaphase 
spreads as a consequence of defect in sister chromatid cohesion (Torok et al., 1997). In 
addition, it was noted that the phenotype for chromosomal aberrations in 0RC2 and ORC5 
mutants became progressively more severe in older larvae (Loupart et al., 2000; Pflumm and 
Botchan, 2001). Presumably, the severity of the phenotype is correlated with the amount of 
maternal ORC contribution. The maternal pools for replication or cell cycle proteins deplete 
over time, and consequently, manifestation of lethality occurs late in development. 
Speculatively, the defects in mitotic figures may be a general phenotype of replication 
defective mutants since PCNA (proliferating cell nuclear antigen) and MCM4 (mini­
chromosome maintenance 4) (factors required during DNA replication) mutants also exhibit 
the same aberrations (Pflumm and Botchan, 2001).
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The recent characterisation of another replication protein, Rfc4 (Replication Factor C), 
linked chromosomal and replication defects with cell cycle checkpoints (Krause et a l, 2001). 
Assuming that Rfc4 only functions in DNA replication, it would be expected that cells lacking 
Rfc4 should arrest at S phase and not enter mitosis. The report of a higher mitotic index to 
replication activity in Rfc4 mutants as compared with wild-type suggested that additional 
functions are mediated by Rfc4 during the cell cycle after S phase (Krause et al., 2001).
Indeed, treating Rfc4 mutants with several agents, that damage DNA and lead to cell cycle 
arrest, revealed that cell cycle checkpoints were defective in Rfc4 mutants since a significant 
fraction of treated cells progressed through mitosis (Krause et al., 2001).
The described molecular characterisations of orc2, orc5, and Rfc4 mutants point to a 
much more intimate connection between DNA replication and cell cycle progression, and may, 
in fact, be critical targets during cell transformation. Chapter 4 begins by presenting data, 
which link TRX mediated chromatin integrity at late developmental stages with DNA 
replication. The results demonstrate that TRX has additional, distinct functions other than its 
maintenance role in embryogenesis, and imply that chromatin integrity is an important step 
for the allowance of DNA replication. Only MLL-AF9 was observed to display similar 
chromatin defects in diploid cells as late lethal trx mutants and replication defective mutants, 
although a hyper-initiation of DNA replication was observed. MLL and MLL-AF4 
expressing diploid cells were found to exhibit wild-type mitotic figures and were associated 
with normal DNA replication. Taken together with the earlier finding that the polytene 
architecture from salivary glands of MLL-AF4 and MLL-AF9 (Chapter 3) has been altered, 
accumulative evidence implies that the extent chromatin integrity is compromised, varies 
among MLL fusion proteins. Moreover, these results indicate that MLL fusion proteins 
possess numerous and distinct functions aimed at deregulating various pathways controlling 
the cell cycle. The observed replication effect by MLL-AF9 and not by MLL-AF4, suggests 
that the C-terminal AF9 sequences may aberrantly recruit pre-initiation complexes to origins. 
The results presented in Chapter 4 will be discussed in relation to models proposed for 
replication defective mutants and will consider the novel functional role for TRX at late 
developmental stages.
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4.2 Results
4.2.1 trx mutants, lethal at late larval to pupal stages, exhibit decondensed chromatin
aberrations and reduced DNA replication.
Data from an extensive study on various alleles harbouring different trx mutations 
suggested that TRX is able to incorporate into several complexes whose functions are required 
at different times in development (Breen, 1999). In a heterozygous background, all trx alleles 
are viable, indicating that half the dosage of wild-type TRX is sufficient for proper fly 
development. On the other hand, lethality associated with homozygous trx mutants range in 
its severity depending on the allele. The null TRX mutant, trx^^\ is embryonic lethal, whereas 
several other mutations are lethal at larval or at pupal stages. Two mutants with interesting 
characteristics include the JY16 and the E3 alleles. The trx^^^ mutant is larval lethal when 
combined with a null trx allele (Breen, 1999). Interestingly, this allele was found to consist of 
a translocation point that presumably transcribes an active fusion protein of the longer TRX II 
isoform, although direct evidence is lacking (Breen, 1999). trx^^ corresponds to a deletion 
upstream of the PHD fingers and was observed to exhibit growth defect phenotypes similar to 
signal transduction mutations (Breen, 1999). It is interesting to speculate why minor deletions 
of the trx sequence result in late larval or pupal lethality. A possible explanation may reflect 
additional function(s) for the TRX protein required for the proper maintenance of chromatin 
integrity at late development of the fly. In this case, the maternal contribution of TRX would 
allow development at embryogenesis. Hypomorphic TRX proteins, harbouring minor 
mutations of its sequence, may still acquire their ability to maintain the pattern of gene 
expression set-forth during embryogenesis, and allow development to proceed to later 
developmental stages, in contrast to the null trx mutant which cannot survive past 
embryogenesis. The lack of a presumably distinct and vital TRX function required for late 
development would result in the manifested late lethality. To address this hypothesis, 
dissection of larvae harbouring a copy of the null trx allele {trx^^^) and a copy of the deleted trx
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sequence or was performed to look for any abnormalities of the imaginai discs
giving rise to the adult fly.
As shown in Figure 4.1, the brains from larval or pupal trx mutants were observed to 
be significantly smaller in size than wild-type. This suggests that a lack of cell proliferation or 
an elevation of apoptosis may be the cause for the retarded brain growth. By analysing 
isolated brains for apoptosis with the TUNEL assay (see Chapter 3), it was observed that 
apoptosis was apparently not altered in trx double mutants (Figure 4.8). Interestingly, isolated 
brains from DNA replication defective mutants have been shown to exhibit similar brain-size 
and brain morphological phenotypes as trx mutants (Krause et al., 2001; Pflumm and Botchan, 
2001). To investigate if lack of DNA replication may be a cause for the apparent inhibited cell 
proliferation, isolated trx mutant brains were incubated in a BrdU solution for 1.5 hours at 25 
®C. Staining with a specific monoclonal antibody against BrdU revealed that late larval or 
pupal trx mutants displayed a strikingly reduced level of replicating cells as compared to wild- 
type (Figure 4.1).
A collection of mutagenised Drosophila stocks, which are larval to pupal lethal, 
comprise of the mitotic or replicative defective mutants (see Section 4.1). Both classes of 
mutants often share similar variations of chromosomal aberrations and exhibit cell cycle 
checkpoint or progression defects. In light of the recent discovery that trx mutants are 
associated with a lack of proliferating cells, it is of great interest to document the state of 
chromatin integrity in these affected cells. For this, the Drosophila brain has been 
traditionally employed as the tissue of preference for studies that aim to look at defects in 
chromosomal structures or in cell cycle progression. The brain squashing technique used to 
present the following results, was initially established by Maurizio Gatti and members of his 
laboratory (see Section 7.2.9), and allows the visualisation of mitotic figures, reaching their 
most condensed structure at metaphase.
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DAPI a-BrdU
WT
trx /trx
WT (no BrdU)
Figure 4.1. Late lethal trx mutants are associated with DNA replication 
defect. Isolated brains were incubated in 0.1 mg/ml BrdU solution at 25 °C 
for 1.5 hours, and subsequently, processed for whole-mount staining with 
monoclonal BrdU antibodies. Wild-type brains, incubated in BrdU solution, 
show a characteristic pattern of replicating cells, confined to the lobes and to 
the mid-section of the brains. Wild-type brains without BrdU incubation are 
not stained, trx^"/trx’ '^^  and trx^ ’^/trx^^  mutant brains do not display any 
nuclear BrdU staining, indicating that cells are not replicating. Also, note the 
underdeveloped brain lobes isolated from trx mutants as compared to wild- 
type. Bar = 100 pm.
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Brain squashes were performed with isolated mutant trx brains, and DAPI stained 
chromatin was analysed for chromatin aberrations. As depicted in Figure 4.2, four 
chromosomes comprise the Drosophila genome as indicated. Two pairs with long 
chromosomal arms correspond to the II and III chromosomes. A V-like structure describes the 
X chromosome of Drosophila, while the Y-chromosome consists of one dense tubular 
structure. The final pair of chromosome IV in Drosophila is composed of mostly 
heterochromatin and appears as two dots in metaphase spreads.
Figure 4.2 presents the chromatin phenotype associated with the appropriate trx 
mutant genotypes. In both the trx/^^^ and trx/^, chromatin decondensation was observed, 
resembling “prophase-like” chromatin. Remarkably, the lack of distinct metaphase spreads, 
such as those for wild-type, suggest that nuclei lacking TRX function cannot progress past S 
phase of the cell cycle, by possibly not generating proper condensed chromosomes required 
for completion of the cell cycle. Treatment of trx mutant brains with colchicine, which arrests 
cells at metaphase, revealed an increase of “normal” metaphase spreads to 10-20 per brain.
This number contrasts drastically with colchicine treated wild-type brains, which exhibited 
100-150 metaphase spreads per brain. Again, this result emphasizes the inability of cells 
lacking trx to complete the cell cycle.
The analyses with late lethal trx mutants connect for the first time replicating cells with 
the state of TRX mediated chromatin integrity. The striking result that virtually no 
metaphase spreads from whole trx mutant brains exist, accounts for the lack of proliferating 
cells and for the retardation of cell growth as shown by their inherent smaller brains. In 
addition, the lobes where the majority of the proliferating cells reside appear to be 
underdeveloped as compared to wild-type (Fig 4.1, compare wild-type with the trx mutants). 
The presence of an altered chromatin structure in trx/^^^ and tn/'^ mutants is well linked with 
the replication defect identified. These results imply that TRX possess an additional function, 
which is necessary at late development and which is distinct from its earlier maintenance role, 
for completion of late development.
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wild-type
trx ‘’“ /trx b l l  A E3trx /trx
‘NORMAL’
TROPHASE-LIKE” *
Figure 4.2. Abnormal structures in metaphase spreads from brains of trx mutants.
Flies harbouring either the trx^ ^^ /trx''^ ^^  or the trx^“/trx^  ^ genotype, are able to develop to 
larval or pupal stages, respectively. Brain squashes were performed for these rare surviving 
trx mutant larvae. It was observed that a lower number of cells, as detected by DAPI staining 
were present in one squashed brain as compared to wild-type. Most of the cells appear to be 
in interphase as characterised by dense, small nuclei. The remaining nuclear spreads appear 
“prophase-like”, resembling an initial phase of chromosomal condensation. Around +/- 50% 
of trx mutant cells display this particular nuclear structure. Only 1 or 2 “normal” metaphase 
chromosomes, structurally resembling wild-type metaphase mitotic figures, were detected per 
trx mutant brain (suggesting that in general cells do not reach metaphase). The 
chromosomes, however, seem fluffy. On the other hand, wild-type metaphase spreads show 
homogeneously condensed mitotic figures, as indicated.
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4.2.2 Chromatin defects observed in MLL-AF9 but not in MLL-AF4 transgenic fly
lines.
The discovery that a lack of a proper TRX function has consequences in cell 
proliferation, support well published results linking MLL with cell cycle regulation (Cui et ah, 
1998). It was shown above that mutated versions (deletion, translocation) of the trx sequence 
allows development past its normal embryonic lethal stage (in trx -/-), and appears to alter 
chromatin structures required for proper cell proliferation. In this respect, a mode of action 
by aberrant MLL proteins associated with leukaemia may be the impairment of MLL function 
similar to those in late lethal trx alleles. Specifically, the presence of MLL fusion proteins 
may interfere with the formation of chromatin structures mediated by TRX (and analogously 
in mammals, MLL) and required for properly controlled cell division. The generation of a 
relevant Drosophila model system to study the function associated directly with MLL 
leukaemic fusion proteins (Chapter 2) points to MLL-AF9 and MLL-AF4 inhibiting late 
Drosophila development. It is likely that MLL-AF9 and MLL-AF4 may prevent late TRX 
function necessary for appropriate cell proliferation, resulting in larval or pupal lethality, 
reminiscent of phenotypes in the late lethal trx mutants. To explore this possibility, analyses 
of the chromatin configuration associated with MLL-AF9 and MLL-AF4 expressing flies were 
performed.
MLL, MLL-AF9, and MLL-AF4 transgenic flies were crossed to an ubiquitous Gal4 
driver (daughterless Gal4, which is capable of inducing a high protein level), and progeny were 
monitored to be lethal at 29 °C (Chapter 2, Fig 2.6). Figure 4.3 presents chromosomal 
metaphase spreads from wild-type, MLL, MLL-AF4, and MLL-AF9 transgenic fly lines. 
Spreads from MLL and MLL-AF4 transgenic brains show that MLL mitotic figures are 
indistinguishable from wild-type. However, metaphase spreads from MLL-AF9 transgenic 
brains show a striking effect on chromatin structure. Mitotic figures from MLL-AF9 were 
characterised by decondensed portions along the chromosomal arms of the mitotic figures (Fig. 
4.3d, arrows). These structures were classified as Class II. Interestingly, these chromosomal 
defects have been reported to exist for replication defective mutants (Pflumm and Botchan,
2001), and appear to be less severe in relation to the decondensed effects observed in late trx
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mutants (Fig 4.1). As shown in Figure 4.3E, a large portion of cells possessed fragmented 
chromosomes (designated as Class III). Like for Class II chromosomal defects, Class Ill-type 
chromosomal figures have been observed in replication defective mutants (Loupart et al., 2001: 
Pflumm and Botchan, 2001). Careful analyses have revealed that although not all cells 
expressing MLL-AF9 displayed an observable aberrant chromosomal structure (Class I), a 
significant percentage of Class II and Class III metaphase spreads were associated with the 
presence of MLL-AF9 (Fig. 4.4).
A. B. C.
D. E.
Figure 4.3. MLL-AF9, but not MLL or MLL-AF4, affects global chromatin 
structure. (A) A wild-type metaphase spread of wild-type brain cell is associated with 
homogeneous condensation of chromatin into chromosome arms. (B) Metaphase spreads 
from MLL (B) and from MLL-AF4 (C) expressing larval brain cells display the same 
chromatin conformation as in wild-type (A). (D) Aberrations in chromosome structures 
were clearly observed in MLL-AF9 larval brains. Note the decondensation of chromatin 
along the arms of the mitotic figures (arrows). Such structures are absent in (A-C). (D) 
“Fragmented” mitotic spreads are frequently observed in MLL-AF9 transgenes. (All figures 
were captured at lOOx magnification using a Leica Microscope.)
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CLASS I
“ normal”
CLASS II
partially decondensed
CLASS III
“fragmented”
MLL-AF9
55.7 % (43/77) 30 % (23/77) 14.3% (11/77)
MLL-AF4
88.6% (39/44) 9.1% (4/44) 2.3% (1/44)
MLL
86 % (53/62) 11% (7/62) 3 % (2/62)
wild-type
94% (60/64) 6% (4/64)
Figure 4.4. Detailed analyses reveal that MLL-AF9 significantly alters 
chromatin condensation. At least four independent sets of experiments were 
performed to document in more detail the chromatin condensation defects 
associated with MLL-AF9 expressing larvae. Three types of metaphase spreads 
were noted. “CLASS I” refers to metaphase spreads resembling wild-type mitotic 
figures (see Fig 4.3A). “CLASS 11” refers to moderately modified chromatin 
structure (see Fig 4.3D). “CLASS IH” displays mitotic figures that appear to have 
been fragmented (see Fig 4.3E). As shown above, altered chromatin structures 
were not significantly observed in MLL or in MLL-AF4 expressing larvae. 
Percentages indicate the frequency by which the distinct metaphase spreads were 
observed in two brains, (magnification: lOOx)
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Interestingly, a lower metaphase to anaphase ratio, for MLL-AF9, and minimal for 
MLL-AF4 expressing flies, as compared to MLL and to wild-type was detected (Fig 4.5A). 
Replication deficient mutants have been reported to possess a high metaphase to anaphase 
ratio as compared to wild-type (Loupart et al., 2000; Pflumm and Botchan, 2001), indicating 
that a second arrest point has occurred at metaphase. The fact that the ratio is lower in MLL- 
AF9 may reflect MLL-AF9’s ability to allow continued cell cycle divisions without proper 
checkpoints, or alternatively, to increase the rate of replication in MLL-AF9 cells, resulting in 
greater numbers of observable anaphase. The finding that MLL-AF9 and MLL-AF4 were 
associated with a slight increase in mitotic index relative to MLL, supports their ability to 
allow cell cycle progression (Fig. 4.5B,C).
Taken together, results indicate that MLL-AF9 may cause larval to pupal lethality by 
possibly altering chromatin structures which are required for DNA replication and which are 
likely, mediated by TRX’s later function in development. If this scenario is proven to be true, 
the presence of more condensed chromosomal structures as compared to those detected in late 
lethal trx mutants, may reflect MLL-AF9’s inability to completely inhibit the formation of 
DNA replication structures mediated by TRX. Alternatively, additional functions associated 
with MLL-AF9 may contribute to the manifestation of the lethal phenotype. In this respect, 
the facts that MLL-AF4 exhibited relatively normal mitotic figures and slightly affected cell 
cycle progression as monitored by the mitotic index, suggest that different MLL fusion 
proteins affect late TRX function at different levels, and most likely, require additional 
functions to abrogate cell cycle control.
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Fly Lines Metaphase Anaphase Metaphase: Anaphase Ratio Relative to WT
wild-type 41 19 2.16 1
MLL 29 14 2.07 &96
MLL-AF4 24 15 1.60 0.74
MLL-AF9 18 25 0 J2 033
B.
Fly Lines Phospho-H3 Total No. Cells Mitotic Index Relative to MLL
MLL 23 1344 0.0049 1
MLL-AF4 29 1120 0.007 1.4
MLL-AF9 50 1100 0.0026 1.9
C.
MLL MLL-AF9 MLL-AF4
Figure 4.5. Metaphase to anaphase ratio and mitotic index suggest that MLL-AF9 
cells proliferate faster than MLL and MLL-AF4. (A) The number of cells in 
metaphase and anaphase was counted for two brains in three different experimental set­
ups. The ratio presented is relative to wild-type. The low ratio associated with MLL-AF9 
may reflect the capability of MLL-AF9 to allow cell cycles to progress at a quicker rate. 
(B) Phospho-H3 marks cells that have entered the cell cycle. A slight effect on the 
mitotic index by MLL-AF9 and MLL-AF4 indicates that MLL fusion proteins allow cell 
cycle progression. (C) Controls demonstrating that the Phospho-H3 staining is relevant. 
As shown, the antibodies detect cells going through the cell cycle (Red: PhosphoH3, 
Blue: DAPI).
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4.2.3 Colchicine and hypotonic treatments of metaphase spreads reveal that 
polyploidy is non-existent.
The presence of polytene-like structures observed in MLL and in MLL-AF4 
transgenic lines suggested that polyploid cells exist. To confirm if cells in MLL and MLL-AF4 
transgenic lines are polyploid, isolated brains were treated with colchicine for 1.5 hours at 25 
°C, followed by a hypotonic treatment. Treatment of MLL-AF9 expressing tissues with 
colchicine presumably should not reveal any polyploid cells, since polytene-like structures 
were not detected (Chapter 3).
The treatment of colchicine, which prevents microtubule polymerization and thus 
induces disappearance of mitotic spindles, causes cell cycle arrest at metaphase, whereas 
hypotonic treatment swells the cells, allowing sister chromatids to spread. Figure 4.6A 
illustrates colchicine-treated metaphase spreads from appropriate fly lines. As shown, 
polyploidy was not observed in metaphase spreads from all transgenic lines. Although 
metaphase spreads resembling chromosomal aberration Class III appear to be polyploid, the 
numbers of observable spreads were minimal for MLL-AF9 and MLL-AF4 transgenic lines 
compared to MLL transgenic flies and to wild-type. It should be noted that in several spreads 
loss of chromosomes was detectable (Figure 4.6B).
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A. CLASS I
“normal”
CLASS II
partially decondensed
CLASS III
“fragmented”
MLL-AF9
61.9% (60/97) 36.1% (35/97) 2% (2/97)
MLL-AF4
81.4% (57/70) 15.7%(ll/70) 2.9% (2/70)
MLL
80.6% (58/72) 19.4% (14/72)
wild-type
89.7% (26/29) 10.3% (2/29)
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B. MLL-AF9 MLL-AF4
16.5% (16/70) 10% (7/70)
Figure 4.6. Colchicine-treated brain squashes reveal that polyploidy is non­
existent in MLL and MLL fusion transgenic flies. Isolated brains from 
appropriate transgenic lines were treated with colchicine for 1.5 hours at 25 °C. 
Illustrated are metaphase spreads observed from these squashed brains. (A) Analyses 
of metaphase spreads were performed according to the three classes identified in Fig. 
4.4. As shown, MLL-AF9 displays an appreciable percentage of Class II and Class 
III metaphase spreads as compared to wild-type and to MLL and MLL-AF4 
expressing cells. (B) Intriguily, a significant number of metaphase spreads, which 
lacked chromosomes and which resembled Class I mitotic figures, were observed in 
MLL-AF9 and MLL-AF4 expressing fly lines. Percentages indicate the frequency by 
which the distinct metaphase spreads were observed in two brains.
4.2.4 in vitro BrdU incorporation reveals a hyper-initiation of DNA replication for
MLL-AF9 transgenic flies
The discovery of chromosomal aberrations similar to those in replication defective and 
late lethal trx mutants encouraged experiments directed at exploring whether DNA replication 
was intact in MLL fusion transgenic lines. In light of the chromatin phenotype documented 
above, it is expected that only MLL-AF9 should associate with a defect in DNA replication.
The indication that abnormal DNA replication existed in MLL-AF9 came from 
experiments using BrdU as a marker for cells undergoing replication. Figure 4.7 depicts brains 
that have been labelled with BrdU for 1.5 hours in vitro. As shown, replicating cells are 
normally confined to the two optic lobes of the hemisphere and to the rental ganglion in wild- 
type Drosophila. This typical pattern of proliferation zones was observed in MLL and in 
MLL-AF4 transgenic flies. However, an increase of replicative cells was observed for MLL- 
AF9 transgenic flies. The effect on cell replication was tightly linked to the amount of protein 
levels since only the most severe, lethal transgenic line displayed, at this resolution, a higher
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level of replicating cells under the same experimental condition (compare MLL-AF9-T2 
(100% pupal lethality) vs. MLL-AF9-T5 (75% pupal lethal)).
The results presented here also correlate with the presence of the chromatin 
phenotype described above in MLL-AF9 and not in MLL nor in MLL-AF4 expressing cells. 
Interestingly, although chromatin aberrations were found to be similar to the published 
phenotype exhibited by replication defective Drosophila mutants (Loupart et al., 2000; 
Pflumm and Botchan, 2001) and to late lethal trx mutants (compare Fig 4.2 and Fig 4.3D and 
Fig. 4.4 MLL-AF9 Class II and Class III), the higher number of replicating cells observed for 
MLL-AF9 opposes the lack of replication in replication deficient and in late lethal trx 
mutants. This observation may indicate that MLL-AF9 may not only inhibit the late TRX 
function identified, but may also contribute dominant effects such as hyper-initiation of DNA 
replication. Alternatively, a delay in progression at S phase by MLL-AF9 would also explain 
the observed pattern of BrdU positive cells. In both respects, it appears that MLL-AF9 
targets more than one pathway to disrupt controlled cell proliferation during leukemogenesis.
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DAPI a-BrdU
%
WT
MLL
MLL-AF4
MLL-AF9-T2
MLL-AF9-T5
Figure 4.7. in vitro BrdU incorporation demonstrates that only MLL-AF9 affects 
DNA replication. Isolated brains from appropriate flies were subjected to in vitro  
BrdU treatment, and were subsequently stained for BrdU incorporation. As shown, 
nuclear staining of BrdU positive cells were equal for wild-type, MLL, and MLL- 
AF4. However, in MLL-AF9, a higher number of cells incorported BrdU indicating 
that initiation of DNA replication was elevated. This effect was dependent on MLL- 
AF9 levels since the only more severe transgenic line exhibited a clear defect (MLL- 
AF9-T2). Bar = 100 pm.
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DAPI TUNEL
WT
MLL
MLL-AF9
MLL-AF4
Figure 4.8. TUNEL assay on isolated brains from MLL and MLL fusion 
transgenic flies, and double trx mutants, reveals phenotypically similar 
apoptosis pattern as in wild-type brains. MLL, MLL-AF9, and MLL-AF4 were 
crossed to daughterless-Gal4 and raised at 29 °C. The trx  double mutants were raised 
at 21° C. As shown above for one brain, isolated brains from wild-type 3rd instar 
wandering larvae raised at 29° C, display minimal apoptosis activity as detected by 
the TUNEL assay. Likewise, brains from all transgenic fly lines and trx double 
mutants exhibited similar phenotypes, indicating that an abnormal level of 
apoptosis is not present.
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4.2.5 in vivo BrdU labelling indicates that cell cycle progression is perturbed in MLL-
AF9 expressing flies.
It has been proposed that defect in the timing of DNA replication can lead to 
chromosomal aberrations (Loupart et ah, 2000). To analyse in more detail the connection 
between replicating cells and chromatin structure defect, BrdU was fed to appropriate larvae 
for 20 minutes, 1 hour, 2-4 hours and for 8 hours. Feeding of larvae for 6-24 hours with BrdU 
is sufficient to observe complete BrdU labelling of mitotic figures in wild-type, while less than 
4 hours BrdU in vivo labelling allows partial incorporation of BrdU into wild-type mitotic 
figures (Loupart et al., 2000). Figure 4.9 illustrates metaphase spreads obtained from various 
time points of BrdU exposure. At 8 hours, like wild-type, MLL, MLL-AF9, and MLL-AF4 
mitotic figures were completely labelled with BrdU in a substantial number of cells (Fig 4.9A). 
At 2-4 hours BrdU labelling, whole or partial BrdU incorporated mitotic figures were observed 
for all MLL transgenic lines, although only rarely for wild-type (Fig. 4.9B). However, when 
pulsed with BrdU for shorter time intervals, it was observed that MLL-AF9 exhibited 
metaphase spreads that have partially incorporated BrdU, while mitotic figures from MLL, 
MLL-AF4, and wild-type were not observed to be BrdU positive (Fig. 4.9D).
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a-BrdU DAPI
MLL-AF9
MLL-AF4
MLL
WT
A. 8 hrs BrdU
95 -
Decondensation o f  chromatin by trx mutants and MLL-AF9
a-BrdU DAPI
I
MLL-AF9
MLL-AF4
MLL
WT
B. 2-4 hr BrdU
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a-BrdU DAPI
MLL-AF9
MLL-AF4
MLL
WT
C. 1 hr BrdU
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a-BrdU DAPI
MLL-AF9
MLL-AF4
MLL/ WT
D. 20 min BrdU
Figure 4.9. in vivo BrdU labelling indicates that the presence of MLL-AF9 induces 
faster mitotic entry. Third instar larvae were fed a mixture of D rosoph ila  instant food and 
BrdU (50 mg/ml) for the indicated times at 29 °C. A 8 hours (A) and 2-4 hours (B) BrdU 
incubations are sufficient to incorporate BrdU completely into mitotic figures from MLL 
transgenic lines and wild-type (WT). However, at BrdU exposure of 1 hour (C), mitotic 
figures from MLL-AF4 and wild-type larvae were not observed to incorporate BrdU, whereas 
MLL-AF9 and MLL displayed BrdU labelled mitotic figures. As shown, MLL-AF4 
exhibited only interphase nuclei labelled with BrdU speckles, possibly corresponding to the 
nucleolus (arrow-heads). Similar stained nuclei were observed in wild-type brain squash 
preparations. As shown in this case, mitotic figures in wild-type preparations were clearly not 
labelled. Interestingly, mitotic figures labelled at heterochromatic regions, such as the 
centromeres (arrows), were frequently observed in MLL squashed preparations, whereas a 
completely labelled anaphase was detected in MLL-AF9. (D) 20 minutes of BrdU pulse is 
sufficient to observe interphase nuclear staining in MLL-AF4, MLL and wild-type, as 
shown. Only MLL-AF9 exhibited partially labelled mitotic chromosomes (arrows point to 
incorporated BrdU at the centromeres). These results indicate that MLL-AF9 induces faster 
mitotic entry.
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The in vivo BrdU incorporation data indicate that MLL-AF9 is able to initiate DNA 
replication at a quicker rate than the other transgenic lines and wild-type since a 20 minute 
pulse of BrdU exposure was sufficient in timing to allow incorporation of BrdU partially 
into mitotic figures. At 1 hour BrdU exposure, euchromatin of MLL-AF9 mitotic figures had 
been labelled. This distinction is pertinent because this implies that BrdU was incorporated 
at the beginning of S phase, and that 1 hour allowed progression of BrdU replicated DNA to 
reach metaphase. On the other hand, MLL showed heterochromatin labelled figures at this 
time point, reflecting that BrdU incorporation commenced at the end of the S phase. The fact 
that no metaphase spread displayed BrdU labelled euchromatin suggests that 1 hour is not 
sufficient to allow BrdU incorporated DNA at early S phase to reach metaphase. The in 
vitro BrdU incubation of whole brains already hinted that the presence of MLL-AF9 
contributed to mitotic entry, since a larger number of replicating cells were observed (Fig 
4.7). The finding with in vivo BrdU labelling corroborates the in vitro data.
Furthermore, timing of DNA replication is not altered relative to chromosomal 
location in MLL transgenic lines as documented for orc2 and orc5 mutants (Loupart el al., 
2000). Early replicating euchromatin was observed to be completely labelled with BrdU 
prior to late replicating heterochromatin at the centromeres. This fact suggests that MLL- 
AF9 affects aspects of cell cycle progression, other than timing of DNA replication.
Possibly, MLL-AF9 may shorten the G2 phase, and thus consequently, allow a larger 
number of observable BrdU labelled mitotic figures.
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4.3 Discussion
4.3.1 trx is required to allow cells to replicate in late Drosophila development.
To date, it is not known precisely how PcG and trxG members regulate their loci at the 
mechanistic level. It has been postulated that the formation of appropriate higher order 
chromatin environment represents an important level of regulatory mechanism by trxG and 
PcG members (Paro, 1990; Pirrotta, 1998; Francis and Kingston, 2001). The range of trx 
mutants exhibiting various phenotypes (Breen et al., 1999) indicates that possibly PcG and 
trxG members have a wider repertoir of functions than only the maintenance of proper higher 
order chromatin at early development. The finding that PcG/ trxG bind to numerous target 
sites, argues for this speculation (Zink and Paro, 1989; Franke et al., 1992; DeCamillis et al., 
1992; Rastelli et al., 1993; Chinwalla et al., 1995; Tripoulas et al., 1996; Francis and Kingston, 
2001).
Late lethal trx mutants exhibit similar phenotypes as mutants affecting essential cell 
cycle functions isolated by Gatti and Baker (Gatti and Baker, 1989). The molecular 
characterisation of several cell cycle mutants, as described above, revealed that DNA 
replication has been compromised, and that DNA replication mediators are essential for cell 
cycle progression (Pflumm and Botchan, 2001; Loupart et al., 2000; Krause et al., 2001). The 
analysis of late lethal trx mutants has connected late TRX mediated chromatin regulation with 
the ability of cells to replicate. Possibly, frx impinges directly or indirectly on the DNA 
replication machinery. Although classically trx is thought to keep chromatin structure open, 
the paradox, that in late trx lethals chromatin appears to be incapable of condensing, can be 
accounted by proposing that trx has two distinct functions: (1) modulation of labile chromatin 
for transcriptional regulation at embryogenesis, and (2) regulation of higher order, structured 
chromatin present at later stages in development. The first function involves making target 
genes more accessible for transcription, while the second function is probably associated with 
making chromatin favourable to replication and thus non-expressible. The possibility that trx 
is involved in both opening and closing of chromatin is not that remote, as several studies have 
shown that trxG members regulate not only active genes but also repressed loci (Rastelli et al..
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1993; Collins et al., 1999; Kal et al., 2000; LaJeunesse and Sheam, 1996; Gildea et al., 2000; 
Brock and van Lohuizen, 2001; see Section 1.3.4). The lack of DNA replication in late larval 
to pupal trx lethals implies that probably TRX regulation of structured, higher order 
chromatin prior to the on-set of S phase is necessary for the completion of Drosophila 
development. The lack of properly formed chromatin structure may have the consequence of 
preventing correct recognition of origins by the replication machinery. The inability to initiate 
replication results in accumulation of interphase and "prophase-like" nuclei observed in these 
trx mutant alleles, and suggest that cell cycle progression to metaphase has been impaired, 
possibly by the activation of cell cycle checkpoints. It has been well established that 
chromatin environment plays a large role in determining correct transcriptional activity. The 
results presented here expand the repertoire to include chromatin structure imperative for 
DNA replication.
4.3.2 MLL-AF9, and not MLL-AF4, appears to interfere with cell cycle progression.
An intriguing outcome from Chapter 4 experiments is the link between chromatin 
aberrations and defects in replicating cells, as shown with the late lethal trx mutants and with 
MLL-AF9. Importantly, the similar phenotypes exhibited among replicative defective 
mutants, late lethal trx mutants, and MLL-AF9 strongly suggest that TRX and MLL-AF9 
compromises DNA replication to account for their effects on cell cycle progression. Two 
models have been formulated to account for the chromatin defects observed in replication 
mutants lacking proper DNA replication. Both models propose that DNA replication plays 
an important role in generating proper chromatin configurations.
The first model considers the impact a lower rate of DNA replication has on chromatin 
structure (Pflumm and Botchan, 2001). It is postulated that during DNA replication, loops 
are formed while DNA goes through the replication machinery, forming the first degree of 
condensation. The notion that the DNA replication machineiy remains attached, and 
consequently would create a defined length of chromosomal contraction, was proposed to 
avoid entangled DNA during replication (Sundin and Varshavsky, 1980; Hearst et al., 1998). 
During mitosis, these loops become more tightly coiled creating highly compact chromosomal
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structures. In replication defective mutants, the number of functional replication centers is 
rare. As a result, the model predicts that fewer and larger loops are formed from lack of 
adequate number in functional replication centers. During mitosis, the coiling of these larger 
loops create shorter, decondensed, and disorganised mitotic figures.
The second model incorporates replication timing as a factor in generating chromosomal 
abnormalities (Loupart et al., 2000). In this model, delay of euchromatin replication, as 
demonstrated from BrdU in vivo labelling in replication mutants is linked to the generation of 
decondensed chromosomal areas. The number of "landing pads" created by replication factors 
(such as ORCs) is crucial for the proper formation of pre-initiation complex necessary for 
origin firing. Mutants where amount of replication factors have diminished, influence the 
number of functional "landing pads" formed, with particular effect at the first DNA origins 
fired during replication. Euchromatin has been observed to replicate prior to heterochromatin, 
although exceptions do exist, and the mechanisms behind sequential origin firing are not 
understood. The model predicts that the inability to form complete "landing pads" at the right 
time results in regions where DNA is not properly condensed. In areas where DNA 
replication has failed completely, chromosome breaks would occur, generating "fragmented" 
metaphase spreads.
How can the data accumulated for MLL-AF9 fit within these two models? The fact 
that an increase in replicating cells occurs would predict that longer, compact chromosomes 
should be observed during metaphase according to the first model. MLL-AF9 appears to 
cause an elongation of chromosomal arms, but definitely, does not compact chromatin, as 
shown in Fig. 4.3. The second model suggests that hyper-replication would still generate 
chromosomal decondensed areas since timing of replication, whether early or late, has been 
compromised. The observation of correct DNA replication timing in MLL-AF9 expressing 
cells argues against this rationale. Both models do not fully account for the late lethal trx 
mutant’s or MLL-AF9’s chromatin phenotype. The models rely on misregulation of DNA 
replication as the main factor generating the chromatin phenotype. It is more likely that in the 
cases of both late lethal trx mutants and MLL-AF9 transgenic fly lines, compromised 
chromatin architecture influences the ability of DNA replication machinery to faithfully 
replicate the genome (see Chapter 6). Alternatively, TRX and MLL-AF9 may affect other
-  102-
Decondensation o f  chromatin by trx mutants and MLL-AF9
aspects, other than the DNA replication machinery, to directly account for their effects on cell 
cycle progression.
Although MLL-AF4 displayed pairing defects (an indication that the chromatin 
structure "glue" has been altered) in polytenes as MLL-AF9, the effect of MLL-AF4 on 
chromatin integrity in diploid cells was not detectable. Unlike MLL-AF9, the molecular 
similarities between MLL-AF4 and replication defective mutants were non-existent, indicating 
that MLL-AF4 induces fly lethality by interacting with another pathway(s) other than DNA 
replication. In addition, the observation that metaphase spreads from colchicine-treated brain 
squashes resembled wild-type both in morphology and in chromosome number, could not 
confirm results from experiments detecting polytene-like structures in MLL-AF4 expressing 
cells (Chapter 3). The lack of endoreduplicated cells in MLL and in MLL-AF4 expressing 
cells implies that the polytene-like structure documented in Chapter 3 may in fact be rare 
cases of uncontrolled proliferation that have no bearing on the viability of the fly. In this 
respect, it has been reported that an interactive partner with MET (Malignant Brain 
Tumour) mutant, display up to 20% of polytene-like structures in the brain (Reide, 1996b). 
Only 1-2 polytene-like structures were found in MLL and in MLL-AF4 transgenic flies.
Combining the subtle chromatin effect associated with MLL-AF4 with the clear 
chromatin abnormalities induced by MLL-AF9, it is tempting to postulate that maintenance of 
chromatin structure may be a general functional property of MLL fusion proteins. The 
finding that both MLL-AF4 and MLL-AF9 transgenic fly lines are associated with a higher 
number of BrdU positive cells in a short BrdU exposure time indicates that cell cycle 
proliferation has been compromised. Possibly, this effect is a consequence of altered 
chromatin structure induced by MLL fusion proteins. The putative, global modulation of 
chromatin by MLL fusion proteins varies to the extent this property is manifested as 
illustrated in this chapter for MLL-AF4 and MLL-AF9. In this respect, additional functions 
specifically contributed by the C-terminal partner would have a crucial role in deregulating 
additional defensive mechanisms necessary for leukemogenesis. Therefore, a first step in 
leukemogenesis may be the predisposition of cells by creating a more labile-chromatin 
structure, which would then allow additional functions specifically associated with individual 
MLL fusion proteins to deregulate cell cycle control. In the case of MLL-AF9, the
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acceleration of cells replicating may facilitate the accumulation of secondary mutations by 
over-saturating the safeguard mechanisms maintaining correct replication, and thus, bypassing 
cell cycle checkpoints. The aftermath would be the generation of pools of cells that 
intrinsically harbour mutations, for which some allow the onset of leukaemia. On the other 
hand, the characterisation of the Drosophila AF4 homolog, lilli, points MLL-AF4 acting on 
pathways regulated by Ras/MAPK and by PI3/PKB and affecting cell size growth (Wittwer 
et al., 2001; Tang et al., 2001). The extensive similarities between 4 /^  null knock-out in mice 
and the Drosophila lilliputian mutant suggest that conservation exists in the regulation of 
cellular growth (Isnard et al., 2000; Wittwer et al., 2001).
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CHAPTER 5
MLL and MLL fusion proteins exhibit distinguishing binding patterns
on polytenes.
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5.1 Introduction
The PcG and trxG members are regulators of gene expression, acting on higher order 
chromatin fibers. It is not known how members of both families recognise their target 
elements. It is speculated that few PcG/ trxG members are able to contact DNA directly, and 
that specificity is endowed through protein-protein interaction (Paro 1990; Pirrotta, 1998; 
Francis and Kingston, 2001). Alternatively, PcG/ trxG may recognise higher order chromatin 
configurations that are dependent on the DNA sequence. The formation of particular loops 
by the refolding of DNA onto itself may actually be the central recognition module for PcG/ 
trxG members (Francis and Kingston, 2001).
Defining the DNA sequences, which are bound by PcG and trxG members, along the 
genome may unveil consensus elements recognised by PcG/ trxG. For this. Drosophila offers 
the advantage of staining polytenes. Polytenes are special structures found in the salivary 
glands. These "giant chromosomes", as they are sometimes referred to, are consequences of 
continuous replication of the genome in the absence of mitosis. The net result is the formation 
of tubular structures composed of 1000-2000 genomes juxtaposed to one another to form 
bands along the arms of the chromosomes. The bands correlate to genes. Their locations along 
the arms of the chromosomes have been previously determined by in-situ hybridisation against 
sequences spanning the target genes. Importantly, polytene staining allows mapping of 
protein distribution and identification of target genes. It has been shown by using antibodies 
specific to several PcG and trxG proteins on polytenes that these regulatory proteins 
specifically bind to a limited number of elements (Zink and Paro, 1989; Franke et al., 1992; 
DeCamillis et al., 1992; Rastelli et al., 1993; Chinwalla et al., 1995; Tripoulas et al., 1996). 
These binding patterns of several PcG and trxG members have also demonstrated that PcG 
and trxG members share overlapping sites, suggesting that an enormous pool of different 
complexes exist to properly regulate gene expression.
An interest in the mammalian field is to define the genomic distribution of MLL and of 
MLL leukaemic proteins, since to date, evidence is lacking in this respect. Polytene staining 
against MLL would provide the first clues as to which target genes may be regulated by MLL. 
The identification of these target regulatory elements on polytenes would thus provide insight
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into the imdertanding of MLL's vital function(s) in cell regulation. The strong conservation of 
developmental pathways between Drosophila and mammals indicates that the targets 
identified in the fly will likely have relevance in mammals (see Section 1.2). Defining how the 
binding pattern of MLL compares with the distribution of TRX on polytenes will also reveal 
whether MLL can incorporate or even interchange with TRX in physiologically relevant 
complexes.
Most importantly, polytene stainings against MLL and MLL fusion proteins would 
indicate if the new AF9 and AF4 C-terminal sequences perturb MLL protein targeting. 
Chapter 4 has provided evidence demonstrating that MLL-AF9 appears to act through a late 
TRX function in derailing cell proliferation. Data thus far points to MLL-AF9 as possessing 
unique properties halting Drosophila development. Thus, it is expected that MLL-AF9 
controls different target genes as compared to MLL. Additionally, the strong lethality 
observed by MLL-AF4 points to a different protein distribution from MLL. Because MLL- 
AF4 does not interfere with the same pathway as MLL-AF9 to inhibit fly viability, it is 
conceivable that both MLL fusion proteins also display distinguishing binding patterns.
Chapter 5 presents evidence demonstrating that MLL cannot simply replace TRX, and 
that MLL-AF9 and MLL-AF4 distribute differently on polytenes. The chapter begins by 
describing the generation of an affinity-purified TRX antibody. This antibody in conjunction 
with an affinity-purified antibody against the N-terminal region of MLL have been used on 
polytenes to gain insight into the molecular behaviour of MLL and of MLL fusion proteins in 
respect to TRX. Furthermore, co-staining of polytenes against Polycomb (the prototype of 
the PcG family) and N-terminal MLL antibodies suggest that MLL and MLL fusion proteins 
do not interact, and possibly may not require PcG/ trxG members for their functions. The 
distribution of MLL and of MLL fusion proteins, differ considerably and have implications on 
modifications of chromatin. Finally, genetic experiments aimed to ask if MLL can functionally 
replace TRX indicate that inter-changeability between species is not so straight-forward.
These results are discussed on the basis of the molecular mode of action(s) employed by MLL 
and by MLL fusion proteins, and consider their relevancy to the histone code.
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5.2 Results
5.2.1 Generation of affinity pure TRX antibody
The TRX residues spanning 2388-2674 was used to generate affinity pure TRX 
antibodies. Both short (TRX I) and long (TRX II) isoforms of TRX are recognisable by the 
antibody. The region was cloned into the pATH III vector (Fig 5.1a), which allows production 
of large amounts of fusion proteins under the tryptophan inducible system (Koemer et al., 
1991). The tryptophan system remains tightly inactive unless tryptophan or its analogue, 
indoleacrylic acid (lAA), is present. lAA was used to induce the activation of the E.coli trp 
operon promoter, by preventing the binding of the trp repressor (Koemer et al., 1991). The 
fusion protein, TRPE-TRX with the expected size of 68 kDa, was produced in high amounts 
when 2 mg/ml LAA was added to the culture medium (Fig 5.IB, compare lane 3 vs. lane 4).
The insoluble TRPE-TRX fusion protein was purified to homogeneity by gel elution (Fig 
5. IB, lane 2). The purified protein was subsequently used for injections into rabbits.
IgG antibodies were purified from 6^  ^boost semm using a Protein A sepharose column. 
The purified antibody, designated Prot A-TRX, was found to detect 100 ng of the TRPE- 
TRX fusion protein at a 1:10,000 dilution (Fig 5.2A), and was tested on nuclear extract from 
overnight lays of Drosophila embryos. As shown in Figure 5.2B, TRX of estimated size 300- 
400 kDa was recognised. Various TRX antibodies have been previously reported to detect 
degraded forms of TRX, such as the 180 kDa band (Kuzin et al., 1994). These Western blot 
analyses reveal that under these conditions, the ProtA-TRX is able to efficiently detect TRX 
with minimal cross-reactivity against unspecific proteins.
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Figure 5.1. Induction of TRPE-TRX fusion proteins for generation of 
antibodies. (A) Schematic representation of the pATH III vector used to express the 
TRPE-TRX fusion protein (approximately 68 kDa). As shown, the residues 
corresponding to 2388-2674, lie at an unconserved region of the TRX protein 
sequence. (B) Coomassie analysis for induction and estimation of protein production 
after gel purification. Lanes are designated as the following: l.BSA (dark arrow), 2. 
purified TRPE-TRX (open arrow), 3. no induction of TRPE-TRX protein, 4-7. four 
different TRPE-TRX clones induced with 2 mg/ml lAA. Clone from lane 4 was 
used further to induce and to purify additional fusion proteins.
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Figure 5.2. Protein A-TRX antibodies detect TRX in denatured and in native conditions.
(A) Detection of TRPE-TRX fusion protein (100 ng) at 1:10,000 dilution. (B) Detection of 
full-length TRX (300-400 kDa) at 1:5,000 (200 pg of nuclear extract was loaded). The lower 
bands below correspond to TRX degradation produets. Similar degradation products (*) have 
been reported (Kuzin et al., 1994). (C) Staining of wild-type polytenes with Protein A-TRX 
antibodies at 1:200 dilution (40x magnification). (D) The 64-66 region has been reported to be 
bound by TRX, as shown (lOOx magnification) (Chinwalla et al., 1995).
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Since the same construct was used to previously generate antibodies (Chinwalla et al., 
1995), the availability of the TRX binding pattern provides an ideal control for testing of the 
newly generated antibodies on polytenes. As Figure 5.2C details, the antibody strongly sees 
around 80 bands, supporting previous data (Chinwalla et al., 1995). Higher magnification 
analysis also demonstrates that the ProteinA-TRX antibodies specifically detect TRX, since 
TRX has been previously documented to bind 64D, 65E, and 66F (Fig 5.2D).
To ascertain if all bands recognised by Protein A-TRX reflect TRX binding, two trx 
mutants and trx^^) were crossed to create trx^^ '^ /^trx^  ^progeny. Both and
mutants possess deleted portion of the TRX sequence used to generate the antibodies. 
Therefore, it is expected that no bands should be detectable in double mutant larvae with a 
specific TRX antibody. As shown in Fig 5.3, ProteinA-TRX antibodies recognised many 
unspecific proteins.
Figure 5.3. ProteinA-TRX antibodies recognise unspecific proteins. Bands in polytenes 
from trx' '^ /^trx^  ^ mutant larvae should not be detectable by a specific TRX antibody generated 
against the 2388-2674 residues of TRX. As shown, Prot A-TRX serum cross-react with 
numerous unspecific bands. A. Phase contrast. B. Cy3 secondary antibody against rabbit ProtA- 
TRX antibodies.
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To purify antibodies specific against TRX and not against the TRPE portion of the 
fusion protein, the TRX sequence spanning 2388-2674 residues was cloned into the pGEX- 
4T3 vector using ET cloning. The pGEX-4T3 allows production of GST-HIS tag N-terminal 
to the TRX sequence (Fig 5.4A). The Protein A-TRX antibody detected the GST-HIS-TRX 
fusion protein. The new, insoluble GST-HIS-TRX was purified in 6 M Urea over a Ni^^ 
column (Fig. 5.4B). Purified, soluble GST-HIS-TRX in non-denaturing conditions was bound 
onto nitrocellulose, renatured, and then used to affinity purify TRX antibodies from 
ProteinA-TRX serum (see Section 7.2.1). Two batches of antibodies were eluted. The first 
batch (Aff#l-TRX) consistently gave similar unspecific bands as for ProteinA-TRX 
antibodies on polytenes from double mutants (Fig 5.5A). On the other hand, a
significant reduction of detectable signals was observed with the second batch of TRX 
antibodies (Fig 5.5B). This batch, Aff#2-TRX, was used for subsequent antibody stainings, 
and is referred to as a-TRX.
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Figure 5.4. Induction and purification of GST-HIS-TRX. (A) Schematic representation of the 
fusion protein, GST-HIS-TRX, expressed from the pGEX-4T3 vector (Pharmacia). (B) GST-HIS- 
TRX (**, approximately 59 kDa) is detectable by Protein A-TRX antibodies (1:3,000). Lanes: I. 
GST-HIS bacterial lysate; 2. GST-HIS-TRX bacterial lysate. (C) Coomassie stained SDS-PAGE gel 
illustrating the purification of insoluble GST-HIS-TRX protein. GST-HIS-TRX (***) was purified 
to homogeneity over a Ni^  ^column. Lanes: 1. induced GST-HIS-TRX; 2. GST-HIS-TRX bound to 
beads; 3. Elution Fractiond No. 4; 4. Elution Fraction No. 3; 5. Elution Fraction No. 2; 6. 
Wash Step No. I; 7. Wash step No. 2; 8. Flow through.
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Figure 5.5. Aff#2-TRX antibodies reduce unspecific signals to background levels 
on polytenes from trx^ ^^ /^trx^  ^ double mutants. Polytene staining with Aff#l-TRX 
eluted antibodies reveals a persistent detection of unspecific bands on polytenes from 
trx'^ '^ '^ /trx^  ^mutants. The reduction of these signals to background levels was observed 
with Aff#2-TRX purified antibodies. Aff#2 TRX antibodies (designated a-TRX thus 
forth) were used for subsequent antibody stainings.
5.2.2 MLL, MLL-AF9 and MLL-AF4 display distinguishing protein binding
profiles, and co-localise minimally with TRX or Pc on polytenes.
The MLL and MLL-AF9 sequences are tagged with FLAG epitope at their C-terminus 
(see Figure 2.3). The FLAG monoclonal antibody (Sigma) and a specific monoclonal antibody 
against the C-terminal AF4 protein were used in conjunction with a-TRX antibodies to 
explore if MLL or MLL fusion proteins co-localise with TRX on polytenes. Expression of 
MLL, of MLL-AF9, and of MLL-AF4 under the control of a heat shock promoter, was 
induced by heat shocking third instar larvae for 30 minutes and then allowing their recovery at 
18 “C for at least 5 hours. As shown in Fig. 5.6, limited co-localisation, around 10%, was 
detected between MLL and TRX. MLL-AF9 and TRX were mutually exclusive in binding 
pattern while MLL-AF4 rarely co-localised with TRX.
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Figure 5.6. MLL and MLL-AF4 distinctly co-localise with TRX at limited sites on polytenes, 
whereas MLL-AF9 and TRX bind mutually exclusively. Double labelling of polytene 
chromosomes demonstrates that MLL-AF9 and TRX do not co-localize, while MLL and MLL-AF4 
only minimally co-localise with TRX. TRX is detected with polyclonal antibodies (red), whereas 
MLL and MLL-AF9 are detected with monoclonal antibodies to FLAG (green), and MLL-AF4 with 
monoclonal antibodies to AF4 (green). Polytenes on the top were captured at 40x magnifieation, 
whereas lower images are at lOOx magnification. MLL was found to bind strongly at limited sites 
with TRX (left top). Similarly, MLL-AF4 co-localised with TRX at much fewer bands than MLL and 
with a much weaker intensity, possibly reflecting that the bindings by TRX and MLL-AF4 at the 
region is close but not superimposed (right, top). However, MLL-AF9 (green) and TRX (red) bound 
to polytenes exclusively from each other (middle, top). As clearly shown in the lower images 
(arrows), MLL was found to co-localise strongly with TRX at cytological location 2C (left, bottom). 
At the same cytological position 2C, MLL-AF9 was not bound, indicating that the fusion protein 
binds to sites different from MLL (middle, bottom). MLL-AF4, however, appeared to weakly co- 
localise with TRX at 2C. These binding patterns indicate that MLL fusion proteins are targeted to 
different sites on polytenes, and suggest that MLL cannot fully incorporate into all TRX complexes.
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Since the generation of protein expression by heat shock may reflect unspecific binding 
by excessive protein levels, polytene stainings were performed from larvae expressing MLL, 
MLL-AF9, and MLL-AF4 with the daughterless Gal4 driver at 29 °C, to confirm that the 
transgenic protein binding patterns are relevant. Importantly, under this condition, MLL-AF4 
and MLL-AF9, but not MLL, are able to induce the lethal phenotype. A specific N-terminal 
MLL (a-MLL) antibody was used to detect the transgenic proteins. Remarkably, MLL, 
MLL-AF9 and MLL-AF4 displayed distinct, unique binding patterns (Fig. 5.7). A general 
distribution of MLL throughout the chromosomes of polytenes was observed. On the other 
hand, MLL-AF9 was found at limited euchromatic sites, and intriguily, at the 
heterochromatic-rich chromocenter. The binding profile of MLL-AF4 drastically differed from 
MLL and from MLL-AF9 since strong, defined bands were observed regularly throughout the 
polytene arms. The binding patterns of MLL and of MLL fusion proteins in a scenario where 
protein levels should be constant (as in this case when the daughterless Gal4 driver is used), 
were similar to the above staining patterns for MLL, MLL-AF4, and MLL-AF9 induced by 
heat-shock (Fig 5.6), and thereby justify the results presented at Fig. 5.6. Furthermore, a - ' 
TRX staining of polytenes from transgenic lines induced with daughterless-Gal4 driver, show 
that MLL and MLL fusion proteins do not alter the TRX binding pattern (Fig 5.7).
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Figure 5.7. Stainings of polytenes, from salivary glands expressing MLL, MLL-AF9, or 
MLL-AF4 with the daughterless Gal4 driver, uncover distinguishing binding patterns for 
each transgenic protein and show that TRX binds to its target sites regardless of the presence 
of the transgenic proteins. (A) Staining with polyclonal antibodies against MLL (a-MLL) 
demonstrated that the binding profile of MLL-AF9 and MLL-AF4 differ considerably from MLL. 
As shown, MLL was found bound throughout the chromosomes, with limited defined banding. 
Interestingly, MLL-AF9, but not MLL nor MLL-AF4, was largely concentrated at the 
heterochromatin-rich chromocenter (middle, arrow head). On the other hand, MLL-AF4 binding 
pattern confined to many bands along the chromosome arms, and not to the chromocenter, (right, 
arrow head). The arrows in MLL-AF9 point to polytene paring defects (see Fig 3.4). Images are 
illustrated at 40x magnification. (B). Staining with a-TRX antibody on polytenes from MLL, 
MLL-AF9, and MLL-AF4 confirmed that TRX binding is not affected by the presence o f the 
transgenic proteins. Indicated bands in (B) have been reported to be bound by TRX (images at lOOx 
maginification and Kuzin et al., 1994; Chinwalla et al., 1995).
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Although the polytene stainings above show that MLL, MLL-AF9, and MLL-AF4 do 
not co-localise with TRX significantly, MLL may still be able to interact with other members 
of PcG and trxG to form functional complexes, while MLL fusion proteins may aberrantly 
alter PcG/trxG binding patterns. To explore this idea, the Polycomb (Pc) protein was selected 
since not only is it the prototype of the PcG family, but it also shares overlapping binding 
sites with TRX (Kuzin et ah, 1994; Chinwalla et ah, 1995). Double labelling experiments with 
mouse Pc antibodies and the N-terminal MLL polyclonal antibodies revealed that Pc does not 
overlap with any of the transgenic lines (Fig 5.8). These results support experiments showing 
that MLL and TRX rarely co-localise, and imply that MLL fusion proteins may not require 
the association other PcG/ trxG members to induce lethality.
GREEN: a-Pc
MLL-AF9 MLL-AF4
RED: a-M LL
Figure 5.8. Pc and transgenic proteins do not co-localise on polytenes. MLL, MLL- 
AF9, and MLL-AF4 were detected using the N-terminal MLL antibody. Double labelling 
stainings for Pc (green) and MLL, MLL-AF9, or MLL-AF4 (red) illustrate that in all cases, 
the proteins do not co-localise (arrows).
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5.2.3 MLL cannot simply rescue trx mutants
The finding that TRX and MLL only partially co-localise was validated by genetic 
experiments aimed at defining the extent MLL can functionally replace TRX. The and 
mutants (as described in Chapter 4) were used. The trx mutants carry additional 
markers that allow genetic manipulation to be followed. In this manner, fly stocks can be 
generated to include both the trx mutant and the appropriate MLL transgenic construct. A 
crossing scheme allowed the expression of MLL in a heterozygous or homozygous mutant 
background, and investigated if MLL expressing progenies are able to affect viability of flies 
lacking half the dosage of wild-type trx (as in the case of the heterozygous state), or are able to 
survive past larvae into pupae or adults (as in the case of the homozygous state). Since a 
sufficient amount of TRX proteins are present to allow embryonic survival, use of a Gal4 
driver expressing high levels of MLL at later stages of development would be most reasonable. 
The blood MZ1580 and Act5C-Gal4 were chosen as Gal4 sources, since they have been 
shown to produce high levels of Gal4 at larval and pupal stages (unpublished results; Ito et al., 
1997). Corroborating results on polytenes, no rescue of trx double mutants was observed by 
MLL under both conditions (Fig 5.9). Moreover, presence of high levels of MLL did not 
affect flies lacking half the dosage of wild-type TRX (Fig 5.9). Both the polytene staining and 
genetic experiments indicate that lack of rescue of trx mutants by MLL appears to be due to 
MLL’s inability to incorporate into a sufficient number of functional TRX complexes, or that 
MLL behaves as an inert protein in Drosophila. Therefore, at this level, MLL and TRX are 
not interchangeable entities.
Identical crosses were performed for MLL-AF4 and MLL-AF9 to assess the role TRX 
may have on the lethal phenotype induced by the fusion proteins. As shown, reduction or 
lack of TRX did not affect MLL fusion lethality (Fig. 5.9). These results indicate that a gain- 
ojf function TRX activity appears to not be the cause for the lethal phenotype induced by the 
MLL fusion proteins.
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Figure 5.9. Genetic experiments reveal that MLL fusion protein induced lethality is not 
affected by TRX dosage, and that MLL cannot functionally exchange with TRX. To
define more precisely the effect TRX has on the lethal effect induced by the MLL fusion 
proteins, trx alleles {trx"^  ^and trx^ )^ were crossed in. The MLL and MLL fusion proteins were 
expressed with the blood MZ1580 Gal4 driver and with the late expressing Gal4 driver line 
under the control of a strong ActinSc promoter. The use of both Gal4 drivers did not alter the 
outcome of the rescue experiments depicted above. As shown, reducing half the amount of 
functional TRX or omitting TRX does not affect the lethal phenotype induced by the MLL 
fusion proteins. In addition, it was observed that MLL could not rescue the lethal phenotype 
associated with trx double or single mutants, suggesting that MLL at this experimental set-up 
cannot recapitulate TRX function(s). Bars represent the stage to which progenies with the 
indicated genotype (left) developed, whereas percentage reflects the portion of progenies lethal 
at the defined stage.
5.2.4 MLL-AF9 and MLL-AF4 disrupt the distribution of methylated histone H3 at
Lysine 9
The finding that MLL-AF9 concentrates at heterochomatic chromocenter suggested an 
effect on methylated histone H3 at Lysine 9 (me-H3K9), since this type of modification was 
shown to mark heterochromatin. Polytene stainings, with specific me-H3K9 antibodies, 
demonstrated that in polytenes from wild-type larvae, me-H3K9 is predominantly found at 
the chromocenter and at distinct and limited sites in euchromatin (Fig. 5.10). When polytenes 
from salivary glands expressing MLL by the daughterless Gal4 driver were probed with the 
me-H3K9 antibodies, the wild-type pattern was observed (Fig. 5.10). MLL-AF9 polytenes.
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generated from conditions inducing complete lethality, illustrated that the chromocenter 
remained marked by me-H3K9, and significantly, the me-H3K9 bands at euchromatic sites 
were lost (Fig. 5.10). Strikingly, the reciprocal was found for MLL-AF4 polytenes under 
lethal conditions (Fig. 5.10). The chromocenter lost me-H3K9 staining, although euchromatic 
me-H3K9 signals remained. The effect on me-H3K9 pattern by MLL fiision proteins is 
partially reminiscent of the binding patterns on polytenes for MLL-AF9 and MLL-AF4 
(compare Fig. 5.7 and Fig. 5.10). These observations reinforce that MLL-AF4 and MLL-AF9 
regulate higher order chromatin structures and suggest that both proteins employ similar 
mechanisms to deregulate chromatin integrity.
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Figure 5.10. The méthylation pattern of histone 3 at lysine 9 is affected by the presence of 
MLL fusion proteins, but not by full-length MLL. The pattern of méthylation of histone 3 at 
lysine 9 (me-H3K9) on polytenes of wild-type larvae is confined to the chromocenter and to limited 
sites at euchromatin (A, WT). The wild-type me-H3K9 pattern was found to be retained when MLL is 
expressed in the fly (A, MLL). However, expression of MLL-AF9 caused loss of methylated sites at 
euchromatin (A, MLL-AF9-T2). This effect was found to be dependent on protein levels since a 
transgenic line, producing a lower amount of MLL-AF9 and associated with a less severe lethality, 
retained the wild-type me-H3K9 pattern (A, MLL-AF9-T5). Contrary to MLL-AF9, MLL-AF4 
reduces me-H3K9 at the chromocenter and enhances me-H3K9 at euchromatic sites (A, MLL-AF4 (i)). 
A closer look at the chromocenter confirms that the effect is present (A, arrow MLL-AF4 (ii)). 
Interestingly, double labelling of polytenes with both AF4 and me-H3K9 antibodies demonstrates 
that me-H3K9 and MLL-AF4 at the euchromatic arms do not co-localise perfectly (B, +AF4). As 
indicated in the MERGED image, bands modified by me-H3K9 did not have MLL-AF4 bound (green 
arrow), although for several bands co-localisation was observed (yellow arrows). Likewise, MLL-AF4 
was found bound to polytene bands without an apparent modified H3 (red arrow). The effect on me- 
H3K9 by MLL-AF4 is specific since polytenes lacking MLL-AF4 exhibit normal me-H3K9 
distribution (B, -AF4). (magnification: 40x)
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5.3 Discussion
Drosophila offers a unique advantage to look at the distribution of nuclear proteins 
with relative ease. The polytenisation of cells in the salivary glands allows detection of 
protein binding profiles since the genome has been replicated thousands of times without 
mitosis. Since bands on polytenes span over lOOkb, co-localisation by two proteins on 
polytenes does not necessarily reflect that they act in a complex. However, the co-localised 
binding at many chromosomal sites provides a strong indication that the two proteins may 
interact with one another. This chapter has presented evidence demonstrating that MLL and 
MLL fusion proteins display distinct binding profiles on polytenes. Importantly, these 
different binding profiles indicate that MLL-AF9 and MLL-AF4 employ different target sites 
to disrupt developmental progression. The finding that MLL-AF9 and MLL-AF4 affect 
méthylation of histone H3 at lysine 9, supports previous data indicating that MLL fusion 
proteins alter higher order chromatin structure (Chapter 3 and Chapter 4), and extends the idea 
by offering modulation of histone modifications as a common venue through which MLL-AF4 
and MLL-AF9 may accomplish their tasks. In addition, the finding that MLL fusion proteins, 
as well as MLL, cannot integrate into Pc or TRX complexes suggest that MLL fusion proteins 
may not require PcG/ trxG association for their function, and that MLL cannot incorporate 
into PcG/ trxG complexes. The later aspect is supported by genetics showing that at the 
specific experimental condition, MLL cannot functionally replace TRX.
An important question that remains unanswered in the mammalian field is whether 
MLL fusion proteins modulate genes regulated by MLL. Using an affinity-purified antibody 
against the N-terminal portion of MLL, MLL, MLL-AF4, and MLL-AF9 were found to 
display unique protein binding patterns. This finding correlates well with previous data 
(Chapter 2-4) demonstrating that MLL fusion proteins adversely affect fly viability while 
MLL does not, and that MLL-AF9 and MLL-AF4 do not display identical phenotypes (such 
as the chromatin aberrations reported at Chapter 4). An implication from the distinct binding 
patterns between MLL-AF4 and MLL-AF9 is that likely, MLL-AF4 and MLL-AF9 target 
additional pathways other than those regulated by MLL, to eventually deregulate the cell 
cycle. In this respect, MLL fusion proteins may modulate the activities of new target genes 
defined by the AF4 and the AF9 sequences.
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Interestingly, the localisation of MLL-AF9, but importantly not MLL-AF4 nor MLL, 
at heterochromatin-rich chromocenter, suggested that méthylation of H3K9 may be utilised as 
a means to alter higher order chromatin, since it has been shown that this histone modification 
is important for cell cycle progression (see Section 1.3.6). Indeed, the binding profile of 
methylated H3K9 in MLL-AF9 and in MLL-AF4 reflects the protein distribution of MLL- 
AF9 and of MLL-AF4, although complete co-localisation of MLL fusion proteins and 
methylated H3K9 is not observed. This effect on methylated H3K9 appears to be relevant 
since lack of MLL-AF4 or lower doses of MLL-AF9 do not alter the binding pattern of 
methylated H3K9. Therefore, the analyses of these polytene stainings provide the first hints 
that the histone code is a vital pathway through which chromatin regulators may derail cell 
cycle integrity.
The co-localisation experiments between MLL or MLL fusion proteins and TRX or 
Pc, unveiled that MLL and MLL fusion proteins did not significantly co-localise with TRX 
and Pc. MLL fusion proteins may not be able to interact with PC and with TRX as a result of 
their C-terminal sequence or of the lack of conserved domains at their MLL N-terminus. The 
data presented in this chapter accounts for both explanations since the binding patterns of 
MLL-AF9 and of MLL-AF4 differ so extensively with each other. The TRX binding profile 
appears to be not altered in MLL-AF9 and in MLL-AF4 transgenic flies, again supporting 
that the new AF9 and AF4 C-terminal sequences contribute to the generation of distinct 
polytene protein binding profiles. Additionally, the lack of co-localisation between MLL 
fusion proteins and PC or TRX suggests that MLL fusion proteins may not require other 
PcG/ trxG members for their functions.
The finding that MLL also cannot interact with Pc, as previously shown for TRX 
(Kuzin et al., 1994; Chinwalla et al., 1995), suggests that in this case, the possibility that the 
N-terminus of MLL prevents MLL incorporation into TRX complexes, is more appreciable. 
The lack of extensive co-localisation between MLL and TRX may be expected since only 
MLL or TRX would be able to incorporate into complexes. The sites, which illustrate MLL 
and TRX co-localisation may simply reflect MLL and TRX complexes bound to distinct 
chromatin sites at a higher resolution. Genetic experiments were designed at asking whether 
MLL can functionally replace TRX during Drosophila development. The result that no
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rescue of single or of double trx mutants by MLL reinforces the double staining experiments 
between MLL and TRX or Pc. It has been reported that M33, the mouse homologue of Pc, 
can rescue pc  -/- mutants, although the rescue was limited to an intermediate level (Muller et 
al., 1995). The fact that limited conservation between TRX and MLL exists (Chapter 2) 
accentuates the worthiness that Pc and M33 possess each only two conserved domains, the 
chromodomain and a stretch of 30 amino acids at their C-terminus (Müller et al, 1995). The 
later domain has only been found in Pc and M3 3, and therefore, may facilitate their 
exchangeability. Taken together, the N-terminus of MLL, which shares limited sequence 
homology with TRX, may be the primary reason for why MLL cannot functionally exchange 
with TRX.
Finally, the observation that reduction or absence of a functional trx level does not 
modulate the lethal phenotype induced by MLL-AF9 and MLL-AF4 suggests several 
implications. First, the lethal phenotype appears to not involve a direct TRX gain-of-function 
activity. If so, it would be expected that reduction of functional trx level should have enhanced 
MLL fusion protein associated fly viability. Second, the dominant activities relayed by the 
MLL fusion proteins may inhibit downstream, likely architectural proteins, which may be 
regulated by TRX at late development and which are necessary for DNA replication or for 
transcription activation of essential target genes. In this case, lack of functional trx would not 
impact the interference associated with MLL fusion proteins. If anything, an enhancement in 
the severity of the lethal phenotype is expected. Third, MLL fusion proteins may have a more 
direct effect on TRX itself by preventing TRX from incorporating into complexes required for 
its function. This scenario may not be the case since TRX binding patterns seemed intact in 
MLL-AF9 and in MLL-AF4 flies. However, it is conceivable that TRX alone is required for a 
specific function necessary for cell proliferation. In this case, MLL fusion proteins would 
directly prevent TRX from acting, and thus loss of trx function would mimic the dominant 
negative activity by MLL-AF9 and MLL-AF4. Finally, the absence of an effect by TRX on 
MLL fusion protein-induced lethality may simply reflect a non-existent participation by 
TRX. Alternatively, the limitation of the experimental set-up may prevent the observation of 
a partial alleviation of the lethal phenotype by reduction of TRX (such as if viability is 
restored minimally at the cellular level). The isolation of MLL-AF4 and of MLL-AF9
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complexes will be required not only to further understand how MLL fusion proteins derail cell 
cycle control at the molecular and at the mechanistic levels, but also to unravel more precisely 
the relation between MLL fusion proteins and TRX during late Drosophila development.
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6.1 Insights into the mode of action for MLL fusion leukaemic proteins.
The use of Drosophila to study the direct actions associated with aberrant MLL 
proteins has unveiled a striking effect on fly viability by these protein fusions. As discussed 
in Chapter 2, MLL-AF9 and MLL-AF4 specifically induced late larval lethality. Unlike cell 
culture studies, the results reflected the effects conferred directly by MLL-AF9 and MLL- 
AF4 in an in vivo multi-cellular, chromatin environment. Analyses of animals expressing 
MLL-AF4 and MLL-AF9 revealed that only the presence of the fusion proteins was not 
sufficient to cause leukaemia as defined by over-proliferation of blood cells. This probably 
reflects the necessity for additional mutations, which is precluded by the lethality induced by 
MLL-AF9 and MLL-AF4. This is consistent with studies of mice harbouring the MLL-AF9 
transgene, which develop leukaemia with a latency of 4-12 months (Corral et ak, 1996). The 
monoclonality of these tumours indicated that additional mutations must occur before the 
appearance of leukaemia (Corral et al., 1996; Dobson et al., 1999).
Furthermore, the Drosophila system has addressed the ambiguity involved in the role 
MLL-AF4 and MLL-AF9 have on apoptosis. As introduced in Section 1.5.4, it is not clear 
the effect MLL fusion proteins have directly on programmed cell death. By generating cells 
expressing and not expressing MLL fusion proteins within the same time in development, a 
correlation between MLL fusion protein expression and apoptosis was unfounded. Thus, it is 
likely that the apoptosis observed in the mammalian system is an indirect consequence of 
MLL fusion proteins.
The finding that in Drosophila chromatin architecture is altered by MLL fusion 
proteins substantiates the previous notion that MLL fusion proteins somehow abrogate MLL 
function. In this respect, possibly, MLL fusion proteins mimic partial loss-of-function 
mutations for trx and MIL Since trx and MU act at the chromatin level, modulation of 
functional TRX/ MLL protein levels conceivably results directly in improper chromatin 
structures. As discussed previously in Chapter 4, loss of normal trx is associated with a 
striking accumulation of interphase and “prophase-like” nuclei. This phenomenon can be 
explained by the requirement of trx for the proper formation of higher order chromatin 
structure, prior to the onset of S phase (see Section 4.3.1). In this scenario, lack of functional
- 1 3 0 -
Overall discussion and perspectives
trx may disrupt proper chromatin formation of origins recognised by the pre-replication 
complex (pre-RC), and thus, prevent accessibility of the DNA replication machinery to 
origins (Fig. 6.1 A). In the leukaemic case, data from flies expressing MLL-AF9 and MLL-AF4 
indicate that MLL fusion proteins elicit the actions of histone modifying enzymes to alter 
higher order chromatin structures (see below). The fact that only MLL-AF9 generated 
aberrant mitotic figures and exhibited faster replicating cells, would suggest that MLL-AF9 
creates a more favourable DNA replication environment, by perhaps stabilising higher order 
chromatin structures, comprising the origins. This chromatin context would enhance pre-RC 
accessibility to origins, and consequently, a higher initiation of DNA replication occurs, or 
would reduce G2 phase, as reflected by the number of cells positive for BrdU mitotic figures 
(Fig 6. IB). The facts that the AT hooks at the N-terminus of MLL remain within the fusion 
protein and that these AT hooks have been implicated to interact with non-histone HMGs, 
suggest that MLL-AF9 may interefere with HMGs to create this chromatin context (Zhao et 
al., 1993; Khadake and Rao, 1997). However, since MLL-AF4 did not exhibit any significant 
chromosomal chromatin defect or affect DNA replication, this level of chromatin remodelling 
is minimal, if non-existent. Thus, it is more likely that the effect on DNA replication and on 
chromosomal abnormalities by MLL-AF9 is a consequence of modulated TRX function and is 
specific for this fusion protein. Notably, it is not excluded that MLL-AF9 induced lethality 
may also be independent of TRX function.
The disparity between MLL-AF4 and MLL-AF9 on DNA replication underscores the 
importance of the C-terminal partners and suggests that (i) the sole disruption of TRX/ MLL 
function is not sufficient to abrogate cell homeostasis and (ii) that the C-terminal sequences of 
MLL fusion proteins specify additional pathways, which are targeted by the chimeras. The 
AF9 C-terminal sequence may have a role in modulating DNA replication, whereas AF4 may 
be functionally responsible for regulating cell growth. The possibility that trx may regulate 
gene expression of components within the RAS/MAPK and/or PI3/PKB pathways, for 
example, by modulating Hox gene activity, is indicated by late trx lethal mutants, which 
display growth defect phenotypes similar to signal transduction mutants (Breen, 1999).
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Figure 6.1. Mode of action for MLL fusion leukaemic proteins. The evidence presented in this 
thesis demonstrates that TRX is required for the completion of late development in D ro so p h ila . 
Particularly, this novel function is distinct from TRX’s role as a maintenance factor in early 
embryogenesis, although similar mechanisms of epigenetic regulation are likely employed by TRX 
to regulate proper chromatin formation. This finding may account for the extensive number of 
mutated PcG and trxG members implicated in cancer, a process that occurs late in development. 
The model presented here speculates that TRX is required to ensure proper higher order chromatin 
structures necessary for pre-replication complex (pre-RC) binding. Under this condition, DNA 
replication is possible. In the case for MLL-AF9, MLL-AF9 appears to enhance the stability of 
higher order chromatin structures dependent on TRX, facilitating the accessibility of origins to pre- 
RC. In this scenario, DNA replication is favoured and not inhibited. The acceleration of DNA 
replication facilitates accumulation of secondary mutations, which would be necessary for cell 
transformation. MLL-AF4, on the other hand, does not exhibit aberrant mitotic figures, although 
rate of cell cycle divisions was observed to be elevated as in MLL-AF9. The fact that pairing defect 
on polytenes exists in MLL-AF4, suggests that MLL-AF4 also affects chromatin integrity, 
apparently at a milder level than MLL-AF9. The alteration in H3K9 méthylation pattern supports a 
role for MLL fusion proteins in modulating chromatin architecture and reinforces the importance of 
the histone code for cell homeostasis. An effect on the expression of H ox genes by trx  and 
consequently MLL fusion proteins, can not be excluded as an alternative and intriguing venue for 
deregulation. In this case, the lack or enhancement of replicating cells would be an indirect 
consequence of aberrant H ox gene expression. In addition, MLL fusion proteins may compromise 
other aspects controlling cell cycle progression, which exclude the DNA replication machinery. The 
model proposed centers around the lack of proper chromatin context, and considers the effects of 
abnormal chromatin conformations on cell functions, such as DNA replication.
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6.2 PcG/trxG members are important for the allowance of cell replication.
As discussed above, lack of replicating cells was observed in late trx mutants. In 
addition to its role in chromatin structure formation, conceivably, trx may also have a more 
direct influence on the replication machinery to halt the cell cycle. The connection between 
proteins required for mitosis and PcG members have already been reported (Lupo et al.,
2001). In the study, it was shown that barren, a non-SMC (structural maintenance of 
chromosomes) protein likely associated with condensin, was found to interact with 
polyhomeotic (Ph). Interestingly, mutants forph and barren both exhibit chromosome 
segregation defects. A more direct evidence of a PcG member interacting with DNA 
replication factors includes the interaction between cramped (Crm) and PCNA, which enables 
DNA polymerases to be processive (Yamamoto et al., 1997). In addition, the recent report 
that in orc2 mutants, HPl localisation is perturbed, demonstrates that DNA replication 
factors, such as 0RC2, are closely linked to chromatin regulators, such as HPl (Pak et al., 
1997; Huang et al., 1998). In this respect, it has been suggested that in addition to its general 
role in DNA replication, ORC is required for Drosophila heterochromatin assembly later in 
embryonic development (Huang et al., 1998; Shareef et al., 2001). Reciprocally, lack of HPl 
has been shown to induce telomeric fusion which may have a consequence on the ability of the 
DNA replication machinery to copy the genome, and thus lead to lethality at late Drosophila 
stages (Fanti et al., 1998). Intriguily, Drosophila AF 10 (the human homologue is a C-terminal 
partner of an MLL leukaemic fusion protein) was found to associate with HPl (Linder et al., 
2001). This association raises the possibility that the abrogation of the AFIO physiological 
function by MLL-AFIO leads to release of silenced target genes or that MLL-AFIO recruits 
HPl-mediated silencing to MLL target genes, which should be kept active.
Importantly, the modulation of Hox gene expression cannot be excluded as a possible 
venue through which trx regulates cell proliferation and/ or DNA replication. This possibility 
becomes more appreciable eonsidering that MU +/- mice displayed retarded growth and 
reduced B-cell population (Yu et al., 1995). Furthermore, in mammals several Hox genes, such 
as HoxA9 and HoxAlO, have been shown to influence proliferation of myeloid progenitors, and
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significantly, have induced acute myeloid leukaemia (Nakamura et ah, 1996; Bjomsson et ah, 
2001; Buske et ah, 2001).
6.3 MLL-AF4 and MLL-AF9 alter méthylation of H3K9.
Although MLL-AF4 and MLL-AF9 appear to target distinct pathways to cause larval 
to pupal lethality, probably as a function of their C-terminal sequences, MLL-AF4 and MLL- 
AF9 were found to alter the pattern of methylated H3K9. This result has special significance 
because it implies that MLL-AF4 and MLL-AF9, and thus possibly all MLL fusion proteins, 
may employ similar mechanisms to derail their associated pathways. In addition, the 
importance of the histone code as a regulatory mechanism is reinforced. Modifications in 
chromatin structure and consequently in DNA replication and cell proliferation, may underlie 
the leukemogenic effects of MLL fusion proteins. Interestingly, PML-RAR, an oncogenic 
protein associated with leukaemia, was recently reported to induce gene hypermethylation and 
silencing of target promoters by recruiting DNA methyltransferases (Di Croce et al., 2002). 
DNA méthylation has been shown to be dependent on histone méthylation of H3K9 (Tamaru 
and Selker, 2001), and therefore, méthylation of H3K9 may also be affected by PML-RAR, as 
shown here with MLL-AF9 and MLL-AF4. The recent demonstration that lack of 
hSUVAR39 activity induces defects in chromosome segregation and condensation is also 
clearly reminiscent of the effects described for trx and MLL fusion proteins (Peters et al., 
2001). This suggests that epigenetic proteins have a greater influence on the stability of 
chromatin throughout the cell cycle, and that chromatin context is likely to direetly influence 
cell proliferation as shown by the silencing of the cyclin E promoter by the recruitment of the 
SUVAR39H1 -HP 1 association by Rb (Nielsen et al., 2001). Indeed, the misregulation of the 
epigenetic integrity of chromosomal information might play a more important role in the onset 
of cancer than previously considered. In this respect, “epigenetic crosstalk” has been termed 
to describe the interplay by several chromatin regulators to establish correct epigenetic 
chromatin contexts (Ben-Porath and Cedar, 2001).
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6.4 Epigenetic regulators have a more prominent role in controlling the cell cycle.
Accumulation of data linking epigenetic regulation with cell cycle control over the 
recent years has clearly demonstrated the importance of epigenetic mechanisms in cell 
homeostasis. Epigenetic regulators are classically illustrated as modifiers of chromatin 
structure maintaining gene expression pattern during early embryogenesis. The finding that 
key elements (“nodal points”, see Section 1.1) contributing to the decision of whether a cell 
survives or dies, have been epigenetically modified, has uncovered a new pathway through 
which epigenetics function. A precedent in this respect is the well-established connection 
between Bmi-1, a PcG mouse homologue of Posterior sex combs (Psc), and ink4a-Arf, a cell 
cycle control gene. The work presented in this thesis has linked TRX mediated higher order 
chromatin structures with yet another vital pathway, DNA replieation. The implication of 
these results offers DNA replication as a pathway through which oncogenes may target, with 
the consequence that additional mutations required for completion of cancer formation is 
facilitated. In addition, aberrant DNA replication may have a more direct effect on the Rb- 
E2F proliferative control pathway, since it has been shown that dRb {Drosophila Rb) and 
dE2F {Drosophila E2F) complexes appear to regulate origins of DNA replication and that 
dRb-dE2F interacts with ORCl and 0RC2 (Bosco et al., 2001; Cayirlioglu and Duronio, 
2001). The importance of chromatin context in DNA replication is exemplified by the study 
demonstrating that positions of nucleosomes adjacent to origins by ORC is essential for 
initiation of replication (Lipford and Bell, 2001).
The work presented here introduced Drosophila melanogaster as an additional model 
system to study the functions directly associated with MLL fusion proteins. The use of 
Drosophila offers a flexible system through which mechanistic questions can now be clarified. 
Of great interest will be the elucidation of the components which are directly associated with 
MLL-AF4 and MLL-AF9. Are components of the DNA replieation maehinery targeted 
directly by MLL-AF9? Do MLL fusion proteins interact with mutants for other chromatin 
regulator proteins, such as HPl or SUVAR39, to partially alleviate their assoeiated lethality? 
Questions such as these are easier to answer in Drosophila since propagation of flies is not
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limited, and a large repertoire of mutants for several mitotic genes is available. In addition, a 
more profound characterisation between trx and MLL fusion proteins will be required to 
define precisely to what extent the lack of trx (and thus, MU) function and novel activities 
contributed by the C-terminal partner contribute to leukemogenesis. Already, MLL-AF9 and 
MLL-AF4 transgenic flies indicate that the C-terminal partner is crucial for the manifestation 
of the lethal phenotype and for the fusion protein’s specifieity in its interference of different 
pathways. Identification of these pathways through which MLL-AF9 and MLL-AF4 act in 
Drosophila, may also reveal the physiological roles of AF9 and AF4 in mammals, which to 
date are unknown. By subjecting staged mRNA isolated from MLL, MLL-AF9, and MLL- 
AF4 expressing animals onto microarrays, results would identify potential target elements 
modulated by the transgenic proteins. It is clear that Drosophila will uncover novel pathways 
through which MLL-AF4 and MLL-AF9 act. If the behaviour of MLL fusion proteins 
observed in the fly, remains conserved in mammals, a greater understanding of the role MLL 
and its C-terminal partners play in leukemogenesis will be achieved.
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7.1 Materials
7.1.1 Fly stocks
The following stocks were obtained from Bloomington, Indiana, USA, unless otherwise 
noted. Stocks were raised on standard fly food (10 L water, 80 g agar, 180 g dry yeast, 100 g 
soya-flour, 220 g honey, 800 g commeal, 24 g nipagin (methyl-4-hydroxybensoate; Merck), 
62.5 ml propionic acid (Sigma)) at 18 °C or 25 °C with 60-70% relative humidity.
Fly Stock Obtained from
Wild-type Canton S
w
trx
trx
trx
B(2;3)/ hs-P[lethal] 
armadillo Gal4/ CyO 
en2.4Gal4/ SM5, Cy 
GawB/ CyO 
Act5c-Gal4/ CyO 
hs-FLP
Ay-Gal4 [Act5c-FRT-yellow-FRT-Gal4]
daughterless-Gal4
V2
V37
MZ1580 
gem/ CyO 
elav Gal4 
p52A/ CyO
P. Becker (Adolf-Butenandt-Institut, Universitat München)
T. Breen (Southern Illinois University, US)
T. Breen (Southern Illinois University, US)
G.Merdes (ZMBH, University of Heidelberg, Germany)
J.Dura (CNRS, Montpellier, France)
A.Brand (Wellcome/CRC Institute, Cambridge, UK) 
A.Brand (Wellcome/CRC Institute, Cambridge, UK) 
A.Brand (Wellcome/CRC Institute, Cambridge, UK)
F.Sauer (ZMBH, University of Heidelberg, Germany)
G. Merdes (ZMBH, University of Heidelberg, Germany) 
G. Merdes (ZMBH, University of Heidelberg, Germany)
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Antigen Source Obtained from
FLAG mouse Sigma
Phospho-H3 rabbit Upstate Biotech
TRX rabbit this work
Pc mouse A. Franke (ZMBH)
BrdU rat Harlan Sera Laboratories
MLL (#169) rabbit E. Canaani (Weizmann Institute, Israel)
AF4 mouse E.Canaani (Weizmann Institute, Israel)
me-H3K9 rabbit T. Jenuwein (Research Institute of Molecular Pathology, Austria)
a-rabbit Cy3 goat Dianova
«-mouse Alexa 488 goat Molecular Probes, Inc
«-rat Cy3 goat Dianova
«-rabbit HRP goat Amersham Life Sciences
«-Fluorescine rabbit TUNEL assay kit (Roche)
7.1.3 Bacterial strains
The following bacterial strains were used to clone appropriate constructs or to express 
proteins as indicated in the Methods section.
E. coli 
strains
Genotvne Practical Use
C600 thi-1, thr-1, leuB6, lacYl, ton A ll,  sup E44, mcrA TRPE-TRX protein expression
BL21
(DE3)
F", ompT, hsdSs, (rs-, mg.), dcm, gal, 7,{DE3} GST-HIS-TRX protein expression
DH5-« F’/endAl, hsdR17(rLmk^), supE44, thi-1, recAl, gyrA, 
(Naf), relAl, A(lacZYA-argF)ui69 (jt801acZAM15)
All pUAST cloning
JC8679 F thr-1 leuB-6phi-1 lacYl galkl ara-14 xyl-5 mtl-1 proAl 
his-4 argES rpsLSl tsx-33 supE44 recBll recC ll sbcA23 
his-328 lambda’
ET cloning
139-
Materials & Methods
7.1.4 Plasmid vectors
The pATH III vector (Koemer et ah, 1991), harbouring the 2388-2674 residues of 
TRX, was a gift from P. Harte (Case Western Reserve University, Cleveland, OH). TRPE- 
TRX fusion protein expressed from the pATH III vector was used to immunise rabbits for 
antibody production. The subcloning of the TRX sequence into the pGEX-4T3 vector 
(Pharmacia Biotech) allowed purification of specific TRX antibody pools. Both the pATH III 
and the pGEX-4T3 vectors are ampicillin resistant.
pUAST vector consists of a series of 5 Gal4 binding sites, juxtaposed to the hsp70 
minimal promoter, followed by the multiple cloning site and the terminal sequence of SV40, 
and is selected with ampicillin (Brand and Perrimon, 1993). MLL, MLL-AF9, and MLL-AF4 
cDNA sequences were cloned into pUAST for generation of transgenic lines. Detailed 
description is found in the "DNA Constructs" section in Methods.
7.2. Methods
7.2.1 Generation of affinity pure TRX antibodies
Expression and isolation of TRPE-TRX protein for antibodv production.
The TRX residues, spanning 2388-2674 of the TRX sequence, was expressed as a 
fusion protein with TRPE. The pATH III TRPE-TRX vector was transformed into the 
expression E.coli C600 strain. Colonies were picked and grown overnight in standard LB 
medium containing 100 pg/ml ampicillin. Overnight cultures were diluted 1:2 in fresh M9 
medium (0.5% Casamino acids, lOpg/ml thiamine) supplemented with tryptophan (20p,g/ml) 
and with ampicillin (100 pg/ml) to a final volume of 10 ml. Cells were allowed to grow with 
vigorous shaking at 37 °C until an O.D. of 0.2-0.4 was reached. The 10 ml culture was then 
poured into 100 ml M9 medium supplemented only with ampicillin, incubated at 37 ®C for 1.5 
hours, and subsequently induced with lAA (indoleacrylic acid; 2.5 mg/ml in 95% ethanol) at
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10 pig/ml final concentration. After an additional growth of 4 hours with vigorous shaking at 37 
cells were harvested in two 50 ml Falcons by centrifugation at 3000 g for 5 minutes.
Extraction of the induced fusion protein was performed as follows. The harvested cells 
were washed in 50 ml 10 mM Tris pH 7.5, were pelleted again, and were resuspended in 20 ml 
10 mM Tris pH 7.5, 5 mM EDTA. To lyse the cells, lysozyme at a concentration of 3 mg/ml 
was added to the resuspended solution, and the mixture was incubated on ice for 2 hours. 1.4 
ml of 5 M NaCl and 1.5 ml of 10% NP40 was added to minimise the number of aggregates, 
while sonication for 30 s at 350 W disrupted genomic DNA. The processed solution was 
centrifuged for 10 minutes at 9000 g. The soluble fraction was saved for later analysis on 
SDS-PAGE, while the pellet was further washed with 20 ml of 10 mM Tris-HCl pH 7.5, 1 M 
NaCl and with 20 ml of 10 mM Tris-Cl pH 7.5, and was finally resuspended in 1 ml 10 mM 
Tris-HCl pH 7.5. Both soluble and insoluble fi*actions were analysed on 10% SDS-PAGE 
protein gels. The remaining solutions were aliquoted and immediately stored at 
-80 T .
Purification of insoluble TRPE-TRX via electrophoresis.
To induced frozen pellets stored at -80 °C, large scale 10% SDS-PAGE electrophoresis 
was performed using BioRad PROTEAN II. Approximately 300 pil of protein pellet was 
loaded onto one gel, and the gel was run overnight for good protein separation. For 
visualisation of the proteins, the SDS-PAGE gel was incubated on ice for 30 minutes to 1 hour 
in ice-cold 250 mM KCl solution, previously kept on ice overnight. KCl allows the 
precipitation of proteins in gel at 0 °C; the precipitated proteins appear white in a black 
background. The desired protein band was excised, and diced to fine pieces to allow efficient 
recovery of the protein. The gel pieces were then placed on one side of an electrophoresis cup 
(Colora) filled with eluting buffer (12.5 mM Tris base, 12.5 mM glycine, 10 mM SDS), and 
elution of protein from the gel pieces was performed for 1.5 hours at 430 V, with occassional 
agitation every 15-30 minutes. As shown in Figure 7.1, protein migration is driven by 
electrostatic forces as the negative-charged, SDS coated protein, is attracted to the positive 
electrode. Around 200 p,l of eluted protein was recovered from the positive side of the
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electrophoresis cup. 200 p,l of PBS was used to wash the chamber and was added to the 
original eluted protein solution. The protein was then dialysed overnight at 4 °C with stirring 
against 10 mM NH4HCO3/ 10 mM SDS buffer using three changes over 24 hours. The 
dialysed protein solution was stored at -80 °C. A 10 pi aliquot of this protein solution was 
run on 10% SDS-PAGE gel to determine the extent of protein degradation, while protein 
concentration was determined by comparing the Coomassie stained band intensity against a 
series of known quantities of BSA. A 1:1 mixture of 250 pg of the eluted TRPE-TRX protein 
and of Freund’s Adjuvant (Sigma) was injected into rabbits for antibody production. The 
rabbits were boosted six times before bleeding.
protein migration
elution 
buffer ' eluted protein
electrophoresis
chambers
protein gel pieces
Figure 7.1. Purification of insoluble TRPE-TRX fusion protein.
The appropriate band corresponding to the TRPE-TRX fusion protein 
was excised from a large SDS-PAGE gel. The band containing the 
fusion protein, was cut to smaller pieces and was transferred to the 
electrophoresis cup. Elution buffer was filled in both the cup and the 
electrophoresis chambers to allow the migration of the negatively 
charged proteins toward the positive electrode. Around 200 pi of 
eluted protein was recovered.
Purification of rabbit serum for affinity purified TRX antibodies.
Affinity purified TRX antibodies were obtained by purifying the serum over a Protein 
A column, followed by denaturing and renaturing purification over a nitrocellulose blot. For 
this purpose, the TRX sequence, corresponding to 2388-2674 residues, was cloned into 
pGET-4T3 vector to prevent isolation of antibodies against the TRPE portion of the fusion
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protein used to immunise rabbits (as described in “Cloning and expression of GST-HIS-TRX 
fusion protein”).
To enrich for IgG antibodies, the serum was subjected to a first round of purification 
using Affi-Gel Protein A column (Biorad). 5 ml of Affi-Gel Protein A beads were transferred 
into a 25 ml column capacity (Biorad) and washed with 3 rounds of 20 ml PBS, with 20 ml 0.1 
M glycine, pH 2.8, and finally, with sufficient PBS until the pH was neutral. Washing steps 
were performed at a rate of 3 ml/min.
After equilibration of the Protein A column, 20 ml of undiluted serum was added to the 
column at a flow rate of 1 ml/min. The serum was allowed to run through the column 3 times. 
To eliminate unspecific protein binding to the column, PBS was run through the column until 
the OD280 reached less than 0.01. Elution of IgG bound to the column was performed with 20 
ml of 0.1 M glycine, pH 2.8. Thirty 1 ml aliquots were recovered, and to each aliquot, 50 pi 1 
M Tris pH 8.0 was added to obtain a neutral pH. An OD280 profile was obtained for the 
fractions. The fractions with OD280 higher than 1.0 were pooled and stored at -80 ®C.
Purified GST-HIS-TRX (as described in “Cloning and expression of GST-HIS-TRX 
fusion protein”) was allowed to bind to nitrocellulose blot at room temperature for 30 
minutes. The blot was washed excessively with PBS for 5 minutes, equilibriated with excess 
0.1 M glycine, pH 2.8, and neutralised with PBS for 10 minutes. The blot was then incubated 
with the pooled IgG pure serum (described above) overnight at 4 °C, washed twice with excess 
PBS for 10 minutes at room temperature, and finally eluted twice with minimal volume (10 
ml) of 0.1 M glycine, pH 2.8 for 10 minutes. To the recovered eluted antibodies, sufficient 
amount of 1 Ox PBS was added to a Ix PBS final concentration. The antibodies were 
lyophilised overnight and resuspended in 500 pi ddH20. The resuspended solution was then 
aliquoted, stored at -20 °C, and tested on polytenes (described in “Antibody staining of 
polytenes.”) and on nuclear extract (described in “Generation of nuclear extract”).
Cloning and expression of GST-HIS-TRX fusion protein.
Resides 2388-2674 of TRX was cloned into the pGEX-4T3 vector by restriction 
digestion of both pATH III TRPE-TRX and pGEX-4T3 with EcoR I and Sal I. After gel band
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elution, isolated bands corresponding to TRX (EcoRI/ Sal I) and to pGEX-4T3 (EcoRI/ Sal I) 
were ligated overnight to obtain pGEX-4T3-TRX construct. A HIS tag was introduced 
between the GST and TRX sequences for purification purposes by using the ET cloning 
method. As shown in Fig. 7.2, ET cloning uses the proteins recE and recT to specifically 
recombine a linear DNA fi-agment into a circular plasmid (Zhang et al., 1998). Homology arms, 
which span the amplified chloramphenicol gene, was designed against the GST sequences of 
the pGEX-4T3 vector. A Clal site was introduced to allow excision of the chloramphenicol 
marker while keeping the GST-HIS-TRX sequences in fi*ame (Fig. 7.2).
The ET reaction was performed as follows (Zhang et al., 1998). Cells constitutively 
expressing recE and reef (JC8679) were grown to an OD 28o of 0.4-0.5 in LB medium. The 
cells were then made electrocompetent by three rounds of harvesting (spins at 7000 rpm for 
10 minutes) and resuspending of cells with ice-cold water. Before the final spin, cells were 
resuspended with ice-cold 10% glycerol/water solution. Final resuspension used the remaining 
glycerol/water solution within the tubes after removal of excess glycerol/water. Co­
electroporation of 0.3 pmol PCR-amplified chloramphenicol fragment and 0.2 pmol pGET- 
4T3-TRX into 50 pi electro-competent ET cells (JC8679) was performed using Eppendorf 
Electroporator 2510 at 2000 V. Cells were recovered for 1.5 hours at 37 °C, and correct 
transformants were selected on LB plates supplemented with ampicillin (100 pg/ml) and 
chloramphenicol (12.5 pg/ml).
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A.
homologous regions
introducing a HIS tag
PCR fragment 
chloramphenicol gene + vectorpGEX-4T3-GST-TRX
recE/ recT
chloramphenicol
C la l
C la l
Cla I digest
in-frame HIS tag
pGEX-4T3-GST-HIS-TRX
B.
5’ Primer: 5’ TAA TGT GTG GAA TTG TGA GCG GAT A AC A AT TTC AC A
CAG GAA ACA GTA TTC ATG ate acc ate aee ate aca teg atto aat aaa tee tgg tgt eee tgt 3’
3’ Primer: 5’ TCG AGT GGG TTG CAC AAG GCC CTT AAT TTT CCA ATA ACC
TAG TAT AGG GGA ate gat tta ege eee gee etg eea ete ate g  3 ’
Figure 7.2. Modification of pGEX-4T3-TRX by the ET cloning method.
(A) recE and recT allow faithful recombination between two pieces of DNA at a 
desired location via homologous recombination (reviewed in Muyrers et al., 
2001). ET cloning was used to introduce a HIS tag between the GST and the 
TRX protein sequences. Chloramphenicol was used as a selection marker, and 
was designed to be excised by Cla 1 digestion. (B) Primers used in the ET 
cloning reaction. Capital letters: 5’ GST sequence of pGEX-4T3, 3’ TRX 
sequence corresponding to 2388-2404 residues; bold letters: Cla I site; 
italicised letters: homologous sequence against the chloramphenicol gene used 
for PCR.
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GST-HIS-TRX was expressed by treating cells with IPTG (isopropyl-p-D- 
thiogalactopyranoside). Cells, diluted 1:10 from overnight cultures, were growth for 2 hours at 
37 °C. To the growing cultures, IPTG was added to the final concentration of 1 mM. Cultures 
were incubated at 37 °C with vigorous shaking for an additional 3 hours. Cells were harvested 
by centrifugation at 5000 g for 30 minutes.
To purify the insoluble GST-HIS-TRX protein, pellets were resuspended in 50 mM 
Tris pH 8.0, 1 mg/ml lysozyme (5 ml buffer per 30 ml culture), and incubated for 30 minutes 
at 30 °C. The resuspension was equilibriated with Triton-X to a final concentration of 0.1 %, 
and sonified for 10-15 seconds. The cell extract was spun at 20000 g for 15 minutes, and 
pellets resuspended in 5 ml Binding buffer (20 mM Tris pH 7.9, 0.5 M NaCl, 5 mM 
imidazole, 8 M Urea) per 30 ml culture. Rotation for 1 hour at room temperature dissolved the 
pellet containing GST-HIS-TRX. The protein solution was again centrifuged at 39000g for 20 
minutes to remove any insoluble debris. The supernatant was added to pre-equilibriated Ni^ "^ - 
NTA beads (Quiagen), and the resulting slurry solution was rotated for 1-2 hours at room 
temperature. The bead-protein mixture was poured into a column. The colunm was washed 
with 10 column volumes of Binding buffer and with enough Wash buffer (20 mM Tris pH 7.9, 
0.5 M NaCl, 60 mM imidazole, 8 M Urea) until OD280 was less than 0.01. GST-HIS-TRX 
protein was eluted with a solution of 20 mM Tris pH 7.9, 0.5 M NaCl, 1 M imidazole, 8 M 
Urea. The eluted protein was analysed on 10% SDS-PAGE gel and used for affinity antibody 
purification as described above.
Generation of nuclear extract
2 g of dechorionated embryos from overnight lays was transferred into a glass 
homogeniser containing 8 ml of buffer B (15 mM Hepes pH 7.6, 10 mM KCl, 5 mM Mg CI2, 
0.1. mM BDta, 0.5 mM EGTA, 1 mM PMSF, 1 mM DTT, 2 pg/ml leupeptin, pepstatin, 
aprotinin). The embryos were homogenised with Pestle A, and filtered through Miracloth into 
30 ml Corex tubes. The cloth was washed with 5 ml buffer B, and the resulting mixture 
centrifuged at 2000 g for 10 minutes at 4 ®C. The pellet was resuspended in 4 ml buffer B and 
layered on 1:1 v/ v cushion of buffer B-0.8 M sucrose. After spinning for 10 minutes at
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10,000 g using a swing-out rotor, the supernatant was discarded, and the pellet resuspended in 
2 ml of buffer B-150 mM KCl. 220 pi of 4 M ammonium-sulphate, pH 7.6, was added, and 
the mixture was incubated on ice for 15 minutes. The solution was spun for 1 hour at 33,000 
g using Beckman SW55Ti rotor. The supernatant was recovered, and proteins were 
precipitated by adding 0.3 g/ml ammonium sulphate. After 15 minutes spin at 15,000 g at 4 
°C, the nuclear protein pellet was resuspended in 300 pi Buffer C (25 mM Hepes pH 7.6, 100 
mM KCl, 0.1 mM EDTA, 1 mM DTT, 0.5 mM PMSF, 10% glycerol).
7.2.2 BLAST analyses for Drosophila homologues of the human AF9 and the human 
AF4 proteins.
Full-length protein sequence of the human AF9 (Accession Number (Pubmed):
L I3744) and the human AF4 (Accession Number (Pubmed): L13773) proteins were obtained 
fi*om NCI Pubmed database. Protein sequences were submitted for BLASP analysis against 
the predicted protein sequences in the available database from the Berkley Genome Sequence 
Project. Significant matches (i.e. lowest probability against random sequence analysis P(N)) 
indicated that homologues of AF9 and AF4 exist in Drosophila melanogaster (see Figure 2.2).
7.2.3 Generation of transgenic fly lines.
DNA constructs
The appropriate cDNA constructs were cloned into pUAST through a series of PCR 
amplification and ligation steps. Correct cloning of sequences was monitored after each 
PCR/ligation round by sequencing. The full-length MLL cDNA was cloned into the EcoRI site 
of the pUAST vector. The fusion MLL-AF9 construct consist of the first 4086 nucleotides 
from the MLL cDNA juxtaposed to 1432-1704 nucleotide sequence from the AF9 cDNA.
The MLL-AF9 fusion construct was cloned into the EcoRI site of pUAST. Additionally, 
both the MLL and MLL-AF9 construct contains a FLAG epitope (GAC TAG AAG GAC 
GAC GAT GAC AAG) 3’ to the end of the cDNA sequence. The MLL-AF4 construct
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includes the first 4218 nucleotides of the MLL cDNA sequence fused in frame to the 1041- 
3633 nucleotides from the AF4 cDNA sequence. The MLL-AF4 construct was cloned into 
the Xho I and Xba I sites of pUAST and can be released by double digestion with Xho I and 
Nhe I.
Transformation of w^ ^^  ^with pUAST constructs.
The appropriate pUAST constructs (300 ng/pl, described in "DNA Constructs") were 
coinjected into w^ *^  ^embryos with the helper DNA pUChsjtA2-3 (100 ng/pl). Embryos were 
recovered from 30 minutes egg lays at 25 °C. The embryos were transferred to 18 °C, were 
dechorionised with a 1:5 dilution of bleach (14%)-water solution, and then were washed 
extensively with water until bleach odor was no longer detectable. Around 70-100 embryos 
were lined on 16% agar plates and were transferred onto a double-sided sticky tape on a 
coverslip. The embryos were dehydrated in a closed chamber containing Silica gel for 7 
minutes and then covered with Voltalef 10 S oil (Lehmann & Voss & Co.). Microinjection of 
the pUAST/helper DNA solution into embryos was performed using the Eppendorf FemtoJet 
microinjector. Larvae from injected embryos were collected into standard fly food and allowed 
to develop. Eclosed flies were crossed to w^ ^^  ^virgins or males; progenies were then scored 
for pigmented eyes. At least 5 different independent transformants were kept as stocks, and 2 
lines were selected for experiments.
7.2.4 RT-PCR & Western Blot Analysis
RT-PCR (Reverse-Transcription PolyChain Reaction) and Western blot analysis were 
employed to verify that the desired proteins were expressed when GAL4 was present.
For detection of specific mRNA, 10 mg worth of heads from appropriate transgenic fly 
lines was attained. Process of tissue samples was performed aceording to instructions in the 
Invitrogen’s SNAP Total RNA Isolation kit. Primers used for detection of specific mRNA are 
the following: 5’PRIMER: 5’ GTG ACT CTT GGG GAT ACA ACA GCT GTC 3’;
3’PRIMER: 5’ GTC CAC CAC GTT CTT CAC AAC ACT GCT 3’. These primers should 
amplify a 900 bp fragment corresponding to the sequence of 2842-3717 of MLL cDNA.
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For detection of appropriate proteins, imaginai discs were isolated from 20 larvae and 
homogenised in IxSDS buffer. The extract was then boiled for 10 min, and loaded onto 5% 
SDS-PAGE gels. The protein contents from the SDS gel was transferred onto nitrocellulose 
membrane (Hybond™ECL™) overnight at 100 mA, using the 0.0037% SDS, 39 mM glycine, 
48 mM Tris, 20% methanol Transfer Buffer. Nitrocellulose blots were then processed with 
a-MLL N-terminal rabbit antibodies overnight at 1:1000 dilution in 0.2% Tween-20/PBS, at 4 
®C, followed by 2 times 15 minutes washes with 0.2% Tween-20 /PBS, and incubated with 
HRP conjugated secondary antibodies against rabbit (1:5000) for 1 hour at room temperature. 
After washing the pellet 3 times with 0.2% Tween-20/PBS for each 10 minutes, signals were 
detected according to instructions from ECL™ (Amersham Pharmacia Biotech). Namely, the 
blot was precisely incubated for 1 minute with a solution of 1:1 volume of solution 1 and of 
solution 2. Excess liquid was removed, and the processed blot was sealed in plastic to prevent 
drying out. Films were immediately placed on the sealed blot for signal detection.
7.2.5 Phenotypic analyses of transgenic fly lines with various GAL4 driver lines.
To determine the effect expression of MLL, of MLL-AF9, and of MLL-AF4 has on 
fly development, virgins from transgenic lines were crossed to males from several Gal4 driver 
strains. Crosses were kept at 18 °C, 25 °C, or 29 °C. Progenies were then scored for the effect 
the trangenic proteins have on fly development.
7.2.6 Generation of transgenic lines in a double trx mutant background.
To determine if expression of MLL can functionally rescue trx mutant phenotypes, 
appropriate trx alleles {trx^^^ ,^ trx^^^), and transgenic fly lines or Gal4 driver strains, were first 
balanced over B(2;3), and then crossed to one another to generate a stable stock consisting of 
the following genotype: transgenic fly line/ Gal4 driver strain; trx allele/ B(2;3). Rescue of the 
embryonic or larval lethality associated with the trx mutant background was monitored upon 
expression of appropriate transgenic proteins with various Gal4 driver lines.
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7.2.7 Isolation of the hemolymph and hemocyte counts from Drosophila transgenic 
lines.
Larvae expressing transgenic protein by using the blood Gal4 driver line, MZ1580, was 
washed in 100% ethanol and dried on filter paper. Using 5c forceps (Sigma), the cuticle was 
carefully opened to avoid breaking fat bodies. The hemolymph was allowed to accumulate 
around the larval carcass. Using a 20 pl-micropipettor, the hemolymph, which varies from 0.2- 
0.5 pi, was collected, and was transferred to a hemocytometer, which had been covered with 
minerol oil. The coverslip was dropped on top of the sample and cells were counted for six 50 
pm X 50 pm (according to the laboratory of S. Govind, City College, New York, NY). The 
number of hemocytes per pi was determined by using the following formula: the number of 
hemocytes/ (1/ 0.024 mm^).
7.2.8 TUNEL assay of imaginai discs
Clones which express MLL, MLL-AF4, or MLL-AF9 were generated by heat- 
shocking first instar larvae for 1 hour at 37 °C. Larvae were recovered at 25 ®C. Imaginai discs 
from developed third instar larvae were isolated and subjected to the TUNEL assay (In Situ 
Cell Death Detection Kit, AP from Roche). Briefly, imaginai discs were fixed with 4%
PFA/PBS for 20 minutes on ice, were washed 3 times 5 minutes with PBS, and were 
permeabilised in 0.1% Triton X-100/ 0.1% NaCitrate/PBS. After two times PBS washes, 
apoptotic cells in imaginai discs were labelled with the TUNEL reaction mix for 1 hour at 37 
°C. Again, the labelled imaginai discs were washed 3 times with PBS for 5 minutes.
Antibodies against Fluorescine (1:80) were incubated with the imaginai discs overnight at 4 ®C. 
The imaginai discs were washed with PBS, and incubated with a secondary antibody (a- 
rabbit-Cy3) for signal amplification. After PBS washing, the discs were mounted in Mowiol.
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7.2.9 Brain & polytene squashes
Detection of metaphase spreads from brain squashes by DAPI staining.
To detect mitotic figures, two brains were isolated in 0.7% NaCl. The brains were then 
transfered onto poly-L-lysine (PLL) slides, and incubated for 30 sec in 45% Acetic Acid/PBS 
followed by a 3 minutes incubation with 60% Acetic Acid/PBS. A freshly cleaned cover slip 
was gently placed on top of the brains. Between two layers of Whatmann paper, the brains 
were squashed without moving the cover slip. Slides were immersed in liquid nitrogen, and 
cover slips flicked off. Subsequently, slides were dehydrated in two consequetive steps with 
70% EtOH followed by 100% EtOH for each 3 minutes. To overnight air-dried slides, 
rehydration in PBS was performed for 2 minutes, followed by 5 minutes DAPI (200 ng/ml) 
staining. Slides were allowed to drain fi*om excess PBS solution and mounted in Mowiol.
Colchicine and hvpotonic treatments of brains.
Immediately after isolation of intact whole brains, brains were either treated with 10'  ^
M colchicine solution dissolved in PBS for 1.5 hours at 25 °C, or were directly processed in 
the following way. 0.5% citrate solution was used to hypotonic treat the brains for 7 minutes. 
Colchicine treatment halts cell cycle progression at metaphase while hypotonic treatment 
separates sister chromosomes.
Phospho-H3 labelling of squashed brain preparations.
Phospho-H3 is used as an indicator for replicating cells, since histone H3 is 
phosphorylated during mitosis. For staining of brain squashed preparation with histone H3, 
the brain squash protocol (described in “Detection of metaphase spreads from brain squashes 
by DAPI staining”) was modifed in the following manner. Isolated brains were transferred into 
a drop of 25% acetic acid/PBS and squashed as described above. The squashed preparation 
was then incubated for a further 5 minutes. After removal of the cover slip with liquid
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hydrogen, slides were washed in PBS for 2 minutes and then fixed in 4% PFA/ 45% acetic 
acid/ PBS solution for 10 minutes. Subsequently, the slide was washed in 0.1% Triton/ PBS 
(PBS-T), blocked for 1 hour in fresh 3% BSA/PBS blocking solution, and incubated overnight 
with 1:500 dilution of phospho-H3 antibodies. The slide was washed three times with PBS-T 
for each 5 minutes, and then incubated for 1.5 hours with secondary antibodies at a dilution of 
1:200 (rabbit Alexa 488). Again, the slides were washed with PBS-T three times at each 5 
minutes. DAPI staining and mounting were then performed as described previously.
BrdU labelling of brains in vitro and in vivo.
At least 4-5 whole brains were dissected from appropriate fly lines, and incubated in 
0.1 mg/ml BrdU dissolved in 0.7% NaCl, for 1.5 hours at 25 °C. The brains were then rinsed 
with PBS and permeabilised for 10 minutes using 0.1% Triton-X/PBS (PBS-T). A 4% 
paraformaldehyde-PBS solution was used to fix the brains for 20 minutes. After rinsing with 
PBS-T for 5 minutes, the brains were incubated in 2 N HCl for 30 minutes at room 
temperature, followed by a 10 minutes PBS-T wash. The brains were blocked with 0.3%
BSA in PBS for 30 minutes at room temperature, and then, incubated with 1:2 dilution of a- 
BrdU rat monoclonal antibodies overnight. Detection for BrdU labelling was performed with 
a-rat Cy3 secondary antibodies at 1:200 dilution, while nuclei were stained with DAPI (200 
ng/ml).
For in vivo labelling of brains with BrdU, larvae were fed with a mixture of 1 g 
Drosophila Instant food (Sigma) and of 100 mg BrdU dissolved in 2 ml water. Red food 
coloring was added to allow detection of ingested third-instar larvae. Brain squash and 
detection of BrdU were then performed.
Orcein staining of polvtenes and brain squashes.
Salivary glands and brains were isolated in 45% acetic acid/PBS. The tissue was 
transferred to a drop of 1 N HCl and incubated precisely for 1 minute. The tissue was then 
washed with 50% lactic acid/ 30% acetic acid, was stained for 10 minutes with orcein (2% 
orcein/ 30% lactic acid/ 30% acetic acid), and was rinsed with 45% acetic acid. A clean
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coverslip was then placed on top of the tissue. After brain squashing, the slides were sealed 
with nail polish.
Antibodv staining of polytenes.
Two pairs of salivary glands were isolated in 0.7% NaCl and were transferred onto one 
poly-L-lysine (PLL) coated slide. The glands were incubated in 45% Acetic Acid / 5% fresh 
para-formaldehyde / ddH20 fixative for 10 minutes. Salivary glands were then squashed and 
were spread by gently moving the cover slip. Slides were immersed in liquid nitrogen, and 
coverslips flicked off. Slides were washed in PBS twice for 5 minutes, permeabilised for 10 
minutes in 1% Triton-X/PBS, blocked in a saturated solution of non-fat milk powder (blocking 
solution) for 30 minutes, and incubated with appropriate primary antibody dilution (mouse a - 
Pc 1:40, rabbit a-meH3K9 1:500, rabbit a-TRX 1:10; mouse a-FLAG (Sigma) 1:200) for 1 
hour at room temperature, followed by overnight at 4 °C. After washing three times with 
saturated solution of milk powder, slides were incubated for 1 hour with secondary antibodies 
(a-rabbit Alexa-488, 1:200; a-mouse Cy3, 1:500) at room temperature. Slides were rinsed in 
PBS, and washed for 15 minutes in 0.2% NP-40, 0.2% Tween 20-80, 300 mM NaCl, and in 
0.2% NP-40, 0.2% Tween 20-80, 400 mM NaCl solutions. If me-H3K9 antibodies were used, 
an additional 15 minutes washing step was performed with 0.2% NP-40, 0.2% Tween 20-80, 
500 mM NaCl solution. Finally, the slides were DAPI (100 ng/pl) stained for 10 minutes and 
were mounted in Mowiol.
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